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Abstract 
More than 20% of colorectal cancers are diagnosed following an emergency presentation in 
England, which is associated with poor survival. Little is known on the clinical circumstances 
surrounding emergency presentations and on the complex contribution of demographic, 
clinical and tumour factors. Such information is crucial to develop effective strategies for 
reducing emergency presentations, particularly among higher risk groups. 
In this thesis, I reviewed the literature on the role of comorbidities in influencing timely cancer 
diagnoses and used an epidemiological population-based approach to profile variation in risk 
of emergency presentations. Specifically, I examined the type and timing of symptoms, 
comorbidities and benign diagnoses prospectively recorded during the months or years pre-
cancer diagnosis using individually linked cancer registration, primary care and secondary care 
data on nearly 9,000 colorectal cancers diagnosed in England 2005-2010.  
The project revealed that emergency presenters have similar ‘background’ consultation history 
as non-emergency presenters. Their tumours seem associated with less typical symptoms, 
however one fifth of emergency presenters had consulted with typical alarm symptoms 
indicating opportunities for earlier diagnosis. Patients with proximal colon cancer had a higher 
risk of emergency presentations, despite having more frequent consultations with relevant 
symptoms, highlighting that tumour factors contribute to emergency presentations. ‘Serious’ 
comorbidities (diabetes, cardiac, respiratory diseases) diagnosed/treated in secondary care 
were associated with emergency cancer diagnosis, possibly because they might have 
distracted doctors and patients from prompt cancer investigations. The risk of emergency 
presentation was greater for women aged 40-59 years with gynaecological or recently 
diagnosed benign intestinal conditions, which might have provided alternative explanations.  
In conclusion, this thesis has contributed to the understanding of the distinct influence of 
patient (age, sex, comorbidities) and tumour/disease factors (type and timing of symptoms 
and tumour sub-sites) on the risk of emergency presentations, highlighting potential 
responsible mechanisms that can be targeted by future interventions. Greater integration 
between primary and secondary care, multidisciplinary diagnostic centers and novel 
technologies, such as quantitative faecal haemoglobin testing (FIT), might help to seize the 
opportunities for earlier diagnosis and reduce emergency presentations. 
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Chapter 1 –Backgrounds, aims and methods overview 
 
Background 
Cancer survival in the UK is poorer than in other European countries2. Despite some recent 
progress, diagnosis of cancer following an emergency presentation still occurs in as many as 
23% of colorectal cancers, with significant socio-economic inequalities. Emergency presenters 
have poorer survival3 4, even after controlling for stage at diagnosis5. The 12-month survival for 
colorectal cancer after emergency diagnosis is 50%, compared to more than 80% for non-
emergency cases6. Moreover, emergency presentations are associated with worse patient-
reported outcomes7 8 and quality of life and disruptions to hospital services9. Reducing 
emergency presentations could lead to more efficient and appropriate use of health services 
and improve health outcomes. It is an important public health target, considering the number 
of affected patients and their poor survival: among the 33,000 incident colorectal cancers 
diagnosed in England every year, 1 in 4, i.e. more than 8,000 patients/year are diagnosed as an 
emergency6. Diagnosing cancer earlier, improving outcomes and reducing socio-economic 
inequalities are among the priorities recently highlighted by the Independent Cancer 
Taskforce10 .  
However, there is a dearth of evidence on the clinical events preceding emergency 
presentations, and on the role played by patient, tumour and healthcare factors11. Such 
information is crucial to develop effective strategies for earlier diagnosis.  
Epidemiology of colon and rectal cancers  
Worldwide colorectal cancer is the third most common cancer and the fourth cause of cancer-
related death12. In the UK it is the 4th most common cancer (41,804 new cases in 2015), with 
71 and 56 new cases for every 100,000 men and women, respectively (male:female ratio 
13:10)13. Over the last decade the UK incidence rates have increased by 5%, possibly due to 
changes in risk factors and the introduction of the bowel screening programmes in the mid-
2000s13. Approximately 90% of colorectal cancers are diagnosed in people aged 50 and above 
and 44% of cases occur after age 7514.  
There are important gender differences regarding the anatomical site of colorectal cancers 
(figure 1): rectal cancers represent 32% of all colorectal cancers among men and 23% among 
women; on the other hand, the proportions of cancer of the caecum and the ascending colon 
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are higher among women (17% in the caecum and 10% in the ascending colon) than men (12% 
and 7%, respectively)13.  
Overall, 90% of colorectal cancers are adenocarcinomas resulting from malignant 
transformation of benign adenomatous polyps14, which have developed 10-15 years earlier. 
Polyps are present in 1/3 of the western population, but only 1-10% of cases become invasive 
cancer13 15.   
 
 
 
Figure 1: Distribution of colorectal cancers. Source: Cancer Research UK13 
 
Clinical presentation and diagnosis of colorectal cancer  
Clinical presentation  
The majority of colorectal cancers (90%) in England are diagnosed after symptoms have 
developed16. Patients might experience ‘abdominal’ symptoms (e.g. rectal bleeding, change in 
bowel habit) or systemic symptoms (e.g. weight loss)16-18. Often these symptoms can be due to 
benign conditions, making it difficult for patients and GPs to decide on the need for 
investigations17 19. For example, rectal bleeding is most frequently due to haemorrhoids 
(diagnosed in 19% and 17% of symptomatic men and women within 3 years from first 
symptom recording in primary care)20. 
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According to cancer patients the most common initial symptoms are change in bowel habit 
(43%), rectal bleeding (34%) or fatigue (23%), with 61% reporting a single first symptom and 
lower proportions reporting multiple symptoms17. Based on GP records, the most common 
symptoms presented in primary care are rectal bleeding (42%), abdominal pain (42%), 
diarrhoea (38%), weight loss (27%) and constipation (26%)16. The Positive Predictive Value 
(PPV) for these symptoms, among people aged 40 years or more, range between 2.4% for 
rectal bleeding and 0.42% for constipation16. Haemoglobin <10.0gdl-1 has been reported in 11% 
of colorectal cancer patients (PPV=2.3%). PPV values are higher if more symptoms are 
reported, if symptoms are reported repeatedly over time and for older patients20.  
 
Diagnosis of colorectal cancer 
For patients presenting with possible cancer symptoms the new NICE guidelines on cancer 
diagnosis21 22 encourage prompt testing and referrals and direct access to investigations. 
Urgent assessments (within two weeks) are recommended for patients with 'alarm symptoms' 
as indicated by the guidelines. However, many cancer patients present to primary care with 
non-specific symptoms and the best diagnostic strategy for these patients has not been 
established23 24 25.  
Based on the NICE guidelines colonoscopy should be offered to people with suspected 
colorectal cancer in case they have no major comorbidity, otherwise flexible sigmoidoscopy 
then barium enema should be offered. Computed tomographic colonography can be an 
alternative in specific centres. The NICE guidelines also highlight the importance of safety 
netting, defined as “active monitoring in primary care of people who presented with 
symptoms. It has two separate aspects: a) timely review and action after investigations; b) 
active monitoring of symptoms in people at low risk (but not no risk) of having cancer to see if 
their risk of cancer changes.”  
Thanks to screening, 10% of colorectal cancers in England are diagnosed before symptoms 
develop26 27. The population screening programme for colorectal cancer was introduced in 
England in 2006. It offers faecal occult blood test (FOBT) every 2 years to people aged 60-74 
(with an uptake of 56% among invited individuals16). In addition, in 2015 a bowel scope 
screening programme was rolled out in England as a one-off test for people aged 5528.  
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Diagnostic pathways and Emergency presentations  
Routes to Diagnosis 
The main routes to colorectal cancer diagnosis in England in 2013 include 30% via urgent GP 
‘two week wait’ referral (introduced in 2000 to allow GPs to refer suspected cancer patients 
urgently, so that they can expect to see a specialist within 2 weeks), 24% via routine GP 
referral, 24% as an emergency, 10% as a hospital in/outpatient, 10% via the national screening 
programme, 2% unknown29. The prevalence of emergency diagnosis is however markedly 
different for colon and rectal cancers (31% and 15%, respectively)30.  
This information is available thanks to the 'Routes to Diagnosis' project4 6 conducted by Public 
Health England, which allows to define one specific diagnostic route for each cancer diagnosed 
in England over the last decade. It is based on an algorithm, which relies on several routine 
inpatient and outpatient administrative data sources (Hospital Episode Statistics, Cancer 
Waiting Times, screening programme and cancer registration data) (see also 'Study population 
and data sources' and flowchart in Appendix for further details).  
 
Definition of emergency presentations  
The following overview on definitions and risk factors for emergency colorectal cancer 
diagnosis has been enabled by a recent in-depth review by Zhou et al.31 (with contributions by 
a group of authors, including myself) on emergency presentations for various cancers. 
Internationally, studies used different definitions of emergency diagnosis and a variety of data 
sources (figure 2)31. The majority of evidence has been provided by studies using 
administrative electronic health-records, with the Routes to Diagnosis data in England being 
the most extensively used; other studies relied on reviews of medical records. Definitions of 
emergency diagnosis range from a clinical definition (e.g. in case of life-threatening 
symptoms), to 'contextual' definitions (if emergency services were used) and definitions based 
on algorithms applied to electronic health-records31. According to the Routes to Diagnosis 
algorithm emergency presentations include patients diagnosed after they presented to an 
Accident and Emergency unit, those referred by their GP as an emergency and those who 
followed other in/outpatient emergency pathways. 
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Figure 2: Data sources and definitions of emergency presentations. Source: Zhou et al.31 
 
Frequency of emergency colorectal cancer diagnosis and trends over time 
A total of 18 studies, using population-based evidence, reported on emergency presentations 
for colorectal cancer, with the majority referring to the UK and the remaining referring to the 
USA, Sweden, Canada, France and Ireland31. Internationally between 14%32 and 33%33 of 
colorectal cancers are diagnosed as an emergency31. 
In England, emergency diagnoses accounted for 25% of colorectal cancers in 2006-2013 and 
they include the following emergency pathways: the majority (62%) of emergency colorectal 
cancer patients have presented to an Accident and Emergency unit, 28% have been referred by 
their GP as an emergency and 10% have followed other in/outpatient emergency pathways6.  
Emergency diagnoses have somewhat decreased in England over the last decade34, going from 
27% in 2006 to 23% in 20156. It is noteworthy that emergency presentations for rectal cancer 
have remained stable since 2006 (15%), with a slight decrease for colon cancers (from 35% to 
31%)30. The decrease suggests that modifiable patient and/or health-care related factors might 
be at play and that further reductions might be achieved in the future. It has been partially 
linked to the bowel cancer screening programme and other early diagnosis/cancer awareness 
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initiatives9 35. However, despite some encouraging findings based on ecological studies, there is 
a lack of longitudinal individual-level studies31.  
Overall, there is a dearth of population-based evidence on patient, tumour and healthcare-
related factors associated with emergency diagnosis and on whether and how emergency 
presentations could be prevented11 31. 
 
Healthcare, tumour and patient factors and the risk of emergency 
presentations 
Healthcare factors and health-care use 
Limited evidence is available on symptomatic presentations and healthcare use before the 
emergency diagnosis11 31. According to studies based in London36 and Exeter37 most colorectal 
cancer patients consulted their doctor during the pre-diagnostic months, often with non-
specific symptoms. Audits and patient interviews38 39 have provided insights into opportunities 
for earlier diagnosis, but are limited by their voluntary nature and participation bias. Multiple 
GP consultations before referral have been reported in 18% of colorectal cancer patients, 
which is associated with longer primary care intervals40. Presentations with symptoms of low 
predictive value (e.g. weight loss, diarrhoea) are associated with longer diagnostic intervals 
and a higher risk of emergency diagnosis36 37 41, however less than half of patients have GP 
records of typical alarm symptoms23 42.  
In one small study43 26% (10/39) of colorectal cancer patients, in 2002, had an emergency 
diagnosis while waiting for planned specialist appointments, suggesting that reducing waiting 
times might prevent some emergency presentations. A few studies44-46 reported that 
emergency presenters had less frequently investigations during the months before diagnosis 
(colonoscopy: 10% versus 63% among emergency and non-emergency presenters; abdominal 
imaging: 15% versus 61%)44. It is unknown whether investigations were for symptomatic 
presentation or screening. 
More frequent past secondary healthcare use among emergency presenters has been 
reported36 45 47, possibly related to comorbidities or higher use of emergency services because 
of personal preferences or barriers to primary care31. The latter explanation is supported by 
one US study, showing that patients with ‘preventable hospitalizations’ prior to colorectal 
cancer (possibly reflecting poor primary care access) were at higher risk of emergency 
diagnosis45. A UK study using the Quality and Outcomes Framework indicators, reported that 
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GP practices in England with better access and overall quality of clinical care had lower 
emergency diagnosis rates in 2007-201048. However, another study49 found no such 
association with continuity of care. 
Prior hospital visits might also represent missed opportunities to diagnose cancer earlier31. 
Based on a US study50 missed opportunities after symptomatic presentations can occur in as 
many as 20-30% of colorectal cancer diagnoses, a proportion which is higher in elderly 
patients, and those with comorbidities and from ethnic minorities50.  
 
Tumour factors 
Relatively few studies have examined colon and rectal cancers separately, even though the 
prevalence of emergency diagnosis is markedly different: 31% for colon and 15% for rectal 
cancers30 41 44 46 51. Such differences might be explained by distinct clinical presentations and 
different risks of obstruction/perforation. Emergency presentations are more frequent among 
recto-sigmoid cancers (16%) compared to rectal cancers (11%)52. There is mixed evidence on 
the risk for left- versus right-sided colon cancers45 46 51. 
According to several studies, emergency presenters are more likely to be diagnosed at 
advanced stage (Odds Ratio 1.28 to 4.8, p-values<0.05)31, possibly due to the longer time 
before diagnosis or due to different intrinsic tumours characteristics, with greater malignant 
potential of some tumours31. Similar considerations can also apply to tumour grade, with 
emergency diagnosis being associated with high-grade cancers (poorly 
differentiated/undifferentiated/anaplastic)31 52. 
 
Patient factors 
The risk of emergency diagnosis is higher for women30, older11 and more deprived people33 53, 
but the underlying mechanisms are not well understood. Differences in tumour characteristics 
(tumour site and type) or differences in help-seeking and/or inequalities in accessing 
healthcare services might play a role31. There is limited evidence on psychosocial factors, but 
unmarried individuals (reflecting possibly lack of social support) have increased risk of 
emergency diagnosis (OR 1.24; 95%CI 1.04-1.49)31 41 52.  
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Comorbidity 
There is a widely held belief that chronic morbidities (hereafter called comorbidities) influence 
the timely diagnosis of cancer and the risk of emergency presentations, but evidence on their 
effect and the underlying mechanisms is scant11 31 54 55. Patients affected by comorbidities are 
often considered to have a higher risk of emergency cancer diagnosis5 45-47 54 56. However, some 
studies reported a possible beneficial effect of comorbidity on earlier diagnosis. In a Swedish 
study the prevalence of hypertension was higher among non-emergency colon cancer patients, 
suggesting that regular visits for blood pressure management might have provided 
opportunities for earlier diagnosis55. Complex mechanisms are probably at play with 
comorbidities influencing patients' help-seeking, healthcare providers’ decision-making and 
access to healthcare services along the diagnostic pathways. They might act as barriers or 
facilitators for earlier diagnosis, depending on the type and severity of comorbidities and on 
the cancer symptoms characteristics57.  
 
Theoretical frameworks and study hypotheses 
According to the Model of pathways to treatment (figure 3)58, the process to diagnosis is 
dynamic, with ‘forward & backward movement’ and multiple possible pathways. The progress 
through diagnostic pathways is influenced by patient, healthcare and disease-related factors.  
A framework specifically addressing emergency cancer diagnosis (figure 4)31, incorporating 
aspects of the Model of pathways to treatment, suggests that emergency diagnoses can be 
divided into potentially avoidable ones and those that are mostly unavoidable. Unavoidable 
emergency presentations include cases presenting dramatically with minimal or no prior 
symptoms (due to non-modifiable tumour factors). Potentially avoidable cases include: a) 
patients who, despite having symptoms, delayed help-seeking due to psycho-social factors or 
healthcare barriers; b) patients who sought help but opportunities were missed due to atypical 
symptoms, deficiencies in investigations or other factors. Appropriate interventions addressing 
patient, doctors and healthcare system factors might reduce the subgroup of avoidable 
emergency diagnoses. The proportion of patients falling into each of the above categories is 
however unknown31 59 60.  
Figure 5 summarizes the cyclical processes leading from the initial appraisal and symptomatic 
presentation to an emergency or non-emergency diagnosis, following various possible 
pathways. It highlights how symptoms might evolve over time, with patients and doctors 
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having to re-evaluate them repeatedly. Taking these cyclical processes into account and 
considering the theoretical frameworks and available evidence, I hypothesised that for some 
patients initially presenting to primary care with symptoms, opportunities for earlier diagnosis 
might be missed and this might be associated with a higher probability of emergency 
diagnosis. I hypothesised that tumour, patient and healthcare factors might play a role. In 
particular, I evaluated the following hypothesis: A notable proportion of patients diagnosed 
with cancer as an emergency have primary care consultations with possible cancer 
symptoms prior to the cancer diagnosis and this could offer opportunities for earlier 
diagnosis. Such opportunities might vary by socio-demographic characteristics and they 
might be influenced by the presence of specific comorbidities.  
I used the Aarhus statement for the conduct of cancer diagnostic studies as reference for the 
present project61. 
 
 
Figure 3: The model of pathways to treatment. Source: Scott et al.58 
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Figure 4: Factors influencing emergency presentations. Source: Zhou et al.31 
 
 
 
Figure 5: Overview of the cyclical processes along the diagnostic pathways and factors 
influencing the diagnosis of colorectal cancer (CRC) as an emergency  
 
Screening 
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Aims and Objectives  
The project aims to identify opportunities for reducing emergency cancer diagnoses and 
provide population-based evidence that can inform policies and interventions for diagnosing 
cancer earlier. In particular, the project aims to evaluate primary care consultations and 
related symptoms preceding the cancer diagnosis and identify socio-demographic factors and 
clinical characteristics (symptoms and comorbidities) associated with an increased risk of 
emergency diagnosis, taking tumour sub-sites into account.  
Specific objectives: 
1. Examine primary care consultations before a cancer diagnosis and related symptoms, 
comparing patients diagnosed as an emergency with those diagnosed through non-
emergency routes, and identify opportunities for reducing emergency presentations.  
2. Evaluate the role of demographic factors in influencing consultation patterns, 
symptoms and diagnoses recorded before emergency and non-emergency 
presentations, evaluating possible reasons for inequalities and focusing on specific 
opportunities for reducing emergency presentations in women and men. 
3. Evaluate the role of comorbidities in influencing timely cancer diagnosis along 
diagnostic pathways and their impact on emergency presentations, examining possible 
opportunities for earlier cancer diagnosis in patients with comorbidities.  
 
Methods overview 
The project includes longitudinal data-linkage studies addressing each of the above objectives. 
It also includes a literature review on the role of comorbidities in influencing timely cancer 
diagnosis. The longitudinal studies are based on individually-linked cancer registration, primary 
and secondary care data on approximately 9,000 colorectal cancers diagnosed in England 
2005-2010. Taking advantage of the prospectively recorded linked data, I examined healthcare 
utilization patterns, symptoms and comorbidities recorded before emergency and non-
emergency cancer diagnosis. In addition to using conventional statistical methods for 
evaluating clinical and socio-demographic factors influencing emergency presentations, I also 
employed potential-outcomes or counterfactual approaches within the causal inference 
framework for determining comorbidity-specific effects at population level.  
The project includes the following studies addressing each of the above objectives: 
Objective 1-2: Consultation patterns in primary care and possible inequalities 
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Two longitudinal data-linkage studies are performed, based on cancer registration data 
individually linked to primary and secondary care data.  
 Study 1: Longitudinal data-linkage study examining consultation patterns in primary 
care and related symptoms 
 Study 2: Longitudinal data-linkage study on the role of demographic factors in 
influencing symptomatic presentations and possible inequalities in emergency 
cancer diagnosis 
 
Objective 3: The role of comorbidities in symptomatic presentations and emergency cancer 
diagnosis 
Two studies are performed: a critical review of the literature and a longitudinal data-
linkage study. 
 Study 3.1: A critical review on the role of comorbidities in influencing timely cancer 
diagnosis and emergency presentations  
 Study 3.2: Longitudinal data-linkage study on comorbidity-specific effects on 
emergency cancer diagnosis  
 
Ethical approvals 
The longitudinal data-linkage studies are part of a wider programme of work conducted within 
the LSHTM Cancer Survival Group and are covered by the following ethics approvals: 
a) ISAC-Protocol 08_031R and 16_011R_ISAC Evaluation of protocols for research involving 
CPRD data; 
b) Linkage of national Cancer Registry data to the CPRD CAG reference: PIAG 3-06(f)/2008. 
 
Longitudinal data-linkage studies: overview studies 1, 2, 3.2 
In line with the previously described research objectives, I have performed three longitudinal 
studies using individually linked cancer registration, primary care and secondary care data for 
colorectal cancer patients diagnosed in England between 2005-2010. In study 1 I examined 
patterns of symptomatic primary care consultations during the months and years before the 
cancer diagnosis, comparing patients diagnosed with colorectal cancer following an emergency 
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presentation with non-emergency presenters, in order to identify opportunities for reducing 
emergency diagnoses. In study 2, I examined the effect of demographic factors to identify 
possible inequalities in emergency cancer diagnosis. In Study 3.2 I evaluated the role of 
comorbidities in influencing emergency presentations.  
Using primary and secondary care records I analysed healthcare utilization patterns, symptoms 
and comorbidities recorded during the years pre-cancer diagnosis. In addition to focusing on 
the year immediately before the cancer diagnosis, earlier clinical records, up to 10 years pre-
diagnosis, were used to characterise each patient regarding his/her 'baseline GP consultation 
pattern' and 'baseline health profile' (comorbidity and symptom profile) before cancer onset. 
Historic records have also been used to classify symptoms and comorbidities in ‘new' versus 
‘chronic'. In addition to using conventional statistical methods, study 3.2 also employed 
potential-outcomes approaches for determining comorbidity-specific effects at population 
level. 
 
Study population and data sources 
Cancer patients in England are registered in the National Cancer Registry and I used this 
population-based data for identifying the study population. The study cohort includes 8,979 
patients with an incident colon or rectal cancer (ICD10 codes C18 and C19-C20, respectively) 
recorded in the National Cancer Registry in 2005-2010 with individually linked primary care 
data (from the Clinical Practice Research Datalink, CPRD), secondary care data (Hospital 
Episode Statistics, HES) and Routes to Diagnosis data62 63. Linkage procedures were agreed with 
CPRD. Inclusion criteria were: ages 18 years or over at cancer diagnosis, no previous cancer at 
any site and having at least one year of CPRD records prior to cancer diagnosis. I excluded 
records not meeting the CPRD quality criteria (e.g. ‘up-to-standard’ date). Patients with a 
previous cancer diagnosis merit to be examined separately, as their consultation and referral 
patterns are likely to be different from patients with no cancer history (e.g. due to higher 
cancer awareness and regular followed-up visits; their doctor might also have a lower 
threshold for referrals/investigations).   
The data sources used for the project are listed in table 1.  
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Table 1: Data sources and specific information used for addressing each research objective  
Data source Information Type of variable/use  Objective 
Cancer Registry (CAS) Incident colon/rectal cancers Study sample selection Objective 1-3 
 Date of diagnosis Covariate Objective 1-3 
 Tumour sub-site Covariate Objective 1-3 
 Age, gender, deprivation Covariates  Objective 1,3 
  Exposures Objective 2 
Routes to Diagnosis  Emergency cancer diagnosis Outcome  Objective 1-3 
CPRD Signs/symptoms in primary care   Exposures Objective 1 
  Covariates Objective 2,3 
 Comorbidity Exposures Objective 3 
HES Comorbidity Exposures Objective 3 
 
Clinical Practice Research Datalink  
The Clinical Practice Research Datalink (CPRD, previously known as GPRD) provides 
anonymised primary care data on over 11 million patients from 674 general practices in the 
UK. It is validated and extensively used for epidemiological research and is considered to be 
representative of the UK population20 42 49 62-66. CPRD included 4.4 million active patients in 
2013 (alive and currently registered with CPRD), representing 7% of the total UK population. In 
the UK, 98% of the population is registered with a GP and all patients registered with a GP 
practice taking part in CPRD are included in the dataset, unless they have specifically 
requested to opt out. English GP practices can take part in a data linkage scheme allowing to 
link patient-level information to other datasets. Currently 75% of English practices have agreed 
to linkage (representing 58% of all UK CPRD practices)65.  
The database includes medical information recorded during routine medical consultations by 
general practice staff using version 2 Read codes (a hierarchical clinical classification system 
comprising over 96,000 terms)65. CPRD includes prospectively recorded patient-level 
information on each episode of illness, symptom/signs occurrences, all significant clinical 
contacts, diagnoses, prescriptions, referrals and abnormal test results. 
The quality of the data is evaluated within CPRD and a patient-level quality measure is 
provided, based on registration status, valid age and gender; moreover, an “up-to-standard” 
date indicates for each practice when the data meets pre-defined quality criteria in over 80 
variables65. To reduce the risk of missing or inaccurate data I only included records meeting 
these criteria.  
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Routes to Diagnosis 
I used the routes to diagnosis data4 for defining emergency and non-emergency cancer 
diagnoses. The routes to diagnosis data (provided by Public Health England) has been 
extensively used for research and public health purposes4 5 29. It is based on an algorithm which 
relies on several routine inpatient and outpatient administrative data sources in order to 
define one specific route to diagnosis for each cancer patient in England. It works backwards 
through patient pathways to examine the events leading up to a cancer diagnosis. In order to 
define the end-point of the route it uses HES data to identify the specific inpatient or 
outpatient episode that is closest to the date of diagnosis and that led most immediately to 
diagnosis. Then HES data is further examined going back to the initial referral into secondary 
care. Subsequently, using screening and Cancer Waiting Time data, routes can be changed to a 
Screen Detected Route, if cases can be linked to screening activity, or to 'two week wait' 
urgent referral. Screen Detected Route takes priority over a 'two week wait' for those patients 
where both screening and 'two week wait' data are available. An Emergency Presentation 
route is assigned in those cases where the HES data shows that there was an Emergency 
Presentation and the admission date was within 28 days from the decision to treat date. For 
case where there is no HES activity during the six months before the date of diagnosis, the 
route is classified as Unknown or Death Certificate Only. 
 
Hospital Episode Statistics 
The Hospital Episode Statistics (HES) includes data on all contacts with English NHS hospitals 
(including hospital admissions, out-patient and emergency visits), coded using the 
International Statistical Classification of Diseases and Related Health Problems, 10th revision 
(ICD-10). HES provides data for administrative purposes and healthcare analysis, but it can also 
be used for research. Inpatient data has been collected since 1989 in England, while HES 
outpatient data is available since 2003.  
HES contains clinical, administrative, and demographic information about individual patients. 
The coding accuracy in HES for diagnosis codes is approximately 90%67 . Recent studies 
comparing comorbidity data from clinical notes with HES data in patients undergoing 
colectomy has shown good positive predictive values and specificity; however, sensitivity and 
negative predictive values are substandard, due to relatively large numbers of false negatives 
or missed cases in comorbidity codes in HES database68.  
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Linkage of datasets 
The present project used individually linked primary care data (CPRD), secondary care data 
(HES) and Routes to Diagnosis data62 63. Linkage was enabled by CPRD who provided a linkage 
file for deterministically linking primary care data and the CAS-Cancer Analysis System data 
provided by Public Health England, using a multistep approach based on unique 
pseudonymised patient identifiers. For each patient, cancer registration records were linked 
with his/her primary and secondary care records. According to recent reports, the linkage 
algorithm achieves 96% matching between CPRD and HES following the initial steps of the 
algorithm, with the remaining 4% of patients being matched thanks to the final steps69.  
 
Outcome, exposures and covariates 
Primary outcome: The outcome of interest for all studies included in the project is an 
emergency cancer diagnosis4 70, defined according to the Routes to Diagnosis algorithm as a 
cancer diagnosed following presentation to Accident and Emergency, GP emergency referrals 
or emergency pathways for in/out-patients (more details in the previous Routes to Diagnosis 
section). Non-emergency cancer diagnoses include routine GP referrals, two-week wait 
referral, inpatient elective/outpatient and screening5. 
Main explanatory variables: Explanatory variables for study 1 are signs/symptoms recorded in 
primary care before the cancer diagnosis. CPRD provides patient-level information on 
signs/symptoms and test results (e.g. iron-deficiency anaemia) recorded prospectively in 
primary care (details described in the CPRD data source section above). 
Based on the literature and guidelines21 36 42, I operationally defined relevant signs/symptoms 
that could prompt further diagnostic work-up for a possible colorectal cancer. Clinical experts 
reviewed the list and Read codes for relevant symptoms (e.g. rectal bleeding, change in bowel 
habits, anaemia) were identified and applied to CPRD records. I have further expanded the list 
using the Read code hierarchy to make it as comprehensive as possible.  
Covariates: Patient characteristics and tumour sub-sites are included as covariates. This allows 
taking the circumstances into account at which consultations and referrals are made.  
 Socio-demographic variables: age, gender, deprivation index. The Index of Multiple 
Deprivation (IMD)71 provides an ecological measure of deprivation for small areas in 
England. Each area is ranked according to an index (1 to 32,844), but quintiles are 
commonly used.  
 Tumour sub-sites: right or left colon, rectum, other sub-sites.  
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For study 2 demographic factors are considered as explanatory variables with a particular 
focus on gender. For study 3.2 the main explanatory variables are comorbidities recorded pre-
cancer diagnosis in primary and secondary care. Based on the literature I operationally defined 
a list of specific comorbidities that could influence the cancer diagnosis through different 
mechanisms. Read codes for each condition recorded before the cancer diagnosis (e.g. irritable 
bowel syndrome, gynaecological conditions) were identified and applied to primary care 
records referring to the 10 years pre-cancer. Moreover, an algorithm developed by the Cancer 
Survival Group has been used for identifying comorbidities recorded during hospital 
admissions in HES and referring to different pre-diagnostic time-periods72 73.  
 
Data analysis  
Descriptive analysis of emergency presentations 
Colon and rectal cancers are examined separately throughout. Socio-demographic 
characteristics, comorbidities and type and timing of symptoms preceding the cancer diagnosis 
are described by routes to diagnosis. Chi-square test and test for trend are used for univariable 
analyses.  
Multivariable and exploratory analyses (Objectives 1, 2, 3.2)  
 I modelled the association between emergency diagnosis and symptoms and 
comorbidities using multivariable logistic regression analysis, taking patient socio-
demographic characteristics, tumour factors and year of diagnosis into account. 
Interaction between the variables included in the final models have been examined. I 
performed stratified analyses by gender and age-groups.  
 I modelled the association between emergency diagnosis and consultation rates for 
relevant symptoms, using Poisson regression examining their variation with socio-
demographic characteristics and comorbidities. Random effects were added to 
account for patient-level clusters.  
 In addition, for study 3.2 I estimated the effects of specific comorbidities on the risk of 
cancer being diagnosed through emergency rather than non-emergency routes in the 
population of colon cancer patients using potential-outcomes or counterfactual 
approaches. When using observational data for estimating average effects in the 
population, traditional epidemiological methods can lead to biased results due to non-
comparability of examined groups. Potential-outcomes or counterfactual approaches 
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can overcome this limitation74-76 and are also valuable for primary care and public 
health research77. When examining complex factors, for which many possible 
interventions exist, it is challenging to estimate causal effects 78 and in such 
circumstances potential-outcomes are particularly useful to clarify the relevance of the 
issue under examination79-81 and critically consider the complex relationships between 
exposures and outcomes. 
Details on the analysis employed for each study are described in the subsequent chapters.  
Statistical analyses were performed using STATA statistical software (Stata Corporation, 
College Station, TX, USA). 
 
Power calculation: Among the approximately 9,000 colorectal cancers with linked records, at 
least 1,800 can be expected to be emergency diagnoses (20%). We can also expect at least 
1,620 colorectal cancer patients with a missed opportunity for earlier diagnosis (18%-33%)38 50 
and we hypothesise that this will occur more frequently among emergency than non-
emergency presenters. With an estimated 1,890 colon cancer patients having an emergency 
presentation (i.e. 30% among the estimated 6,300 colon cancers in our sample) and 405 rectal 
cancer patients with an emergency presentation (i.e. 15% among the estimated 2,700 rectal 
cancers) we can expect to have 80% power to detect a minimum RR=1.2 at the 0.05 level of 
significance for colon cancers and RR=1.4 for rectal cancers. The sample size and power are 
larger in the case of colon cancers, as their incidence and proportion of emergency 
presentations are higher30 31. 
 
Critical review on the role of comorbidities: overview study 3.1 
In line with objective 3.1, I have performed a critical review of the literature evaluating the 
evidence on the effects of comorbidities, overall and by specific type, on each step along the 
cancer diagnostic pathways to elucidate likely mechanisms through which comorbidities can 
influence timely cancer diagnosis. The review employed a systematic methodology, including 
extensive literature searches of quantitative and qualitative studies, systematic data extraction 
and quality assessment using the Mixed Methods Appraisal Tool82. A narrative data synthesis 
complemented quantitative findings. Studies were included if they provided information on 
the effects of comorbidities on the following outcomes: help-seeking for possible cancer 
symptoms, clinicians’ decision-making regarding investigations, time to diagnosis, cancer stage 
and emergency presentations. Integrating the available evidence and encompassing disease, 
patient, healthcare provider and system factors, I propose a conceptual framework illustrating 
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how pre-existing morbidities can facilitate or impede the diagnostic process influencing the 
timeliness of cancer diagnosis. 
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Chapter 2 - Patterns of pre-diagnostic symptomatic presentations: 
a longitudinal data-linkage study (Study 1) 
 
 
This chapter addresses the first objective of the thesis, i.e. to examine patterns of primary care 
consultations before a cancer diagnosis and related symptoms, comparing patients diagnosed 
as an emergency with those diagnosed through non-emergency routes, and identify 
opportunities for reducing emergency presentations. 
The work performed for this chapter resulted in a research paper published in the British 
Journal of Cancer1, which is included here. The chapter also provides an overview of the study 
background, objectives, methods, the main findings and a discussion of how the paper fulfils 
the objectives and possible implications for further research and practice. 
 
Background 
According to recent data, as many as 23% of colorectal cancers in England are diagnosed 
following an emergency presentation, which corresponds to more than 8,000 patients per 
year6. Emergency presenters have poorer survival3 4, even after controlling for stage at 
diagnosis5. The 12-month relative survival for colorectal cancer after emergency diagnosis is 
50%, compared to more than 80% for non-emergency cases6. Reducing emergency 
presentations could lead to more efficient and appropriate use of health services and improve 
health outcomes. It is considered an important public health target and is among the priorities 
highlighted by the Independent Cancer Taskforce10 and Public Health England Cancer Board 
Plan for 2017-202183. 
However, there is a dearth of evidence on symptoms and healthcare use preceding emergency 
presentations11. According to two previous studies based in London36 and Exeter37 most 
colorectal cancer patients consulted their doctor during the pre-diagnostic months, often with 
non-specific symptoms. Audits and patient interviews38 39 have provided insights into 
opportunities for earlier diagnosis, but are limited by their voluntary nature and participation 
bias. Only few studies have examined colon and rectal cancers separately, even though the 
prevalence of emergency diagnosis is markedly different (31% for colon and 15% for rectal 
cancer)84. A US study50 suggested that missed opportunities after symptomatic presentations 
can occur in as many as 20-30% of colorectal cancers, a proportion which might be higher in 
some sub-groups, such as the elderly. It is unknown whether similar figures also apply to 
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patients in England and what proportion of emergency cancer diagnoses are potentially 
avoidable.  
Population-based high quality cancer registration data linked with longitudinal primary and 
secondary care and ‘routes to diagnosis’ data can provide an in-depth understanding of clinical 
events preceding the diagnosis of cancer. This information is essential for developing 
appropriate strategies and interventions aimed at improving early cancer diagnosis and 
survival. 
 
Aims and Objectives 
The overall aims of the study are to identify opportunities for reducing emergency cancer 
diagnoses and provide population-based evidence that can inform policies and interventions 
for diagnosing cancer earlier and improve the quality of care and cancer outcomes.  
As described in the BJC publication1 the specific objectives are to examine patterns of primary 
care presentations with symptoms/signs potentially related to colon and rectal cancer during 
the months and years pre-cancer diagnosis. In particular, the study aimed to compare 
consultations patterns of patients with a cancer diagnosis following an emergency 
presentation with patients diagnosed after non-emergency referrals, taking socio-demographic 
factors into account, in order to identify opportunities for reducing emergency presentations 
and identify higher risk groups.  
 
Methods - Study sample and data sources 
In order to provide a population-level picture of symptomatic presentations during the months 
and years before emergency and non-emergency cancer diagnoses I used national cancer 
registration data individually linked to clinical data prospectively collected in primary care 
within the Clinical Practice Research Datalink (CPRD-previously GPRD). As described more 
extensively in the previous sections of the thesis, CPRD is particularly suited for the present 
study as it provides details on the medical history of patients, including prospectively recorded 
patient-level information on each episode of illness, symptom occurrences, all significant 
clinical contacts, diagnoses and abnormal test results. The work published in the BJC1 is based 
on linked cancer registration and CPRD/GPRD data for colon and rectal cancers diagnosed in 
2005-2006. This was the most recent cancer cohort with linked CPRD data initially available to 
me. Linked CPRD data referring to more up-to-date cancer cohorts became available during 
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the course of my PhD work and has been used for study 2 and study 3, which are also included 
in the thesis. 
 
Main results 
The research findings have been reported in the paper entitled “Do colorectal cancer patients 
diagnosed as an emergency differ from non-emergency patients in their consultation 
patterns and symptoms?  A longitudinal data-linkage study in England”, which was published 
in the British Journal of Cancer in 20161.  The findings have also been presented at various 
conferences (listed on page 10-11). 
The study has demonstrated the usefulness of linked cancer registration, ‘routes to diagnosis’ 
and primary care data for research on cancer diagnosis and emergency presentations and 
provided novel insights into patients’ consultation behaviour and symptoms preceding a 
diagnosis of colon or rectal cancer. Overall, among the study cohort, 35% of colon and 15% of 
rectal cancer patients had an emergency diagnosis, with women, older and more deprived 
individuals having a higher risk. Examining information on pre-diagnostic consultations 
referring to 5 years before the cancer diagnosis, the study findings refute the hypothesis that 
emergency presenters are a patient group with reduced access to primary care or a propensity 
to use primary care less often than non-emergency presenters. They have similar 'background' 
consultation rates (2-5 years pre-diagnosis) for any reason and for relevant symptoms as non-
emergency presenters until a few months before diagnosis. Only a small minority of patients 
(2.4% and 3.1% of colon and rectal cancers, respectively) never saw their GP the year pre-
diagnosis, with minimal differences between diagnostic routes. Consultation rates increased 
dramatically during the last months pre-diagnosis for both emergency and non-emergency 
presenters. Focusing on relevant symptoms (i.e. symptoms potentially related to colon or 
rectal cancer) has shown that the majority of patients had at least one consultation with a 
relevant symptom in the pre-diagnostic year (80% and 84% among colon and rectal cancers, 
respectively). However, the proportion of patients with at least one relevant symptom was 
significantly lower in emergency Vs non-emergency presenters, particularly when excluding 
the 30 days pre-diagnosis (colon: 48% Vs 71%, p<0.001; rectal cancers: 49%Vs 61%, p=0.043). 
‘Alarm’ symptoms (i.e. rectal bleeding, change in bowel habit, anaemia) were recorded less 
frequently in emergency presenters (e.g. rectal bleeding among rectal cancer patients: 9% Vs 
24% (p=0.002)). However, about a fifth of emergency presenters (18% and 23% for colon and 
rectal cancers) had records of GP consultations with 'alarm' symptoms the year before 
diagnosis, suggesting possible opportunities for reducing emergency presentations. 
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Multivariable logistic regression analysis has shown that the risk of emergency colon cancer 
diagnosis was lower for patients with a record of anaemia (OR=0.38; 95%CI 0.3 to 0.6), change 
in bowel habit (OR=0.47; 95%CI 0.3 to 0.9) or rectal bleeding (OR=0.22; 95%CI 0.1 to 0.4) in the 
period from 30 days to 12 months pre-diagnosis. On the other hand, emergency diagnosis was 
more likely in women (OR=1.37; 95%CI 1.0 to 1.8) and people aged 80 years or more (OR=1.84; 
95%CI 1.2 to 2.7), independently of symptoms. For rectal cancers, only rectal bleeding during 
the pre-diagnostic year was associated with a lower risk of emergency presentation (OR=0.25; 
95%CI 0.1 to 0.6), while socio-economic deprivation increased the risk independently of 
symptoms (e.g. most deprived category OR=3.47; 95%CI 1.5 to 8.0). 
 
Conclusions 
The study findings have shown that emergency presenters have similar ‘background’ 
consultation history as non-emergency presenters. During the months pre-diagnosis they 
consulted with less typical symptoms. Emergency presenters might more often have tumours 
with a dramatic clinical presentation and non-typical prior symptoms. Nevertheless, about one 
in five emergency presenters had primary care consultations with typical 'alarm' symptoms 
and 16% had 3 or more consultations with relevant symptoms, suggesting possible 
opportunities for earlier diagnosis.  
 
Fulfilment of the study objectives and implications for research and practice 
This chapter addresses the question whether colon and rectal cancer patients diagnosed as an 
emergency differ from non-emergency presenters in their primary care consultation patterns 
and symptoms. The study provided specific clinical insights for colon and rectal cancers 
regarding the pre-diagnostic period, highlighting variations in symptomatic presentations 
during the years before diagnosis. Strengths of the study include the use of prospectively 
recorded population-based data and the definition of emergency and non-emergency 
diagnoses according to validated methodologies.  
By simultaneously evaluating symptomatic presentations and patient socio-demographic 
characteristics, I have identified subgroups at higher risk of missed opportunities and 
emergency diagnosis, who could benefit from increased clinical and public health efforts. In 
particular, the findings underscore the importance of dedicating specific attention to patients 
consulting more frequently than usual, even if their symptoms are not immediately suggestive 
of cancer. Women, older and socio-economically deprived individuals are at higher risk, even 
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after taking symptomatic presentations into account, and therefore deserve specific attention. 
The research findings highlight the importance of closer interaction and easier access to 
specialist advice for GPs, and the importance of multi-disciplinary diagnostic centres. 
Moreover, systematic use of safety-netting and prompt specialist referrals and diagnostic 
investigations might help reduce emergency diagnoses for patients presenting with relevant 
symptoms.  
Further research is warranted to better understand why certain subgroups of the population 
(women, socio-economically deprived and older individuals) have a higher risk of emergency 
presentations. The role played by clinical and tumour factors potentially complicating the 
diagnostic process (including comorbidities and cancer sub-sites), as well as patient factors 
(e.g. missed follow-up visits) and healthcare factors (delays in diagnostic work-up, wrong 
diagnosis, previous investigations with normal/borderline results) would merit to be 
investigated in detail.  
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Do colorectal cancer patients diagnosed as an
emergency differ from non-emergency patients
in their consultation patterns and symptoms?
A longitudinal data-linkage study in England
C Renzi*,1,2, G Lyratzopoulos1,3, T Card4,5, TPC Chu6, U Macleod7 and B Rachet2
1Health Behaviour Research Centre, Department of Epidemiology and Public Health, University College London, WC1E 6BT
London, UK; 2Cancer Survival Group, Department of Non-communicable Disease Epidemiology, London School of Hygiene and
Tropical Medicine, WC1E 7HT London, UK; 3Cambridge Centre for Health Services Research, University of Cambridge, CB2 0SR
Cambridge, UK; 4Division of Epidemiology and Public Health, University of Nottingham, NG5 1PB Nottingham, UK; 5Nottingham
Digestive Diseases Centre Biomedical Research Unit, University of Nottingham, NG7 2UH Nottingham, UK; 6Division of Child
Health, Obstetrics and Gynaecology, University of Nottingham, NG7 2UH Nottingham, UK and 7Hull York Medical School,
University of Hull, HU6 7RX Kingston upon Hull, UK
Background: More than 20% of colorectal cancers are diagnosed following an emergency presentation. We aimed to examine
pre-diagnostic primary-care consultations and related symptoms comparing patients diagnosed as emergencies with those
diagnosed through non-emergency routes.
Methods: Cohort study of colorectal cancers diagnosed in England 2005 and 2006 using cancer registration data individually linked
to primary-care data (CPRD/GPRD), allowing a detailed analysis of clinical information referring to the 5-year pre-diagnostic period.
Results: Emergency diagnosis occurred in 35% and 15% of the 1029 colon and 577 rectal cancers. ‘Background’ primary-care
consultations (2–5 years before diagnosis) were similar for either group. In the year before diagnosis, 495% of emergency and
non-emergency presenters had consulted their doctor, but emergency presenters had less frequently relevant symptoms
(colon cancer: 48% vs 71% (Po0.001); rectal cancer: 49% vs 61% (P¼ 0.043)). ‘Alarm’ symptoms were recorded less frequently in
emergency presenters (e.g., rectal bleeding: 9 vs 24% (P¼ 0.002)). However, about 1/5 of emergency presenters (18 and 23% for
colon and rectal cancers) had ‘alarm’ symptoms the year before diagnosis.
Conclusions: Emergency presenters have similar ‘background’ consultation history as non-emergency presenters. Their tumours
seem associated with less typical symptoms, however opportunities for earlier diagnosis might be present in a fifth of them.
According to international data, between 14 and 33% of colorectal
cancers are diagnosed as emergencies (Gunnarsson et al, 2014).
Despite some recent progress, in England a diagnosis of cancer
following an emergency presentation still occurs in as many as 22%
of colorectal cancers, with significant socio-economic inequalities
(NCIN, 2015). Emergency presenters are less often treated with
curative intent (McArdle and Hole, 2004), even after controlling
for stage at diagnosis (McPhail et al, 2013), and they have poorer
survival (Elliss-Brookes et al, 2012; Downing et al, 2013).
Moreover, emergency presentations are associated with worse
patient-reported outcomes (Quality Health, 2014) and disruptions
to hospital services (Goodyear et al, 2008). Reducing emergency
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presentations could therefore lead to more efficient and appro-
priate use of health services, and substantially improve health
outcomes.
However, studies examining potentially modifiable risk factors
and circumstances surrounding emergency cancer diagnosis are
limited (Mitchell et al, 2015a). Some studies have shown an
increased risk of emergency colorectal cancer diagnosis for women
(Abel et al, 2015), older (Mitchell et al, 2015a) and more deprived
people (Raine et al, 2010; Mayor, 2012), but the findings are not
always consistent. Few studies have examined colon and rectal
cancers separately (McArdle and Hole, 2004; Rabeneck et al, 2006;
Gunnarsson et al, 2013, 2014; Abel et al, 2015), even though these
two cancer sites often have distinct clinical presentations and the
prevalence of emergency diagnosis is markedly different (31% for
colon and 15% for rectal cancers; Abel et al, 2015). Only very
limited evidence is available on symptoms and health-care use
before emergency cancer diagnosis. According to one Swedish
study on colon cancer (Gunnarsson et al, 2014) and two UK
studies on colorectal cancers diagnosed in London (Sheringham
et al, 2014) and Exeter (Cleary et al, 2007) most patients have seen
their doctor during the 6 months before diagnosis, often with
non-specific symptoms. Case note reviews within clinical audits
(Rubin et al, 2011), qualitative studies (Black et al, 2015) and
patient surveys (Lyratzopoulos et al, 2012) have also provided
some insights into potential opportunities to diagnose cancer
earlier, but they are often limited by participation and recall bias,
due to retrospective data collection after patients received a cancer
diagnosis.
Some emergency diagnoses can be regarded as unavoidable,
such as in the case of cancers with a sudden clinical presentation
with minimal or no prior symptoms (Lyratzopoulos et al, 2014).
Other cases are potentially avoidable and these include: (a) patients
who, despite having symptoms, did not seek help promptly due to
psycho-social factors or health-care system barriers (in this case
public education and removing barriers to health care are
necessary); (b) patients who sought help for symptoms, but
opportunities were missed due to atypical symptoms, or deficien-
cies in investigations or other factors. The proportion of patients
falling into each of the above categories is unknown.
In order to provide a population-level picture of symptomatic
presentations during the months and years before the cancer
diagnosis and to identify opportunities for reducing emergency
diagnoses we used national cancer registration data individually
linked to clinical data prospectively collected in primary care
within the Clinical Practice Research Datalink (CPRD—previously
GPRD). CPRD is a large database of anonymised primary-care
records from over 600 general practices. It is validated and
extensively used for epidemiological research and is considered to
be representative of the UK population (Khan et al, 2010; Dregan
et al, 2012; Tsang et al, 2013; Chu et al, 2015; Din et al, 2015).
The database is particularly suited for the present study as it
provides details on the medical history of patients, including
prospectively recorded patient-level information on each episode
of illness, symptom occurrences, all significant clinical contacts,
diagnoses and abnormal test results.
The objectives of our study were to examine patterns of
presentation in primary care with symptoms/signs potentially
related to colon and rectal cancer during the years and months
before the cancer diagnosis. In particular, we aimed to compare
patients with a cancer diagnosis following an emergency
presentation with patients diagnosed after non-emergency
referrals, taking socio-demographic factors into account, in
order to identify opportunities for reducing emergency pre-
sentations. This will be useful for providing evidence that can
inform the development of interventions aimed at reducing
emergency cancer diagnosis, and for improving quality of care
and cancer outcomes.
MATERIALS AND METHODS
Study sample and data sources. We have conducted a cohort
study using data from the population-based National Cancer
Registry linked to CPRD/GPRD data for patients with an incident
colon or rectal cancer (ICD10 codes C18 and C19–C20,
respectively). We included cancers diagnosed in England in 2005
and 2006, as this represents the latest cohort with linked CPRD
data available to us, providing information on signs and symptoms
for up to 10 years before the cancer diagnosis (Ethics approval:
ISAC-Protocol 08_031R; NHS Health Research Authority
Confidentiality Advisory Group (PIAG 1–05(c)/2007)). The
present study focused on the 5-year pre-diagnostic period, as an
initial examination of consultation patterns going back to 10 years
showed no relevant variations in consultation rates 5–10 years
before the cancer diagnosis.
Inclusion criteria were age 25 years or older, no previous
diagnosis of cancer at any site, at least 1 year of CPRD records
before cancer diagnosis. Individuals with a previous cancer
diagnosis were not included as they probably have different help-
seeking behaviour and health-care use (due to increased cancer
awareness and possibly regular follow-up visits) compared with
primary-care patients overall. Doctors might also be more prone to
consider cancer as a possible explanation for symptoms presented
by these patients. This subgroup merits to be examined separately,
but this was not possible in the present study due to small
numbers.
The CPRD includes an ‘up-to-standard’ date, indicating when
the data meet pre-defined quality criteria in over 80 variables. We
included only records meeting these criteria in order to reduce the
risk of missing or inaccurate data.
Of the 58 359 incident colon and rectal cancer patients identified
in the National Cancer Registry, 1922 patients were linked to
CPRD (3.3%). This was in line with expectations, considering that
about half of all GP practices included in CPRD (coveringB7% of
the population in England) participate in the data-linkage scheme.
Non-participation in the linkage scheme is mostly due to non-
response rather than active refusal. After applying the study-
exclusion criteria a total of 1606 patients were included in the final
study sample (Figure 1). On average, each GP practice contributed
to 8 cancer patients over the total study period.
Variable definitions. Our outcome of interest was an emergency
cancer diagnosis, defined according to the ‘routes to diagnosis’
algorithm based on several routine data sets and provided by
NCIN (Elliss-Brookes et al, 2012; NCIN, 2013). In particular, an
emergency diagnosis is defined as a diagnosis of cancer following
presentation to an Accident and Emergency Unit, or following a GP
emergency referral or following emergency pathways for in/out-
patients (Elliss-Brookes et al, 2012; NCIN, 2013). Non-emergency
cancer diagnoses include routine GP referrals, 2-week wait
GP referrals (introduced in 2000 to allow GPs to refer suspected
cancer patients urgently, so that they can see a specialist within
2 weeks), elective inpatient/outpatient and screening. For the
purpose of our study focusing on emergency presentation, and
similarly to previous research (McPhail et al, 2013), after an initial
description of the different routes we have grouped patients into two
categories: emergency and non-emergency cancer patients
(the latter including all the non-emergency routes).
Our main explanatory variables were signs and symptoms
recorded in primary care prior to the cancer diagnosis. On the
basis of the published literature (Sheringham et al, 2014; Din et al,
2015) and guidelines (NICE Guidelines, 2015), we have
operationally defined signs/symptoms potentially relevant for
colorectal cancer. Our preliminary list has been reviewed by
clinical experts and a final list has been compiled (Supplementary
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Material 1). Examples of relevant signs/symptoms are as follows:
rectal bleeding, change in bowel habits, palpable rectal mass, iron-
deficiency anaemia, abdominal pain and weight loss. Read codes
for relevant symptoms have been identified and applied to records
in CPRD (Supplementary Material 1). The Read codes included in
the final list are as comprehensive as possible, considering that
different codes can be used for similar symptoms (e.g., 16 different
codes were included for identifying patients with diarrhoea). It was
based on codes used in previous studies (Sheringham et al, 2014)
and further expanded following a detailed revision by clinical
experts, as well as an examination of the data and the Read Code
hierarchy (see Supplementary Material 2 for details on the
development of the list of signs/symptoms).
In order to account for patient characteristics we also examined
age, gender and deprivation, based on the income domain of the
Index of Multiple Deprivation for England (Department for
Communities and Local Government, 2008, The English Indices
of Deprivation, 2007 London).
Statistical analysis. We initially described the socio-demographic
characteristics, number, type and timing of symptoms before the
cancer diagnosis separately for patients with emergency and non-
emergency presentation. Colon and rectal cancers were examined
separately throughout.
We then examined predictors of emergency diagnosis in
univariable analyses, and assessed significance using w2-test
(or test for trend for ordered categorical variables). To compare
the median number of consultations for any reason 424 months
before cancer diagnosis in emergency and non-emergency
presenters we used the Wilcoxon rank-sum test. Similarly,
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on 3.3% of cancer
patients*
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N = 146 previous cancer
N = 33 missing RTD
N = 88 unknown RTD
N = 49 CPRD records <1 year
(transfer out /up to standard
date or first CPRD record <1
year before cancer)
Final sample included in the study with linked data:
N = 1606 colorectal cancers
Number of cases before linkage
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N = 58 359 colorectal cancers
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Figure 1. Study sample selection and data sources.
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consultations for any reason during the year before cancer
diagnosis have been examined. As events occurring shortly before
diagnosis might be related to the diagnostic episode itself, rather
than represent opportunities for earlier diagnosis, the 30 days
before diagnosis have been examined separately throughout.
We examined the proportions of patients with at least one
relevant symptom and with each specific symptom in different
time periods before the cancer diagnosis (Figure 1) and we
compared these proportions between emergency and non-emer-
gency presenters using w2 statistics. Consultation rates with
relevant symptoms over the 5-year time period have been
calculated and divided in bi-monthly, six-monthly and yearly time
periods, in order to examine changes in consultation rates over
time. We have examined whether consultation rates with relevant
symptoms significantly varied by emergency presentation status
using Poisson regression. The models included age, sex and
deprivation, and were fitted for each time period separately,
focusing on the 6 months and the year before diagnosis, as well as
13–24 months and 25–36 months before diagnosis. Random effects
were included to account for patient-level clustering of sympto-
matic presentations.
Finally, multivariable logistic regression was used for examining
the risk of emergency diagnosis according to type and timing of
symptoms, and taking into account the number of consultation for
any reason during the year before diagnosis and socio-demo-
graphic characteristics. The final model included variables thought
a priori to be potentially important explanatory variables based on
previous evidence and clinical reasoning (i.e., socio-demographic
factors and number of consultations), and the specific symptoms
that were associated with emergency presentation at univariable
analysis. As observations within GP practices are not independent
(mean 8 observations per practice, range 1–26) robust standard
errors were calculated.
Interactions between the variables included in the final model
were examined (e.g., interaction between each symptom recorded
the year before diagnosis and the same symptom in earlier time
periods, and between symptoms and socio-demographic factors),
but power was limited due to sparse data.
STATA14 software (Stata Corp, College Station, TX, USA) was
used for statistical analyses.
RESULTS
Socio-demographic characteristics and emergency cancer diagnosis.
Among the 1606 included patients 52% of colon and 58% of rectal
cancer patients were men and the median age was 74 years
(interquartile range (IQR) 65–81) and 73 years (IQR 63–80).
The demographic characteristics of our study cohort were comparable
with those of colorectal cancer patients in the 2005 and 2006 Cancer
Registry not linked to CPRD. Among the study cohort, 35% of colon
and 15% of rectal cancer patients had an emergency cancer diagnosis.
An emergency diagnosis was more frequent in women (P¼ 0.04
for both colon and rectal cancers), and older patients, particularly
ages 80 years and above (P¼ 0.04 for colon and P¼ 0.003 for rectal
cancers); it was also more frequent among socio-economic
deprived patients for rectal cancers only (Po0.001; Table 1).
Consultations for any reason before the cancer diagnosis. The
great majority of the study cohort had primary-care information
for the whole of the 5-year pre-diagnostic period, with only 2% of
the cohort having primary-care records covering o2 years before
diagnosis.
GP consultation rates per year for any reason during the time
period 2–5 years before diagnosis were not significantly different
between diagnostic routes, with 88% of both colon and rectal
cancer patients having seen their GP at least once a year (Table 2);
the median number of consultations per year was 5 (IQR 2–10) for
non-emergency and emergency colon cancer patients; and 5
for both non-emergency and emergency rectal cancer patients
(IQR 2–9 and 2–12, respectively). Consultations for any reason
increased for all patients during the 13–24 months before diagnosis
and even more so during the year before diagnosis. Specifically, as
shown in Table 2, during the year before diagnosis consultations
were significantly higher for non-emergency colon cancer patients
(median 12; IQR 7–18) compared with emergency presenters
(median 10; IQR 5–19). Non-emergency rectal cancer patients had
fewer consultations during the year before diagnosis (median 9;
IQR 5–13) compared with emergency presenters (median 12; IQR
6–20). Only a small minority of patients (2.4 and 3.1% of colon and
rectal cancers, respectively) have never seen their GP during the
year before diagnosis, with minimal differences between emergency
and non-emergency presenters.
Consultations for relevant symptoms before the cancer diagnosis.
The majority of patients had at least one consultation with a relevant
symptom recorded during the year before diagnosis (80 and 84%
among colon and rectal cancers, respectively; Table 3). However, the
proportion of patients with at least one relevant symptom was
significantly lower in emergency compared with non-emergency
presenters, particularly when excluding the 30 days before diagnosis
(colon: 48 vs 71%, Po0.001; rectal cancers: 49% vs 61%, P¼ 0.043).
‘Background’ consultation rates with a potentially relevant
symptom were very low and remained stable during the 5-year
period up until B12–17 months before diagnosis (Figure 2). For
both colon and rectal cancer patients, consultation rates increased
markedly during the year before diagnosis, particularly during the
last 6 months, with no apparent differences by emergency
presentation status. Using Poisson regression and controlling for
socio-demographic variables showed that consultation rates during
the year before diagnosis were not significantly different for
emergency vs non-emergency presenters (incidence rate ratio
(IRR) for colon cancer¼ 0.86; 95% CI 0.7–1.1; P¼ 0.182; rectal
cancer¼ 1.26; 95% CI 0.9–1.8; P¼ 0.210). However, when
restricting to the last 6 months before diagnosis, emergency
presenters with colon cancer had a significantly lower consultation
rate (IRR¼ 0.76; 95% CI 0.6–0.9; P¼ 0.039).
Specific relevant symptoms before the cancer diagnosis. The
potentially relevant symptoms/signs most frequently recorded
during the year before diagnosis (excluding the 30 days) were
abdominal pain (25.1%), anaemia (19.2%), diarrhoea (9.9%) and
rectal bleeding (9.4%) among colon cancer patients, and rectal
bleeding (21.5%), change in bowel habits (11.6%), diarrhoea (12%)
and abdominal pain (9.4%) in rectal cancers patients (Table 3).
However, symptoms were different according to emergency
presentation status, particularly for colon cancers where ‘red-flag
symptoms’ were more prevalent among non-emergency presenters
compared with emergency presenters: anaemia (23.2 vs 11.9%;
Po0.001), rectal bleeding (12.6 vs 3.6%; Po0.001) and change in
bowel habits (6.7 vs 3.3%; P¼ 0.022). Among rectal cancer
patients, only rectal bleeding was significantly more prevalent in
non-emergency presenters (23.7 vs 9.2%; P¼ 0.002). Overall, 31.8%
of colon cancer and 36.4% of rectal cancer patients had at least one
of the above-mentioned ‘red-flag’ symptoms recorded between
30 days and 12 months pre-diagnosis. Non-emergency presenters
had a higher prevalence of at least one red-flag symptom compared
with emergency presenters (colon: 39.5 vs 17.5%; Po0.001; rectal
cancer: 38.8 vs 23%; P¼ 0.005).
Among patients with at least one relevant symptom, 47% of
colon and 43% of rectal cancer patients had multiple visits with the
same symptom during the period between 30 days and 12 months
pre-diagnosis, without statistical evidence for variation in this
proportion by emergency presentation status (data not shown).
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Examining potentially relevant symptoms recorded in more
distant years (i.e., between 25–60 months pre-diagnosis) has shown
that emergency rectal cancer patients had more frequently a past
record of anaemia (8.1 vs 2.0%; P¼ 0.002) and change in bowel
habits (2.3 vs 0.4%; P¼ 0.050) compared with non-emergency
presenters. Among colon cancer patients, emergency presenters
had less frequently a past record of rectal bleeding (1.7 vs 3.9%;
P¼ 0.049) than non-emergency presenters. Overall, the prevalence
of at least one red-flag symptom was much lower during the
more distant time periods compared with the year before diagnosis
Table 1. Diagnosis of colon or rectal cancer following EP by patients’ socio-demographic characteristics (univariable analysis)
Colon cancer Rectal cancer
Non-EPa EP Total Non-EPa EP Total
N¼668 N¼361 N¼1029 N¼490 N¼87 N¼577
% % N P-valueb % % N P-valueb
Gender
Men 67.8 32.2 537 0.044 87.5 12.5 336 0.041
Women 61.8 38.2 492 81.3 18.7 241
Age (years)
25–59 67.8 32.2 152 0.041 92.8 7.2 97 0.003
60–69 68.6 31.4 204 85.0 15.0 133
70–79 69.6 30.4 362 86.6 13.4 216
80þ 55.6 44.4 311 76.3 23.7 131
Socio-economic deprivation quintile
1 (least deprived) 67.2 32.8 268 0.159 90.9 9.1 143 o0.001
2 63.0 37.0 211 86.4 13.6 125
3 69.3 30.7 228 87.2 12.8 125
4 63.4 36.6 205 81.1 18.9 111
5 (most deprived) 57.3 42.7 117 72.6 27.4 73
Geographic region
North 66.0 34.0 235 0.780 80.1 19.9 151 0.170
Midlands/East England 62.5 37.5 307 85.3 14.7 177
London 66.2 33.8 71 82.5 17.5 40
South 65.9 34.1 416 88.5 11.5 209
Abbreviation: EP¼ emergency presentation.
aNon-emergency routes included non-urgent GP referrals (colon cancer: 36%; rectal cancer: 45%), ‘two-week wait’ GP referrals (colon cancer: 10%; rectal cancer: 21%) and elective in-/out-
patients (20% for both cancers). Screening accounted only for 0.2% of rectal cancers, as the programme started in 2006.
bw2-Test was used for gender and region. Test for trend was used for age and socio-economic deprivation.
Table 2. GP consultations for any reason for patients diagnosed with colon or rectal cancer following EP vs non-EP
Colon cancer Rectal cancer
Total Non-EP EP Total Non-EP EP
N¼1029 N¼668 N¼361 N¼577 N¼490 N¼87
% % % P-valuea % % % P-valuea
GP visits for any reason 25–60 months pre-diagnosis (number of visits per year)
Median (IQR) 5 (2–10) 5 (2–10) 0.739 5 (2–9) 5 (2–12) 0.226
0 visits 12.1 12.9 10.5 0.756 12.1 12.7 9.2 0.124
1–2 visits 18.8 17.1 21.9 21.5 21.0 24.1
3–4 visits 16.3 17.5 14.1 15.9 16.1 14.9
5–9 visits 28.8 28.0 30.2 27.7 29.2 19.5
10þ visits 24.1 24.6 23.3 22.7 21.0 32.2
GP visits for any reason 13–24 months pre-diagnosis (number of visits per year)
Median (IQR) 8 (3–14) 7 (3–13) 0.038 6 (2–11) 9 (4–15) 0.002
0 visits 6.0 9.1 7.1 0.056 8.4 6.9 8.2 0.002
1–2 visits 13.5 14.7 13.9 18.2 6.9 16.5
3–4 visits 12.4 13.3 12.7 12.2 12.6 12.3
5–9 visits 24.7 24.4 24.6 31.8 28.7 31.4
10þ visits 43.4 38.5 41.7 29.4 44.8 31.7
GP visits for any reason between 30 days and 12 months pre-diagnosis
Median (IQR) 12 (7–18) 10 (5–19) 0.041 9 (5–13) 12 (6–20) 0.010
0 visits 2.4 2.1 3.1 0.008 3.1 3.1 3.5 0.068
1–2 visits 5.3 3.9 7.8 9.2 9.0 10.3
3–4 visits 7.2 6.3 8.9 11.3 12.2 5.8
5–9 visits 26.3 26.8 25.5 29.3 30.6 21.8
10þ visits 58.8 60.9 54.9 47.1 45.1 58.6
Abbreviations: EP¼ emergency presentation; GP¼general practioner; IQR¼ interquartile range; non-EP¼ non-emergency presentation.
aThe Wilcoxon rank-sum test was used for comparing median number of visits. Test for trend was calculated for categorical variable of GP visits.
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(e.g., 5.9 and 4.7% among colon and rectal cancers, respectively,
13–24 months before diagnosis) without apparent differences by
emergency presentation status.
Multivariable analysis examining the effect of symptomatic
presentations and socio-demographic factors on emergency
cancer diagnosis. Multivariable logistic regression analysis,
including socio-demographic factors and relevant symptoms into
the model, has shown that in the period from 30 days to 12 months
pre-diagnosis the risk of emergency colon cancer diagnosis was
significantly lower for patients with a record of anaemia
(OR¼ 0.38; 95% CI 0.3–0.6), change in bowel habits (OR¼ 0.47;
95% CI 0.3–0.9) or rectal bleeding (OR¼ 0.22; 95% CI 0.1–0.4;
Table 4). On the other hand, emergency diagnosis was more likely
in women (OR¼ 1.37; 95% CI 1.0–1.8) and people aged 80 years
and older (OR¼ 1.84; 95% CI 1.2–2.7), independently of symptom
history. For rectal cancers, only rectal bleeding during the year
before diagnosis was associated with a lower risk of emergency
presentation (OR¼ 0.25; 95% CI 0.1–0.6). Socio-economic
deprivation was associated with a higher risk of emergency
presentation for rectal cancer, independently of symptoms (e.g.,
most deprived category OR¼ 3.47; 95% CI 1.5–8.0). Increasing
number of consultations for any reason during the year before
diagnosis somewhat increased the risk of emergency presentation
for rectal cancer (OR¼ 1.03; 95% CI 1.0–1.1). This was also
confirmed after excluding outliers, that is, patients with a very high
number of consultations (upper 5th percentile, corresponding
to 432 consultations during the year before diagnosis; data not
shown). There was some indication that change in bowel habits
(OR¼ 12.0; 95% CI 1.6–92.1) and anaemia (OR¼ 2.67; 95%
CI 0.8–8.9) recorded 25–60 months pre-diagnosis might increase
the risk of emergency rectal cancer but confidence intervals were
wide, reflecting the small number of individuals with such records.
DISCUSSION
Main findings. Linked cancer registration and primary-care data
allowed for a detailed description of clinical presentations in
primary care before a cancer diagnosis, comparing patients
diagnosed as an emergency with those diagnosed through
non-emergency routes. The longitudinal data have shown
that consultation patterns between 12 months and up to 5 years
pre-diagnosis were very similar in emergency and non-emergency
presenters. Consultation rates increased significantly in the last
months before diagnosis independently of the diagnostic route.
Emergency presenters are not a uniform category and they can be
divided into different groups according to their consultation
history. Only a very small minority of emergency presenters have
never consulted for any reason during the year before diagnosis.
However, less than half of emergency presenters have clinical
records of relevant cancer symptoms, which is significantly lower
than among non-emergency presenters. Nevertheless, approxi-
mately a fifth of emergency presenters had typical ‘alarm’
symptoms and 16% had 3 or more consultations with relevant
symptoms, suggesting possible opportunities for earlier diagnosis.
Comparison with other studies and possible explanations for
our findings. Our findings are in line with previous studies
showing that most emergency presenters have primary-care
consultations during the months before the cancer diagnosis
(Cleary et al, 2007; Gunnarsson et al, 2014; Sheringham et al,
2014). Our results are also in agreement with a study based on
direct record reviews reporting that 60% of emergency colorectal
cancer patients had relevant symptoms 1 month or more before
diagnosis (Cleary et al, 2007).
Abdominal pain and rectal bleeding are the most frequent
symptoms among colon and rectal cancer patients, respectively,
(Hamilton et al, 2013) and similarly to previous research, we found
a lower risk of emergency presentation for patients with rectal
bleeding, a well-recognised symptom of colorectal cancer
(Cleary et al, 2007; Gunnarsson et al, 2014; Sheringham et al,
2014). Earlier research highlighted an increased risk of emergency
diagnosis in case of abdominal pain and constipation (Sheringham
et al, 2014), diarrhoea and weight loss (Cleary et al, 2007).
Concordantly, we found that these symptoms/signs were all associated
with emergency diagnosis, but only when focusing on the last 30 days
before diagnosis. These symptoms/signs can be an indication of
progression towards occlusion, which may explain their higher
prevalence among emergency presenters shortly before diagnosis.
Anaemia and change in bowel habits, typical red-flag symptoms
generally leading to prompt investigations, were also associated
with a lower risk of emergency colon cancer diagnosis. Anaemia
and change in bowel habits recorded 2–5 years pre-diagnosis might
increase the risk of emergency presentation, but sparse data limited
our analyses. These sign/symptoms might have been initially
dismissed as benign and subsequently neglected by patients and/or
doctors, as suggested by previous research (Mitchell et al, 2015b;
Renzi et al, 2016).
Importantly, our study has highlighted that during the year before
diagnosis one in five emergency presenters had at least one red-flag
symptom, suggesting opportunities for earlier diagnosis in these cases.
Opportunities are probably even more prevalent, considering that
symptoms are likely to be under-recorded, as suggested by the fact
that one out of three non-emergency presenters had no relevant
symptom recorded the year before diagnosis.
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On the basis of international data, missed opportunities can
occur in 1 out of 3 colorectal cancer patients, with older age,
comorbidities and belonging to ethnic minority groups increasing
the risk (Singh et al, 2009). Multiple factors are often implicated,
including patient, doctor and health-care system factor
(Lyratzopoulos et al, 2015).
We found that between 16 and 22% of colon and rectal
cancer patients had three or more consultations with relevant
symptoms during the year before diagnosis, which is consistent
with UK audit data (Rubin et al, 2011). Our study has
highlighted that consultation rates overall and consultations
with relevant symptoms increased substantially during the
months before diagnosis among emergency and non-emergency
presenters. In the case of rectal cancers the risk of emergency
presentation increased with increasing number of consultations
for any reason. This is in contrast with previous studies
(Sheringham et al, 2014), but differences between colon and
rectal cancers, and changes in the patterns of symptoms during
the last 30 days before diagnosis were previously not taken into
account.
Table 3. GP consulations with relevant symptoms for patients diagnosed with colon or rectal cancer following EP and non-EP by
time before diagnosis
Colon cancer Rectal cancer
Total Non-EP EP Total Non-EP EP
N¼1029 N¼668 N¼361 N¼577 N¼490 N¼87
% % % P-valuea % % % P-valuea
Patients with any relevant symptom
12 months pre-diagnosis 80.1 82.6 75.4 0.005 84.4 86.3 73.6 0.002
Between 30 days and 12
months pre-diagnosis
62.7 70.7 47.9 o0.001 59.3 61.0 49.4 0.043
30 days pre-diagnosis 37.9 29.8 52.9 o0.001 43.0 42.7 44.8 0.706
No. of consultations with relevant symptoms between 30 days and 12 months pre-diagnosis
0 consultations 37.3 29.3 52.1 o0.001 40.7 39.0 50.6 0.094
1–2 consultations 42.9 48.8 31.9 43.2 44.9 33.3
3þ consultations 19.8 21.9 16.1 16.1 16.1 16.1
At least one red-flag symptom (anaemia, rectal bleeding, change in bowel habits)
Between 30 days and 12
months pre-diagnosis
31.8 39.5 17.5 o0.001 36.4 38.8 23.0 0.005
Specific symptoms recorded during the 30 days pre-diagnosis
Abdominal pain 15.7 8.7 28.8 o0.001 4.3 2.0 17.2 o0.001
Anaemia 6.2 7.9 3.1 0.002 3.0 3.1 2.3 0.698
Constipation 4.7 2.0 9.7 o0.001 4.0 2.9 10.3 0.001
Diarrhoea 4.2 2.3 7.8 o0.001 5.9 5.9 5.8 0.950
Rectal bleeding 4.4 5.1 3.1 0.126 17.2 19.0 6.9 0.006
Weight loss 1.8 1.7 1.9 0.733 1.7 1.2 4.6 0.026
Change in bowel habit 2.5 3.0 1.7 0.194 9.7 10.8 3.5 0.032
Fatigue 0.9 1.1 0.6 0.417 0.7 0.4 2.3 0.050
Specific symptoms recorded between 30 days and 12 months pre-diagnosis
Abdominal pain 25.1 25.5 24.4 0.705 9.4 8.8 12.6 0.254
Anaemia 19.2 23.2 11.9 o0.001 6.2 5.9 8.1 0.450
Constipation 8.1 8.7 6.9 0.323 8.2 8.6 5.8 0.375
Diarrhoea 9.9 9.9 10.0 0.962 12.0 11.2 16.1 0.197
Rectal bleeding 9.4 12.6 3.6 o0.001 21.5 23.7 9.2 0.002
Weight loss 3.1 3.1 3.1 0.932 1.7 1.6 2.3 0.661
Change in bowel habit 5.5 6.7 3.3 0.022 11.6 12.2 8.1 0.260
Fatigue 4.4 4.9 3.3 0.226 2.3 2.5 1.2 0.452
Specific symptoms recorded between 13–24 months pre-diagnosis
Abdominal pain 6.6 6.9 6.1 0.625 3.8 3.7 4.6 0.678
Anaemia 4.8 5.1 4.2 0.502 2.4 2.2 3.5 0.501
Constipation 3.7 3.9 3.3 0.645 1.4 1.2 2.3 0.430
Diarrhoea 2.7 3.1 1.9 0.257 3.3 3.7 1.2 0.224
Rectal bleeding 1.2 1.2 1.1 0.898 2.1 1.6 4.6 0.074
Weight loss 0.9 1.2 0.3 0.130 1.0 1.0 1.2 0.913
Change in bowel habit 0.2 0.2 0.3 0.658 0.2 0.2 0.0 0.673
Fatigue 2.4 2.3 2.8 0.602 1.4 1.4 1.2 0.837
Specific symptoms recorded between 25–60 months pre-diagnosis
Abdominal pain 11.7 12.1 10.8 0.528 7.1 7.4 5.8 0.592
Anaemia 3.3 3.0 3.9 0.449 3.0 2.0 8.1 0.002
Constipation 5.5 5.5 5.5 0.999 3.3 2.9 5.8 0.164
Diarrhoea 6.1 5.4 7.5 0.182 4.7 4.5 5.8 0.609
Rectal bleeding 3.1 3.9 1.7 0.049 3.8 3.7 4.6 0.678
Weight loss 1.1 1.4 0.6 0.238 1.6 1.8 0.0 0.203
Change in bowel habit 1.6 1.8 1.1 0.394 0.7 0.4 2.3 0.050
Fatigue 3.3 3.9 2.2 0.151 3.6 3.7 3.5 0.918
Abbreviations: EP¼ emergency presentation; GP¼general practioner; non-EP¼ non-emergency presentation.
aw2-Test.
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Our study has shown that in some cases despite specific
symptoms, cancer was only diagnosed after emergency pre-
sentation, and this more likely occurred in some subgroups.
Women, older and more deprived individuals have been
previously shown to be at higher risk of emergency diagnosis
(Raine et al, 2010; Mayor, 2012; Abel et al, 2015; Mitchell et al,
2015a), and our data indicate that these subgroups are at higher
risk independently of symptomatic presentations. Further
research is warranted to understand the role played by patient
factors (e.g., missed follow-up visits), health-care factors (e.g.,
delays in diagnostic work-up, previous borderline/normal test
results), as well as clinical and tumour factors complicating the
diagnosis (comorbidities, proximal cancers). For example, in-
depth quantitative and qualitative studies would be necessary
examining the role of comorbidities (Barnett et al, 2012;
Mitchell et al, 2015b), their effect on patients’ interpretation
and reporting of cancer symptoms, as well as their effect on
doctors’ decision-making regarding differential diagnosis, refer-
rals and testing.
The bowel cancer screening programme started in 2006 in
England and limited evidence is available on a possible positive
effect of screening and other early diagnosis/cancer awareness
initiatives (NICE Guidelines, 2015; Be Clear on Cancer, 2016)
on emergency presentations (Goodyear et al, 2008; Mansouri
et al, 2015). Due to socio-economic differences in screening
uptake (von Wagner et al, 2011), inequalities in emergency
presentations and cancer outcomes may, however, persist.
Dedicating particular attention to higher-risk groups will therefore
remain paramount.
Strengths and limitations. The strengths of the study include
the use of prospectively recorded population-based data
comparing emergency and non-emergency cancer diagnoses
defined according to validated methodologies (Elliss-Brookes
et al, 2012; NCIN, 2013). Thanks to the high quality of the data
sources, missing information on routes to diagnosis and socio-
demographic characteristics were negligible. Moreover, our study
cohort was comparable in terms of demographic characteristics
to colorectal cancer patients in the Cancer Registry not linked
to CPRD. Our study provided specific clinical insights for
colon and rectal cancers regarding the pre-diagnostic period.
By simultaneously evaluating the role of symptomatic presenta-
tions and patient characteristics we identified subgroups at
higher risk of missed opportunities and emergency diagnosis,
who could benefit from increased clinical and public health
efforts. The study demonstrates the usefulness of linked cancer
registration and primary-care data (such as CPRD) for early
diagnosis research.
Our study will need to be extended to more recent cohorts of
cancer patients with individually linked primary-care data. However,
although some changes occurred since the study period in guidelines,
clinical practice and patient awareness of symptoms (Moffat et al,
2015), the natural history of colorectal cancer and the disease
processes determining the occurrence of signs and symptom will not
have changed. It is also noteworthy that emergency presentations have
remained stable over recent years for rectal cancers with a slight
decrease for colon cancers (Abel et al, 2015); moreover, socio-
demographic inequalities in emergency presentations (Abel et al,
2015) and cancer survival (Ellis et al, 2012) are still relevant (NCIN,
2015). We have performed sensitivity analyses evaluating whether our
results differed for patients diagnosed in 2005 and 2006, which
showed that the overall findings were not affected by the year of
diagnosis in our sample.
Our results have to be interpreted with caution as the examined
symptomatic presentations are based on clinical records and do not
fully reflect all symptoms experienced by patients. However, this
can be assumed to apply equally to emergency and non-emergency
presenters. Moreover, clinical data were recorded prospectively by
4200 GP practices before the cancer diagnosis, and emergency
Table 4. Multivariable logistic regression OR for colon and rectal cancer diagnosed after EP compared with non-EP taking into
account patient socio-demographic characteristics, number of GP consultations for any reason the year before diagnosis
(excluding 30 days) and symptoms recorded in primary care (N¼1606)
Colon Cancer Rectal Cancer
OR 95% CI P-value OR 95% CI P-value
Gender
Men 1 1
Women 1.37 1.04 1.82 0.028 1.49 0.89 2.48 0.128
Age (years)
25–59 1.09 0.68 1.74 0.721 0.47 0.16 1.34 0.158
60–69 1 1
70–79 1.02 0.69 1.53 0.910 0.79 0.41 1.53 0.491
80þ 1.84 1.24 2.73 0.002 1.40 0.75 2.62 0.286
Socio-economic deprivation quintile
1 (least deprived) 1 1
2 1.29 0.84 2.00 0.247 1.48 0.67 3.28 0.333
3 0.88 0.61 1.28 0.513 1.44 0.68 3.06 0.344
4 1.11 0.76 1.62 0.584 2.30 1.00 5.26 0.049
5 (most deprived) 1.50 0.92 2.45 0.106 3.47 1.50 8.03 0.004
No. of GP visits between 30 days and 12 months pre-diagnosis 1.00 0.99 1.01 0.658 1.03 1.01 1.06 0.008
Symptoms recorded between 30 days and 12 months pre-diagnosis
Anaemia 0.38 0.26 0.55 o0.001 0.73 0.28 1.92 0.530
Change in bowel habits 0.47 0.25 0.87 0.017 0.60 0.26 1.41 0.241
Rectal bleeding 0.22 0.12 0.41 o0.001 0.25 0.11 0.58 0.001
Symptoms recorded between 25–60 months pre-diagnosis
Anaemia 1.68 0.75 3.77 0.212 2.67 0.80 8.86 0.109
Change in bowel habits 0.73 0.21 2.50 0.617 11.96 1.55 92.09 0.017
Rectal bleeding 0.46 0.19 1.11 0.085 0.83 0.30 2.30 0.720
Abbreviations: CI¼ confidence interval; EP¼emergency presentation; GP¼general practioner; non-EP¼ non-emergency presentation; OR¼odds ratio.
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and non-emergency patients had similar records regarding their
background consultation history.
Although routine data sources may contain inaccuracies, the
validity of diagnostic coding and consultation rates in CPRD
has been extensively confirmed (Khan et al, 2010; Dregan
et al, 2012). CPRD are electronic versions of case notes and
therefore include data reported by patients and considered
relevant by doctors. It should be noted that sometimes doctors
record clinical information only in free-text format rather than
READ codes (Price et al, 2016). We did not have access to free-
text information, which might have led to an underestimation
of symptoms. Interviews with patients/doctors could verify
the validity and improve accuracy, but this is beyond the
purpose of the present work. Similarly, we lacked data on patient
experience which can provide important insights. The possibility
of linking CPRD records to patient experience data is an area
that would merit future consideration in order to overcome
this limitation.
Implications of findings. This study has shown that emergency
presenters have similar ‘background’ consultation history as non-
emergency presenters and their consultation rates increase
markedly the year before diagnosis. Even though their tumours
seem associated with less typical symptoms, opportunities for
earlier diagnosis might be present in a fifth of them. In order to
reduce emergency presentations, multi-disciplinary system-wide
approaches are needed (Lyratzopoulos et al, 2015) addressing
critical points along the diagnostic process, as well as targeting
different patient subgroups (Borowski et al, 2016). More
specifically, our findings underscore the importance of dedicating
particular attention to patients consulting more frequently than
usual, even if their symptoms are not immediately suggestive of
cancer. In these cases, and in particular if patients belong to
categories at higher risk of emergency diagnosis, such as the
elderly, women and socio-economically deprived individuals, a
variety of approaches could be employed. Specifically, these
can include more pro-active and systematic symptom elicitation
(Birt et al, 2014; McLachlan et al, 2015) and symptom monitoring
ensuring a holistic approach (Mitchell et al, 2015b), possibly with
the support of alternative health-care providers. Considering that a
typical GP will only have around 10min per appointment
(Independent Cancer Taskforce, 2015), a specifically trained nurse
could support the GP during the initial diagnostic phases and for
subsequent follow-up visits and safety-netting. Pre-booked follow-
up visits could be particularly useful for patients belonging to
higher-risk groups (Mitchell et al, 2015b). Moreover, closer
interaction and easier access to specialist advice for GPs would
be important, in addition to the development of multi-disciplinary
diagnostic centres (Independent Cancer Taskforce, 2015).
Clinicians and public education campaigns should not only
emphasise the importance of discussing symptoms with the doctor
when they first appear, but also encourage and support subsequent
monitoring of symptoms facilitating prompt re-evaluation if
symptoms do not improve.
Regarding the subgroup of patients presenting with relevant
symptoms, more systematic use of safety-netting, and prompt
specialist referrals and diagnostic investigations would help to seize
the opportunities for earlier diagnosis.
Reducing emergency presentations will allow more efficient and
appropriate use of health services, improve patient experience of
care and increase survival for cancer patients.
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Chapter 3 - Inequalities in emergency cancer diagnosis: a 
longitudinal data-linkage study (Study 2) 
 
This chapter addresses the second objective of the thesis, i.e. to examine the role played by 
demographic factors in influencing consultation patterns, symptoms and diagnoses recorded in 
primary care before emergency and non-emergency presentations, shedding light on possible 
inequalities and identifying specific opportunities for reducing emergency presentations in 
women and men. 
The work performed for this chapter has led to a research paper, which is in press in the 
European Journal of Cancer Care. The paper is presented here in its accepted form for 
publication, inclusive of tables, figures and references. The chapter also provides an overview 
of the background to study 2 and links to study 1, as well as an overview of the aims, methods, 
the main findings and a discussion of how the paper fulfils the objectives and possible 
implications for further research and practice. 
 
Background to study 2 and link to study 1 
Women, older individuals and those belonging to socio-economically more deprived groups 
have an increased risk of emergency cancer diagnoses, as suggested by some previous 
studies30 31 36 54 and my study 11. Previous research84 showing an increased risk of emergency 
presentation for women versus men did not account for possible variations in relevant 
symptomatic consultations pre-cancer diagnosis and variations between colon and rectal 
cancers. My study 11 allowed to highlight that the higher risk of emergency presentation for 
women persists even after accounting for the type and timing of symptoms presented in 
primary care in the case of colon cancer (OR=1.4; 95%CI 1.02-1.8); gender differences were not 
significant for rectal cancers. Patients aged 80 years or more versus 60-69 years have an 
increased risk of emergency presentation (OR=1.8; 95%CI 1.2-2.7) for colon cancer, with no 
significant association for rectal cancer. Similarly, previous research36 54 reported ORs ranging 
between 1.5 and 4.7 for colorectal cancer patients aged 80 or more. According to study 1, 
patients belonging to the most deprived social group also have an increased risk of emergency 
presentation, but only for rectal cancers (OR=3.4; 95%CI 1.5-7.6)1. Other authors84 reported 
that social deprivation increases the risk of emergency presentation for both colon and rectal 
cancers (ORs between 1.5 and 2 (p<0.05).  
The reasons for inequalities in emergency presentations are not well understood and further 
research is warranted to explore these issues in more detail and increase our understanding on 
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specific opportunities for earlier diagnosis in higher risk groups. Possible explanations include 
patient and healthcare related factors (e.g. patient help-seeking behaviour and access to 
diagnostic investigations), as well as clinical and tumour related factors possibly complicating 
the cancer diagnosis (comorbidities, previous benign diagnoses, atypical presentations, cancer 
sub-sites)31. Risk factors might differ for men and women. For example, proximal cancers occur 
more frequently in women than men, which might lead to gender differences in symptoms and 
diagnostic complexities85. Some benign conditions such as irritable bowel syndrome (IBS) are 
more prevalent in women 86 87, possibly influencing patients’ symptom interpretation and help-
seeking for cancer symptoms88 and/or doctors’ clinical approaches and differential diagnosis. 
Women are often considered more frequent help-seekers 89, but there is a lack of population-
based evidence on symptomatic presentations pre-cancer diagnosis by gender and their 
impact on emergency diagnoses.  
Approximately half of colon cancers occur in women;  they have lower 12-month survival than 
men, both overall90 and across specific diagnostic routes, with women diagnosed after 
emergency presentation having particularly low survival6.  
 
Aims and Objectives 
The overall aim of the study is to evaluate possible gender inequalities in emergency cancer 
diagnosis and provide population-based evidence on specific opportunities for reducing 
emergency diagnoses for women and men.  
The specific objectives are to examine consultation patterns, signs/symptoms and benign 
diagnoses recorded in primary care during the months and years pre-cancer diagnosis, 
comparing emergency and non-emergency presenters by gender, taking age, social deprivation 
and cancer sub-sites into account.  
 
Methods  
Study 2 is based on individually linked cancer registration and primary and secondary care data 
for cancers diagnosed in England in 2005-2010. This is a larger cancer cohort than in study 1, as 
more recent linked data (up to 2010) became available after completion of study 1. The more 
up-to-date cohort included a total of 8,979 colorectal cancer patients with linked data 
responding to the previously described inclusion criteria. I initially examined variations in 
primary care consultations and emergency cancer diagnosis among the 5,745 colon and 3,234 
rectal cancer patients (see Appendix for further details). Subsequently, I focused the analyses 
on colon cancers only, considering their much higher risk of emergency presentations 
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compared to rectal cancer (31.6% versus 15.6%, respectively). Thus the paper presented in this 
chapter includes 5,745 colon cancer patients diagnosed in England in 2005-2010 with linked 
cancer registration, primary and secondary care data. 
 
Main results 
The research findings have been reported in the paper entitled “Opportunities for reducing 
emergency diagnoses of colon cancer in women and men: a data-linkage study on pre-
diagnostic symptomatic presentations and benign diagnoses”, which is in press in the 
European Journal of Cancer Care.  
The findings have also been presented at various conferences (listed on pages 10-11). 
By examining the pre-diagnostic period for patients diagnosed with colon cancer through 
emergency and non-emergency routes, the study provided insights into factors contributing to 
the higher risk of emergency cancer diagnosis in women. In particular, consultation rates with 
relevant symptom pre-cancer diagnosis were higher in women than men and increased 
substantially in the pre-diagnostic year; the increase in relevant consultations occurred earlier 
in women with proximal colon cancer, who were also at increased risk of emergency diagnosis. 
Among emergency presenters, 20% of women and 15% of men (p=0.002) had records of 
primary care consultations with alarm symptoms (anaemia, rectal bleeding, change in bowel 
habit) during the 2-12 months pre-diagnosis. This highlights that opportunities for earlier 
diagnosis might have occurred more frequently in women than men.  
Women with abdominal symptoms (change in bowel habit/constipation/diarrhoea) received a 
benign diagnosis (irritable bowel syndrome/diverticular disease) in the pre-diagnostic year 
more frequently than men with similar symptoms: 12% versus 6% among women and men 
diagnosed as emergencies (p=0.002). Emergency diagnosis was more likely in women 
(OR=1.20; 95%CI 1.1-1.4), independently of socio-demographic factors, symptoms, 
comorbidities and cancer sub-site. Having received a benign diagnosis in the pre-diagnostic 
year (OR=2.01; 95%CI 1.2-3.3) and records of anaemia 2-5 years pre-diagnosis (OR=1.91; 95%CI 
1.2-3.0) increased the risk of emergency presentations in women but not in men. The risk was 
particularly high for women aged 40-59 with a recent benign diagnosis versus none (OR=4.41; 
95%CI 1.3-14.9).  
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Conclusions  
The higher risk of emergency cancer diagnosis in women might be partially due to less specific 
symptoms in women compared to men and their more frequent attribution to benign 
diagnoses. Moreover, women with colon cancer were twice as likely to receive a benign 
diagnosis during the year pre-cancer compared to men, even when presenting with similar 
abdominal symptoms. One-fifth of women diagnosed as an emergency had typical alarm 
symptoms recorded in the pre-diagnostic year highlighting possible opportunities for reducing 
emergency presentations. Furthermore, past records of anaemia 2-5 years pre-cancer were 
associated with emergency presentations in women but not in men, highlighting the need for 
prompt investigations of this early sign, especially in women. 
 
Fulfilment of the study objectives and implications for research and practice 
In this chapter I examined possible inequalities in emergency cancer diagnoses, shedding light 
on factors contributing to the higher risk of emergency presentations in women. The study 
focused in particular on colon cancers, considering that almost one every three patients are 
diagnosed following an emergency presentation. The findings suggest that, especially in the 
case of women, increased attention is necessary not only for patients with typical alarm 
symptoms, but also for those repeatedly presenting with lower risk symptoms. Women aged 
40-59 years with symptoms consistent with a recent onset IBS or diverticular disease are at 
particularly high risk of emergency cancer diagnosis. One-fifth of women diagnosed as 
emergencies had typical alarm symptoms in the pre-diagnostic year highlighting that 
appropriate diagnostic and safety-netting strategies need to be developed targeting in 
particular higher risk groups. Recent primary care research supports the use of innovative 
diagnostic approaches, such as quantitative faecal haemoglobin testing (FIT), to aid the 
diagnostic process of colorectal cancer and other serious bowel diseases in individuals with 
non-typical symptoms and anaemia91. 
The analyses performed for study 2 included an overall comorbidity measure (any comorbidity 
recorded in HES pre-cancer diagnosis). However, further in-depth studies are necessary to 
increase our understanding on the role played by different comorbidities in influencing timely 
cancer diagnosis and the risk of emergency presentations, taking symptomatic presentations 
into account.  
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Abstract  
Objectives: To identify opportunities for reducing emergency colon cancer diagnoses 
we evaluated symptoms and benign diagnoses recorded before emergency presentations 
(EP).  
Methods: Cohort of 5,745 colon cancers diagnosed in England 2005-2010, with 
individually-linked cancer registry and primary care data for the 5-year pre-diagnostic 
period. 
Results: Colon cancer was diagnosed following EP in 34% of women and 30% of men. 
Among emergency presenters, 20% of women and 15% of men (p=0.002) had alarm 
symptoms (anaemia/rectal bleeding/ change in bowel habit) 2-12 months pre-diagnosis. 
Women with abdominal symptoms (change in bowel habit/constipation/diarrhoea) 
received a benign diagnosis (irritable bowel syndrome (IBS)/diverticular disease) more 
frequently than men in the year before EP: 12% versus 6% among women and men 
(p=0.002). EP was more likely in women (OR=1.20; 95%CI 1.1-1.4), independently of 
socio-demographic factors and symptoms. Benign diagnoses in the pre-diagnostic year 
(OR=2.01; 95%CI 1.2-3.3) and anaemia 2-5years pre-diagnosis (OR=1.91; 95%CI 1.2-
3.0) increased the risk of EP in women but not men. The risk was particularly high for 
women aged 40-59 with a recent benign diagnosis versus none (OR=4.41; 95%CI 1.3-
14.9). 
Conclusions: Women have an increased risk of EP, in part due to less specific 
symptoms and their more frequent attribution to benign diagnoses. For women aged 40-
59 years with new onset IBS/diverticular disease innovative diagnostic strategies are 
needed, which might include use of quantitative faecal haemoglobin testing (FIT) or 
other colorectal cancer investigations. One-fifth of women had alarm symptoms before 
EP, offering opportunities for earlier diagnosis.  
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Introduction 
Internationally, emergency colorectal cancer diagnoses range between 14% and 33% 
(Zhou et al., 2017), with only few studies providing separate figures for colon and rectal 
cancers, despite the much higher risk of emergency presentations among colon cancers 
(31% versus 15% for colon and rectal cancers) (Abel et al., 2015). In the UK one in 
three colon cancers are diagnosed as an emergency (Zhou et al., 2017). Reducing 
emergency presentations is important as they are associated with worse 12-month 
cancer survival (51% after emergency versus more than 80% after non-emergency 
colorectal cancer diagnosis) (NCIN). Women, older and deprived individuals have an 
increased risk of emergency presentations (Abel et al., 2015; Renzi et al., 2016a; 
Wallace et al., 2014; Zhou et al., 2017), with the risk for women versus men ranging 
between OR=1.2 and 1.4 (p<0.05) (Abel et al., 2015; Renzi et al., 2016a). Women with 
colon cancer have lower 12-month survival than men, both overall (Quaresma et al., 
2015) and across specific diagnostic routes, with women diagnosed after emergency 
presentation having particularly low survival (NCIN).  However, evidence on the 
circumstances surrounding emergency presentations and on reasons for the higher risk 
of emergency diagnoses among women is scant.  
Patient, healthcare and tumour factors are possible explanations (Zhou et al., 2017), 
including less frequent help-seeking among some subgroups due to cancer fear, fatalism 
or poor cancer awareness (Robb et al., 2009), as well as delays in investigations or 
diagnostic difficulties due to comorbidities, benign diagnoses and atypical 
presentations. Risk factors might differ for men and women: for example, proximal 
cancers occur more frequently in women, possibly leading to gender differences in 
diagnostic complexity, as proximal cancers often present with non-specific symptoms 
and are beyond the reach of flexible sigmoidoscopy (Holme et al., 2017). Generally 
women are more frequent help-seekers (Hansen et al., 2015), but no population-based 
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evidence exists on patterns of symptomatic presentation during the months and years 
before a cancer diagnosis by gender and how this might impact on emergency 
diagnoses.  
Diagnostic pathways might also be influenced by previous diagnoses of benign 
conditions (Renzi et al., 2016b), such as irritable bowel syndrome (IBS) or diverticular 
disease, which can present with overlapping symptomatology with colon cancer 
(Regula, 2016), complicating symptom interpretation and differential diagnosis. 
Diagnostic difficulties might be particularly relevant in women, who have a higher 
prevalence of IBS compared with men (Lovell and Ford, 2012; Sperber et al., 2017).  
Overall, the incidence of colorectal cancer in patients diagnosed with IBS or diverticular 
disease is similar to the general population (Canavan et al., 2014; Norgaard et al., 2011; 
Regula, 2016). However, in the months immediately after the benign diagnosis there is 
an increased risk of colon cancer (Canavan et al., 2014; Norgaard et al., 2011; Regula, 
2016), especially among individuals aged less than 50 (Canavan et al., 2014). It is 
unknown whether colon cancer patients receiving a diagnosis of IBS or diverticular 
disease are at increased risk of an emergency rather than non-emergency cancer 
diagnosis.  
The present study is part of a wider project on emergency presentations based on linked 
cancer registry, primary and secondary care data (Renzi et al., 2016a). We have 
previously shown that consultations increase markedly during the pre-diagnostic year, 
independently of diagnostic route, with emergency presenters having less frequently 
typical alarm symptoms.  
This study aimed to take the previous work further and increase our understanding on 
reasons for the higher risk of emergency presentations among women, in order to 
identify possible opportunities for earlier diagnosis overall and in women in particular. 
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We focused on consultation patterns, signs/symptoms and benign diagnoses recorded 
before the colon cancer diagnosis, comparing emergency and non-emergency presenters 
by gender, taking cancer sub-sites into account. As almost half of colon cancers occur in 
women, reducing their risk of emergency presentations can be beneficial not only for 
the affected individual but also more generally for public health, in terms of overall 
cancer survival and reduced disruptions to hospital services.  
 
Methods 
Study population and data sources 
The present cohort study focused on patients with an incident colon cancer (ICD10 
codes C18) diagnosed in England 2005-2010 recorded in the National Cancer Registry 
and individually linked to primary care data (provided by the Clinical Practice Research 
Datalink- CPRD) and secondary care data (Hospital Episode Statistics-HES). About 
6.9% of the UK population is covered by CPRD and included patients are considered to 
be representative of the general UK population (Herrett et al., 2015). We focused on 
colon cancer, rather than colorectal, given the particularly high risk of emergency 
presentations. 
Inclusion criteria were: ages 18 years or over at cancer diagnosis, no previous cancer at 
any site and having at least one year of primary care CPRD records prior to cancer 
diagnosis. We excluded records not meeting the CPRD quality criteria (e.g. ‘up-to-
standard’ date). Patients with previous cancers were excluded as their consultation and 
referral patterns are likely to be different from patients with no cancer history (due to 
higher cancer awareness, regular follow-up visits, and lower threshold for 
referrals/investigations). As expected, 6.5% of colon cancers from the cancer registry 
were successfully linked to active and up-to-standard CPRD records (N=6,316 patients 
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out of 97,937 incident colon cancers diagnosed in 2005-2010) (details in Appendix 
Figure 1). After excluding patients with missing socio-demographic or route to 
diagnosis information, a total of 5,745 individuals were included.  
The following ethics approval was obtained: ISAC-Protocol 08_031R; NHS Health 
Research Authority Confidentiality Advisory Group (PIAG 1-05(c)/2007). 
Further details on the overall project have been previously published (Renzi et al., 
2016a).  
Study variables 
The outcome of interest was emergency diagnosis, defined as a colon cancer diagnosed 
following presentation to Accident and Emergency, GP emergency referrals or 
emergency pathways for in/out-patients, according to the Routes to Diagnosis algorithm 
(Elliss-Brookes et al., 2012; NCIN). Accident and Emergency and GP emergency 
referrals account for 90% of emergency diagnoses and are characterized by similar one-
year survival (NCIN). Non-emergency diagnoses included routine GP referrals, two-
week wait referral, inpatient/outpatient elective and screening. 
The main explanatory variables were signs/symptoms recorded before the cancer 
diagnosis. CPRD provides patient-level information recorded prospectively in primary 
care on type and timing of signs/symptoms, test results (e.g. iron-deficiency anaemia) 
and referrals. Based on the literature and guidelines (Din et al., 2015; NICE guidelines 
[NG12]; Sheringham et al., 2014), we operationally defined relevant signs/symptoms 
that could prompt diagnostic work-up for a possible colon cancer. Clinical experts 
reviewed the list and Medcodes/Readcodes for relevant symptoms (e.g. rectal bleeding, 
change in bowel habit, anaemia) were identified and applied to CPRD records (code-list 
in appendix). Clinical experts included GPs, gastroenterologist and public health 
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specialists with a specific interest in cancer and expertise in using CPRD. In addition, 
colorectal cancer patients have taken part in discussing relevant signs/symptoms. 
The analysis focused on primary care records referring to the pre-diagnostic year, but 
earlier records, up to 5 years pre-diagnosis, were used to examine frequency of GP 
consultations over time and to categorize each sign/symptom as ‘new' (a symptom 
recorded for the first time during the pre-diagnostic year, with no prior record of the 
same symptom), ‘chronic’ (recorded during the pre-diagnostic year and at least once in 
previous months/years) and ‘past’ (recorded only in the past 2-5 years, with no record in 
the pre-diagnostic year). We developed this classification as we hypothesised that the 
effect on emergency presentation might be influenced by the timing of symptom onset 
and past symptom experience.  
Further explanatory variables were benign intestinal conditions (irritable bowel 
syndrome (IBS), diverticular disease and haemorrhoids) recorded in primary care before 
the cancer diagnosis. We grouped IBS and diverticular disease together due to sparse 
data. These two conditions also have many overlapping features and often present with 
recurrent abdominal symptoms (Strate et al., 2012).  
Relevant referrals for a gastro-intestinal consultation and/or investigations (lower GI 
endoscopies, imaging of digestive tract, abdominal ultrasound scan, CT/MRI) recorded 
in CPRD during the pre-diagnostic year were also examined. A binary variable (any 
relevant referral versus none) was created. Small numbers prevented us from analysing 
specific referrals separately. In line with previous studies we used 3 or more GP 
consultations with relevant symptoms as a proxy for referral delays (Lyratzopoulos et 
al., 2012). 
We identified comorbidities recorded in HES using a previously developed algorithm 
(Maringe et al., 2017; Shack et al., 2010). As linked HES records were available from 
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2003 onwards, a two-year pre-diagnostic time window was chosen, in order to have the 
same secondary care observation period for all patients, including those diagnosed with 
cancer in 2005.   
Cancer sub-sites were classified into distal (left) colon (i.e. splenic flexure, descending 
colon, sigmoid colon) (ICD C18.5-C18.7) and proximal (right) colon (i.e. caecum, 
appendix, ascending colon, hepatic flexure, transverse) (C18.0-C18.4) (Doubeni et al., 
2016; Hansen et al., 2015; Karim et al., 2017). 
Socio-demographic characteristics included gender, age and deprivation based on the 
income domain of the Index of Multiple Deprivation for England. 
Statistical analysis 
We first described socio-demographic characteristics and pre-diagnostic 
signs/symptoms, benign diagnoses and comorbidities comparing emergency versus non-
emergency presenters. Men and women were examined separately throughout. In line 
with previous research (Guldbrandt et al., 2017; Renzi et al., 2016a; Sheringham et al., 
2014), when analysing events occurring in the pre-diagnostic year we excluded the 30 
days pre-diagnosis, as events occurring shortly before diagnosis might be related to the 
diagnostic episode itself, rather than represent opportunities for earlier diagnosis.  
We used Poisson regression to examine variations in consultation rates for relevant 
symptoms before the cancer diagnosis by gender, age, social deprivation, comorbidities 
and cancer sub-sites. Random effects were added to account for patient-level clustering 
due to repeated symptomatic presentations. Consultation rates were divided in bi-
monthly and yearly time periods, in order to examine variation over time. 
Mixed effects multivariable logistic regression was used for examining the risk of 
emergency presentations according to socio-demographic characteristics, cancer sub-
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site, number of consultations and type and timing of sign/symptoms, benign diagnoses 
and comorbidities. Random effects were added to account for clustering of patients by 
GP practice. We then evaluated (i) whether the effect for each sign/symptom and benign 
diagnoses varied for men and women, and (ii) whether age modified the effect of a 
benign diagnosis on the risk of emergency presentation. 
Finally, in order to evaluate whether effects vary by cancer sub-site, we performed 
multinomial logistic regression, including all the previously mentioned variables into 
the model and comparing the likelihood of emergency diagnosis separately for proximal 
and distal cancer compared to non-emergency colon cancer diagnosis.  
Statistical analyses were performed using STATA14 software (Stata Corporation, 
College Station, TX, USA). 
 
Results 
Characteristics of the study cohort and prevalence of emergency cancer diagnosis  
Among the 5,745 colon cancer patients included in the study, 49% were women, with a  
median age of 74 years (IQR 65-82) for women and 72 for men (IQR 64-79). Our 
cohort had comparable demographic characteristics to colon cancer patients in the 
National Cancer Registry unlinked to CPRD (48% women; median age 75 (IQR 66-83) 
for women and 72 for men (IQR 64-80)). Proximal cancer was more frequent in women 
(53% versus 45% in men, p<0.001). Emergency presentations occurred in 34% of 
women and 30% of men, with higher risks for people from more deprived areas and the 
oldest and youngest age groups (Table 1). Distal cancers were associated with a lower 
risk of emergency presentation than proximal and unspecified colon sub-sites. 
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Consultation pattern before a colon cancer diagnosis by gender and cancer sub-site 
Consultation rates with relevant signs/symptoms (rectal bleeding, change in bowel 
habit, anaemia, abdominal pain, constipation) started increasing during the 1-2 years 
pre-cancer diagnosis, independently of gender, diagnostic route and cancer sub-sites 
(Figure 1). A particularly sharp increase was observed in the pre-diagnostic year, with 
the important exception of women with proximal cancer diagnosed as an emergency, 
whose increase started 2 years pre-diagnosis. Patients with proximal cancer had higher 
consultation rates than those with distal cancers, with consultations increasing earlier 
for emergency presenters, particularly among women.  
Consultation rates with relevant symptoms were significantly higher for women 
compared to men, taking age, deprivation and cancer sub-site into account (Appendix 
Figure 2). Consultation rates were also higher for older patients and those in more 
deprived areas, while distal cancers had lower consultation rates compared to proximal 
cancers. Results were similar repeating the analyses including also diagnostic route and 
comorbidity in the multivariable model (data not shown). 
 
Symptoms and benign diagnoses before emergency and non-emergency presentation 
by gender  
Relevant symptoms  
The proportion of patients with at least one consultation for relevant symptoms in the 
pre-diagnostic year was higher among women than men (60% versus 55%, p<0.001), 
with women also having more frequently 3+ consultations with relevant symptoms 
(17% versus 15%, p<0.001) (Table 2). Emergency presenters of either sex had less 
frequently relevant symptoms compared to non-emergency presenters. However, among 
 66 
women diagnosed as an emergency 20% had alarm symptoms (anaemia, rectal bleeding, 
change in bowel habit) during the pre-diagnostic year, versus 15% among men 
(p=0.002).  
Past anaemia 2-5 years pre-diagnosis was more frequent among emergency presenters, 
particularly for women. Anaemia, abdominal pain, constipation and fatigue were more 
frequently recorded in women than men. 
Benign diagnoses  
Women more often had a record of a benign diagnosis (IBS/diverticular disease) in the 
pre-diagnostic year: 6% versus 2% among women and men diagnosed as an emergency 
(p<0.001) (Table 2). Similarly, in the subgroup of people with abdominal symptoms 
(change in bowel habit, abdominal pain, constipation or diarrhoea, n=2046) there was a 
greater probability of benign diagnoses during the pre-diagnostic year for women 
(9.5%) versus men (5.2%) (p<0.001). Further restricting this analysis to persons with 
abdominal symptoms who were diagnosed as emergencies (n=574), 12.4% of women 
versus 6% of men received a benign diagnosis (p=0.002) (data not shown in table). This 
gender disparity in benign diagnoses was also observed when restricting the analysis to 
emergency presenters with alarm symptoms (change in bowel habit, rectal bleeding or 
anaemia): 9.5% versus 2.4% (p=0.01) of women and men had received a recent benign 
diagnosis.  
 
Multivariable analysis examining factors associated with emergency presentation by 
gender and cancer sub-site 
At multivariable analysis emergency presentations were more likely in women 
(OR=1.20; 95%CI 1.1-1.4), as well as among the oldest and youngest age groups and 
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the most deprived, independently of symptoms, number of consultations and cancer 
sub-site (Table 3). Multiple pre-referral consultations with relevant symptoms 
(OR=1.25; 95%CI 1.1-1.6) and comorbidities also increased the risk of emergency 
presentations, while new onset alarm symptoms decreased the risk.  
Among women, a recent benign diagnosis (OR=2.01; 95%CI 1.2-3.3) and a past history 
of anaemia 2-5 years pre-diagnosis (OR=1.91; 95%CI 1.2-3.0) increased the risk of 
emergency presentation in patients with distal and proximal cancers, respectively 
(Figure 2). No such association was observed for past/chronic benign diagnoses and no 
association was apparent between benign diagnoses and emergency presentations in 
men. Results were similar when analysing each cancer sub-site and gender separately 
(Appendix Tables 1-2), but without reaching statistical significance due to sparse data in 
stratified analyses.  
 
Benign diagnoses and effect on emergency presentations among women stratified by 
age  
The prevalence of a benign diagnosis among women with colon cancer diagnosed as 
emergencies was particularly high among 40-49 year olds (18.4%), while it was 8.8% in 
50-59 year olds and lower in all other age groups (4.5-6.8%) (data not shown in table).  
Concordantly, there was statistical evidence of effect modification for a recent benign 
diagnosis on the risk of emergency presentation by age (likelihood ratio test p=0.013). 
Multivariable logistic regression stratified by age and controlling for deprivation, cancer 
sub-site and symptoms highlighted how the risk of emergency presentation was 
particularly high for 40-59 year old women with a recent benign diagnosis compared to 
those without a benign diagnosis (OR=4.41; 95%CI 1.3-14.9). There was no significant 
effect of a benign diagnosis on all other groups (Table 4).   
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Discussion  
Main findings 
The study provides population-based evidence on factors associated with emergency 
colon cancer diagnosis in women and men, highlighting possible opportunities for 
earlier diagnosis. Consultation rates with relevant symptom pre-cancer diagnosis were 
higher in women than men and increased substantially in the pre-diagnostic year; the 
increase in relevant consultations occurred earlier in women with proximal colon 
cancer, who were also at increased risk of emergency diagnosis. Women with 
abdominal symptoms in the pre-diagnostic year were twice as likely to be diagnosed 
with a benign condition (IBS or diverticular disease) compared to men with similar 
symptoms. A new onset benign condition and a past history of anaemia 2-5 years pre-
diagnosis were associated with emergency presentations in women, but not in men. A 
particularly high risk of emergency presentations was observed among women aged 40-
59 with a new onset benign diagnosis, highlighting the need for innovative diagnostic 
strategies for this patient group. These may include use of quantitative faecal 
haemoglobin testing (FIT) or other colorectal cancer investigations.  
 
Comparison with previous literature 
IBS, affecting about 8% of the general population in Western countries and occurring 
more frequently in women (Lovell and Ford, 2012; Sperber et al., 2017) can present 
with abdominal pain, altered bowel habit and bloating in the absence of detectable 
organic disease. According to guidelines, the diagnosis is based on clinical criteria 
(Rome IV criteria) without the need for extensive investigations to exclude other 
conditions (Canavan et al., 2014; Ford et al., 2017; Mearin et al., 2016; Moayyedi et al., 
2017; NICE guidelines [NG12]; Spiegel et al., 2010), as the diagnostic yield is low in 
 69 
the absence of alarm signs/symptoms (Chey et al., 2010). IBS does not increase the risk 
of colon cancer overall, with IBS patients having similar cancer incidence as the general 
population (Canavan et al., 2014; Norgaard et al., 2011). However, in the first 6 months 
after an IBS diagnosis colorectal cancer incidence is 4 to 41 times higher than in 
controls (Canavan et al., 2014), with patients younger than 50 having the highest risk. 
This might be due to symptoms being initially attributed to the benign diagnosis, while 
subsequent investigations revealed the underlying cancer. Contrary to guidelines, many 
gastroenterologists and primary care doctors believe IBS is a diagnosis of exclusion and 
refer patient for tests to exclude serious organic conditions (Spiegel et al., 2010). 
Spiegel et al. (Spiegel et al., 2010) also highlighted that often doctors make an ‘internal 
diagnosis’ when visiting patients, without being willing to ‘externalise’ the diagnosis to 
the patient; less than half of doctors were willing to communicate the diagnosis without 
first performing additional testing. This suggests that the relatively low IBS prevalence 
in our study is an underestimation of cases where the doctor made an ‘internal 
diagnosis’.  
Similar to IBS, diverticular disease is a chronic disorder which often presents with 
recurrent abdominal symptoms (Strate et al., 2012). While not increasing the risk of 
colon cancer overall, during the first year of a diverticular disease diagnosis there is a 
strong association with colon cancer, probably due to misclassification and difficulties 
with differential diagnosis (Regula, 2016). Both IBS and diverticular disease might 
provide ‘alternative explanations’ to cancer. This is in line with a study (Mounce et al., 
2017) reporting how comorbidities providing ‘alternative’ explanations (including IBS 
and diverticular diseases) are associated with longer diagnostic intervals for colorectal 
cancer. Our study shows that for patients with an underlying colon cancer, receiving an 
IBS or diverticular disease diagnosis can be associated with an increased risk of 
emergency presentation. Patients might feel over-reassured or under-supported (Renzi et 
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al., 2016b) after a benign diagnosis and thus not return to their doctor even if symptoms 
worsen, or there might be delays in referrals for investigations.  
Further work is necessary to examine these possible mechanisms, as well as examining 
whether benign diagnoses were supported by previous investigations. Using data from 
electronic health records (as in our study) can reveal patient groups at greater risk of 
emergency presentation, there remain however questions about the exact circumstances 
that could allow for such presentations to be prevented. In that respect, qualitative 
record review studies can be very important. For example, in a study reviewing the 
clinical records of Scottish patients (Murchie et al., 2017) 30% of emergency presenters 
previously seen by their GP with relevant symptoms had an emergency diagnosis while 
awaiting a secondary care appointment; 19% experienced a genuine missed opportunity 
for earlier investigation (with missed opportunities occurring more frequently in women 
than men); while only a small minority of patients had refused or did not attend follow-
up appointments or investigations. Similar approaches have also been employed in US 
healthcare settings (Singh et al., 2009). Complementing such detailed case note reviews 
with population-based epidemiological studies like ours is important to provide a more 
comprehensive picture and inform the development of strategies for reducing 
emergency presentation at population level. By identifying sub-groups of the population 
at higher risk, epidemiological studies can also help priorities further in-depth case note 
review studies. 
In our study we have shown that multiple pre-referral consultations were associated 
with emergency presentations, indicating how generally prompt specialist referrals can 
reduce emergency diagnoses. Women are known to have more frequent consultations 
(Abel et al., 2017; Hansen et al., 2015), longer diagnostic intervals (Din et al., 2015) 
and higher risk of three or more consultations before specialist referrals, particularly in 
the context of urinary tract cancer (Cohn et al., 2014; Lyratzopoulos et al., 2013). It has 
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been suggested that general practitioners interpret symptoms, such as haematuria, 
differently in women compared to men, with possible misattribution of symptoms to 
benign causes, early in the diagnostic process (Cohn et al., 2014; Lyratzopoulos et al., 
2013). This might be a consequence of positive predictive values of various possible 
cancer symptoms being lower in women than in men (Hamilton et al., 2009; Jones et al., 
2007). Differential diagnosis in women can be particularly complicated as recurrent 
abdominal pain and/or anaemia can sometimes be related to gynaecological conditions 
with a risk of over-reassurance or false reassurance. Specifically designed quantitative 
and qualitative studies would be needed to explore these issues further. A greater 
understanding of the interplay between gender, age, benign diagnoses, chronic 
morbidities and symptomatic presentations is necessary in order to optimize diagnostic 
approaches and guidelines for higher risk groups. For example, new onset IBS in 
middle-aged women is an indication for CA125 testing according to NICE 
guidelines(NICE guidelines [NG12]), yet new onset IBS is not currently considered a 
clear indication for quantitative faecal haemoglobin testing (FIT). 
Anaemia is a well-known symptom associated with colon cancer (Hamilton et al., 2009) 
and our findings have highlighted that while new onset alarm symptoms, including new 
onset anaemia, decreased the risk of emergency presentation, a long-standing history of 
anaemia in women can lead to emergency presentations. Previous research also 
suggested that anaemia was a frequent missed diagnostic opportunity in colorectal 
cancer (Singh et al., 2009). 
Limitations 
The study does not reflect the prevalence of symptoms and benign diagnoses in the 
general population, nor does it aim to evaluate the predictive value of symptoms 
comparing cancer patients with the general population, as performed in other studies 
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(Hamilton et al., 2009). Rather, our study focused on identifying factors associated with 
emergency presentations and opportunities for preventing them among cancer patients. 
We relied on clinical records of symptoms/signs which do not necessarily represent all 
symptoms experienced by patients. Despite the likely underestimation of 
sign/symptoms and diagnoses (Price et al., 2016), we have no reason to expect 
differential recording by emergency presentation status, as information was 
prospectively recorded during the months and years before the cancer diagnosis.  
The clinical management of patients with anaemia 2-5 years pre-diagnosis merits 
further examination.  Danish studies showed an increase in prescriptions prior to a colon 
cancer diagnosis (Pottegard and Hallas, 2017). Similar to our findings, this suggests that 
symptoms are attributed to benign diagnoses in some patients. Further work is needed 
exploring the effect of gynaecological and other co-existing conditions on the risk of 
delayed cancer diagnosis and emergency presentations.  
Our study will need to be extended to more recent years. However, even though 
emergency presentations for colorectal cancer have decreased in England between 2006 
and 2010 (from 27% to 23%), they have remained around 23% since 2010 (NCIN). 
Specific data for colon cancer is limited to 2006-2010 (31% diagnosed as an 
emergency) (Abel et al., 2015). It is noteworthy that inequalities in emergency 
presentations (Abel et al., 2015) and cancer survival (Ellis et al., 2012) are still relevant. 
Implications for research and practice 
Our population-based study suggests that there are opportunities for earlier colon cancer 
diagnosis and for reducing emergency presentations in some patients. The findings are 
unlikely to be simply explained by poor clinical practice of some doctors, considering 
that we analysed prospectively collected data from 343 GP practices in England 
(average of 3 colon cancers per practice/year), taking possible clustering by practice 
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into account. Further quantitative and qualitative studies are needed in order to gain 
additional insights into the doctor-patient interactions preceding the emergency cancer 
diagnoses and the clinical management of symptomatic patients, including an analysis 
of prescriptions, referrals and type and timing of investigations performed before an 
emergency cancer diagnosis. Considering that emergency presentations occur due to a 
complex interplay between patient, cancer and healthcare related factors (Holme et al., 
2017; Lyratzopoulos et al., 2014; Murchie et al., 2017; Zhou et al., 2017), multifaceted 
system-wide approaches are probably needed, together with innovations in diagnostic 
technology and optimizing screening. The majority of colorectal cancers are diagnosed 
after symptoms have developed (Goodyear et al., 2008), thus earlier diagnosis in 
symptomatic patients remains crucial. Attention is needed not only for people with 
typical alarm symptoms, but also for those repeatedly presenting with lower risk 
symptoms, especially in the case of women. Organizational innovations in primary care 
can help improve the diagnosis and management of complex cases (BMA, 2016; Hobbs 
et al., 2016; Rimmer, 2017). Greater integration with specialists and multi-disciplinary 
diagnostic centres (Independent Cancer Taskforce, 2015) can also facilitate early 
diagnosis.  
Specific attention is warranted for women aged 40-59 years with a recent diagnosis of 
IBS or diverticular disease, as this age group is characterized by an increase in colon 
cancer incidence, paralleled by a decrease in new IBS onset. It is noteworthy that for 
women aged 50 and over who have been diagnosed with IBS for the first time in the last 
year, NICE guidelines in the UK recommend investigations for ovarian cancer, as IBS 
rarely starts at this age (NICE guidelines [NG12]), while no specific recommendation is 
made regarding the possibility of colon cancer in these patients, unless typical alarm 
symptoms are present. According to international experts, a colonoscopy is indicated for 
all patients aged 50 years and over with symptoms such as diarrhoea and mixed bowel 
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habit (Ford et al., 2017; Moayyedi et al., 2017). Relatedly, the American 
Gastroenterology Association recently recommended excluding colon cancer with 
modern techniques and colonoscopy after the first episode of diverticulitis (Regula, 
2016). 
Our findings suggest that women aged 40-59 with symptoms compatible with a recent 
onset IBS or diverticular disease are at increased risk of emergency diagnosis and 
appropriate strategies will need to be developed to address this. In addition to safety-
netting and specialist advice, quantitative FIT could be considered. According to recent 
research (Hogberg et al., 2017; Mowat et al., 2016) and NICE guidelines (NICE 
guidelines [NG12]), quantitative FIT can be useful for patients presenting with 
abdominal symptoms in primary care in order to identify those who might benefit from 
further investigations.  
With one in three colon cancers diagnosed as an emergency and considering that 12-
month survival for patients with an emergency colorectal cancer diagnosis is 51%, 
compared to more than 80% for non-emergency routes (NCIN), it is important to 
develop innovative diagnostic strategies. Reducing emergency presentations and 
addressing inequalities will help to improve patient experience, quality of care and 
cancer survival.   
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Non-EP EP Total p-value^ Non-EP EP Total p-value^
N=1859 N=940 N=2799 N=2072 N=874 N=2946
% % N % % N
Age (years)
18-59 65.0 35.0 414 <0.001 68.0 32.0 431 <0.001
60-69 75.3 24.7 595 78.2 21.8 780
70-79 72.7 27.3 868 71.4 28.6 1010
80+ 55.4 44.6 922 61.8 38.2 725
SES (deprivation quintile) 
1 (least deprived#) 70.4 29.6 609 0.005 71.5 28.5 708 0.057
2 66.3 33.7 602 69.9 30.1 654
3 66.4 33.6 601 73.7 26.3 574
4 65.9 34.1 513 68.2 31.8 529
5 (most deprived) 58.3 41.7 350 65.2 34.8 353
Geographic region
North 64.2 35.8 586 0.387 69.2 30.8 708 0.877
Midlands/East England 68.5 31.5 841 70.5 29.6 863
London 65.8 34.2 295 70.0 30.0 227
South 66.2 33.8 1077 71.0 29.0 1148
Year of CRC diagnosis
2005-2006 63.8 36.2 889 0.126 67.1 32.9 902 0.034
2007-2008 67.3 32.7 924 72.2 27.8 960
2009-2010 68.0 32.1 986 71.4 28.6 1084
Cancer sub-site
colon proximal 66.8 33.2 1477 0.043 69.2 30.8 1324 <0.001
colon distal 67.8 32.2 1010 73.8 26.2 1329
colon unspecified 60.3 39.7 312 59.7 40.3 293
^Chi-square test comparing emergency Versus  non-emergency presenters
Women Men
Table 1: Diagnosis of colon cancer after Emergeny Presentation (EP)  by patients' socio-demographic 
characteristics and cancer sub-site (N=5745)
Dista l  colon: splenic flexure, descending colon, s igmoid colon; Proximal  
colon: transverse and ascending colon.
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Women vs 
Men EP 
only
Women vs 
Men total 
sample
Non-EP EP Total p-value^ Non-EP EP Total p-value^ p-valueᵃ p-valueᵇ
N=1859 N=940 N=2799 N=2072 N=874 N=2946
% % % % % % 
N. of consultations with relevant symptoms between 2-12 months pre-diagnosis
0 consultations 34.1 50.6 39.7 <0.001 39.8 57.6 45.0 <0.001 0.012 <0.001
1-2 consultations 47.8 33.8 43.1 44.7 29.6 40.2
3+ consultations 18.1 15.5 17.3 15.5 12.8 14.7
At least one alarm symptom (anaemia, rectal bleeding, change in bowel habits) 
2-12 months pre-diagnosis 37.7 20.1 31.8 <0.001 34.5 14.5 28.6 <0.001 0.002 0.009
12-23 months 7.4 8.3 7.7 0.413 5.3 5.3 5.3 0.960 0.010 <0.001
24-36 months 4.5 5.3 4.8 0.316 3.1 4.4 3.5 0.102 0.336 0.017
Specific symptoms* 
Change in bowel habit 
New onset 6.7 2.0 5.1 <0.001 7.0 2.4 5.6 <0.001 0.675 0.347
Chronic 0.1 0.1 0.1 0.1 0.1 0.1
Past 1.6 1.5 1.6 1.2 0.9 1.1
Rectal bleeding
New onset 10.1 3.3 7.8 <0.001 10.3 2.9 8.1 <0.001 0.427 0.940
Chronic 1.2 0.7 1.0 1.1 0.5 0.9
Past 3.2 3.2 3.2 3.5 2.2 3.1
Anaemia 
New onset 17.5 11.7 15.6 <0.001 15.8 7.7 13.4 <0.001 <0.001 <0.001
Chronic 4.1 3.4 3.9 2.5 2.0 2.3
Past 4.6 7.8 5.7 3.4 5.4 4.0
Abdominal pain
New onset 15.1 16.6 15.6 0.781 14.7 14.3 14.6 0.987 0.024 <0.001
Chronic 6.8 6.7 6.8 4.2 4.4 4.2
Past 10.4 10.0 10.3 8.5 8.6 8.5
Constipation
New onset 5.6 6.2 5.8 0.023 4.9 5.8 5.2 0.060 0.021 0.014
Chronic 1.6 3.3 2.1 1.5 1.1 1.4
Past 6.6 6.6 6.6 4.6 6.8 5.3
Diarrhoea
New onset 6.0 6.8 6.3 0.390 6.0 6.0 6.0 0.942 0.028 <0.001
Chronic 2.5 1.6 2.2 0.9 1.0 0.9
Past 8.5 8.9 8.6 5.3 5.7 5.4
Fatigue
New onset 3.9 3.4 3.7 0.160 3.2 3.1 3.2 0.596 <0.001 <0.001
Chronic 1.8 0.9 1.5 0.7 0.3 0.6
Past 7.8 8.8 8.2 4.8 4.1 4.6
Weight loss
New onset 1.9 2.0 2.0 0.962 2.5 2.9 2.6 0.796 0.574 0.061
Chronic 0.1 0.1 0.1 0.2 0.1 0.2
Past 2.0 2.1 2.1 1.3 1.6 1.4
Benign GI diagnosis recorded between 2-12 months pre-diagnosis 
IBS or Diverticular disease ᵒ
New onset 5.1 6.0 5.4 0.678 3.4 2.3 3.1 0.258 0.000 0.000
Chronic 0.8 0.9 0.8 0.5 0.2 0.4
Past 4.6 5.2 4.8 2.1 2.3 2.2
Haemorrhoids
New onset 2.0 0.7 1.6 0.013 2.0 1.1 1.8 0.344 0.421 0.905
Chronic 0.5 0.2 0.4 0.5 0.3 0.5
Past 3.2 2.0 2.8 2.8 3.0 2.8
3+ Pre-referral consultations for relevant symptoms pre-diagnosis (only patients with referral: 687 women and 674 men) 
14.2 21.7 15.6 0.033 12.7 21.0 14.0 0.027 0.897 0.397
Comorbidities recorded in HES between 0-24 months pre-diagnosis 
0 77.6 63.3 72.8 <0.001 74.5 58.1 69.6 <0.001 0.038 0.003
1-2 19.4 30.0 22.9 20.8 32.7 24.3
3+ 3.1 6.7 4.3 4.7 9.2 6.0
Table 2: GP consulations, symptoms and benign diagnoses among patients diagnosed with colon cancer 
following emergency presentation (EP) and Non-emergency presentation (non-EP) 
* New onset=symptom recorded for the first time during the pre-diagnostic year with no prior record of the same symptom; Chronic=recorded 
both during the pre-diagnostic year and in previous years; Past=recorded only in the past 2-5 years, with no record in the pre-diagnostic year
 ᵒ  Irritable bowel syndrome (IBS) and diverticular disease were grouped together due to sparse data (diverticular disease n=183 and IBS n=98)
 WOMEN  MEN  
^Chi-square test comparing EP vs non-EP; ᵃ Chi-square test comparing women EP vs men EP; ᵇ Chi-square test comparing women vs men overall 
(including EP and non-EP)
 81 
OR p-value
Gender Men 1
Women 1.20 1.06 1.35 0.005
Age (years) 18-59 1.83 1.50 2.24 0.000
60-69 1
70-79 1.32 1.11 1.57 0.002
80+ 2.23 1.87 2.67 0.000
SES (deprivation quintile) 1 (least deprived#) 1
2 1.17 0.98 1.40 0.091
3 1.03 0.86 1.24 0.758
4 1.14 0.94 1.37 0.186
5 (most deprived) 1.39 1.13 1.72 0.002
Year of diagnosis 2005-2006 1
2007-2008 0.79 0.68 0.92 0.002
2009-2010 0.78 0.67 0.90 0.001
Cancer sub-site colon proximal 1
colon dis ta l 0.93 0.82 1.07 0.323
colon unspeci fied 1.28 1.05 1.56 0.016
N. visits during 2-12 months pre-diagnosis 0.99 0.98 0.99 0.000
Change in bowel habit Never 1
New onset 0.30 0.21 0.43 0.000
Chronic/past 0.70 0.41 1.19 0.184
Rectal bleeding Never 1
New onset 0.26 0.19 0.35 0.000
Chronic/past 0.62 0.45 0.87 0.005
Anaemia Never 1
Chronic 0.60 0.41 0.87 0.007
New onset 0.44 0.36 0.53 0.000
Past 1.20 0.91 1.58 0.201
Abdominal pain Never 1
Chronic 0.98 0.73 1.31 0.880
New onset 0.99 0.82 1.19 0.914
Past 1.06 0.85 1.32 0.604
Constipation Never 1
Chronic 1.40 0.89 2.20 0.145
New onset 1.13 0.86 1.48 0.392
Past 1.13 0.87 1.47 0.352
Diarrhoea Never 1
Chronic 0.78 0.47 1.32 0.361
New onset 1.04 0.81 1.35 0.743
Past 1.01 0.79 1.29 0.928
Fatigue Never 1
Chronic 0.43 0.21 0.86 0.017
New onset 0.92 0.66 1.29 0.632
Past 0.95 0.73 1.22 0.668
Weight loss Never 1
New onset 1.01 0.68 1.50 0.954
Chronic/past 1.10 0.69 1.74 0.695
IBS or Diverticular disease Never 1
New onset 1.06 0.78 1.45 0.696
Chronic/past 1.19 0.87 1.63 0.278
Haemorrhoids Never 1
New onset 0.49 0.27 0.90 0.022
Chronic/past 0.84 0.58 1.22 0.361
3+ Pre-referral consultations with relevant symptoms 2-12 months pre-diagnosis
0-2 1
3+ 1.25 1.06 1.56 0.048
Comorbidities recorded in HES between 0-24 months pre-diagnosis 
0 1
1+ 2.15 1.87 2.48 0.000
95% CI
Table 3: Mixed effects logistic regression Odds Ratios (OR) for colon cancers diagnosed 
after Emergency Presentation (EP) versus non-EP, taking socio-demographic 
characteristics, GP consultations and clinical history  into account (N=5745)
Adjusted ORs for both genders
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OR p-value
Age (years) 40-59 4.41 1.3 14.9 0.017
60-69 1.43 0.6 3.7 0.464
70+ 1.29 0.8 2.1 0.322
Table 4: Odds Ratios (OR) for the association between a recent benign diagnosis 
(IBS/diverticular disease) and emergency presentations among women only 
stratified by age
Adjusted ORs for women only
95% CI
Mixed effects binary logistic regression ORs estimated in separate models for each age group, 
controlling for sociodemographic factors, cancer sub-site and symptoms
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Figure titles and legends 
 
Figure 1: Consultation rates with relevant symptoms for men and women with proximal or 
distal colon cancer diagnosed following an emergency presentation (EP) and non-emergency 
presentation (non-EP)  
Note: Observed data points and fitted local polynomial regression lines on logarithmic scale 
 
Figure 2: Odds Ratios for women and men diagnosed with proximal or distal colon cancer after 
Emergency Presentation (EP) compared to non-EP  
Note: Multinomial logistic regression taking socio-demographic characteristics, GP 
consultations and clinical history into account 
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Figure 1: Consultation rates with relevant symptoms for men and women with proximal or distal colon cancer diagnosed following an emergency 
presentation (EP) and non-emergency presentation (non-EP)  
 
Note: Observed data points and fitted local polynomial regression lines on logarithmic scale 
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Figure 2: Odds Ratios for women and men diagnosed with proximal or distal colon cancer after Emergency Presentation (EP) compared to non-EP  
a) Women 
 
Note: Multinomial logistic regression taking socio-demographic characteristics, GP consultations and clinical history into account   
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b) Men  
 
Note: Multinomial logistic regression taking socio-demographic characteristics, GP consultations and clinical history into account
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Appendix Figure 1: Study sample and data sources 
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Appendix Figure 2: Incidence Rate Ratios (IRR) for GP consultation rates with relevant 
symptoms the year before colon cancer diagnosis  
  
Note: Multivariable Poisson regression taking sex, age, SES, cancer sub-site and year of 
diagnosis into account 
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OR p-value OR p-value
Age (years) 18-59 2.68 1.75 4.12 0.000 Age (years) 18-59 1.35 0.86 2.12 0.190
60-69 1 60-69 1
70-79 1.21 0.84 1.75 0.312 70-79 1.12 0.75 1.67 0.591
80+ 2.38 1.66 3.41 0.000 80+ 1.98 1.31 2.99 0.001
SES (deprivation quintile) 1 (least deprived#) 1 SES (deprivation quintile) 1 (least deprived#) 1
2 1.33 0.93 1.89 0.118 2 1.06 0.68 1.65 0.792
3 1.20 0.84 1.71 0.327 3 1.16 0.75 1.79 0.510
4 1.28 0.88 1.85 0.200 4 1.18 0.74 1.88 0.478
5 (most deprived) 1.92 1.25 2.93 0.003 5 (most deprived) 1.30 0.80 2.11 0.297
Year of diagnosis (continuous) 0.94 0.88 1.01 0.077 Year of diagnosis (continuous) 0.96 0.88 1.04 0.341
N. visits during 2-12 months pre-diagnosis 0.99 0.98 1.00 0.126 N. visits during 2-12 months pre-diagnosis 0.99 0.97 1.00 0.105
Change in bowel habit Never 1 Change in bowel habit Never 1
New onset 0.26 0.10 0.68 0.006 New onset 0.28 0.14 0.54 0.000
Chronic/past 1.55 0.55 4.38 0.404 Chronic/past 0.56 0.14 2.25 0.411
Rectal bleeding Never 1 Rectal bleeding Never 1
New onset 0.53 0.24 1.17 0.116 New onset 0.24 0.14 0.42 0.000
Chronic/past 1.32 0.71 2.45 0.379 Chronic/past 0.47 0.22 0.98 0.046
Anaemia Never 1 Anaemia Never 1
Chronic 0.72 0.42 1.23 0.231 Chronic 0.30 0.08 1.11 0.071
New onset 0.49 0.36 0.68 0.000 New onset 0.81 0.43 1.52 0.515
Only past 1.47 0.93 2.34 0.098 Only past 1.35 0.63 2.86 0.439
Constipation Never 1 Constipation Never 1
New onset 1.18 0.68 2.04 0.551 New onset 1.12 0.64 1.98 0.689
Chronic/past 1.19 0.80 1.79 0.391 Chronic/past 1.20 0.67 2.15 0.546
IBS or Diverticular disease Never 1 IBS or Diverticular disease Never 1
New onset 1.09 0.63 1.89 0.754 New onset 1.73 0.98 3.08 0.060
Chronic/past 1.06 0.64 1.76 0.815 Chronic/past 1.06 0.50 2.25 0.885
Haemorrhoids Never 1 Haemorrhoids Never 1
New onset 0.49 0.13 1.94 0.312 New onset 0.40 0.11 1.43 0.159
Chronic/past 0.44 0.19 1.00 0.050 Chronic/past 0.43 0.17 1.12 0.083
Comorbidities recorded in HES between 0-24 months pre-diagnosis Comorbidities recorded in HES between 0-24 months pre-diagnosis 
0 1 0 1
1+ 2.02 1.53 2.66 0.000 1+ 1.66 1.18 2.34 0.004
Adjusted ORs 
95% CI
Supplementary Table 1: Women with proximal colon cancer-Mixed effects binary 
logistic regression Odds Ratios (OR) for patients diagnosed after Emergency 
Presentation (EP) versus non-EP  
Supplementary Table 2: Women with distal colon cancer- Mixed effects binary 
logistic regression Odds Ratios (OR) for patients diagnosed after Emergency 
Presentation (EP) versus non-EP
Adjusted ORs 
95% CI
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Chapter 4 - The role of comorbidities in influencing timely cancer 
diagnosis 
 
This chapter addresses the third objective of the thesis, i.e. to evaluate the role of 
comorbidities in influencing timely cancer diagnosis along the diagnostic pathways and their 
impact on emergency presentations.  
This chapter includes the following two studies: 
Study 3.1- The role of comorbidities in influencing timely cancer diagnosis along the 
diagnostic pathways: A critical review of the literature 
The work performed for this study has led to a proposal for a possible publication and Nature 
Review Clinical Oncology agreed to peer-review the manuscript. I include the current version 
of the literature review (inclusive of tables, figures and references) in this chapter.  
Study 3.2- Contrasting effects of comorbidities on emergency colon cancer diagnosis: 
applying a potential outcomes approach within a longitudinal data-linkage study in England 
This study has led to a paper, which is currently under review for a possible publication and I 
present it here in its submitted form, inclusive of tables, figures and references. 
 
I introduce the above studies by providing an overview of the backgrounds and links to study 
2. Moreover, the chapter includes an overview of the aims, methods, the main findings of each 
study and a discussion of how the two papers fulfil the objectives and possible implications for 
further research and practice.  
 
Background and link to study 2 
Chronic health problems (hereafter called comorbidities) affect more than 50% of individuals 
aged 6092 93 or above and about 70% of all cancer cases also occur in patients over 60. 
Although there is a widely held belief that comorbidities influence the timely diagnosis of 
cancer and the risk of emergency presentations, evidence on the underlying mechanisms and 
on the size and direction of these postulated associations is scant31 58 60 94 95. In fact the 
available evidence has shown some contrasting findings. Complex mechanisms are probably at 
play with comorbidities influencing different stages along the diagnostic pathways, from 
patients’ help-seeking for new or evolving symptoms to clinicians’ decision-making about 
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differential diagnosis and diagnostic investigation strategies. Comorbidities might act as 
barriers or facilitators for timely diagnosis, depending on the type of comorbidity and on the 
cancer symptoms characteristics57. In the analyses performed for study 2, I have included a 
generic comorbidity measure (any comorbidity recorded in HES pre-cancer diagnosis); this has 
shown that overall having a comorbidity is associated with an increased risk of emergency 
colon cancer diagnosis. However, further work is needed to increase our understanding on the 
role played by specific comorbidities in influencing timely cancer diagnosis and the risk of 
emergency presentations in order to provide evidence that can help improve diagnostic 
strategies. 
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Study 3.1- The role of comorbidities in influencing timely cancer diagnosis along 
the diagnostic pathways: A critical review on comorbidity-specific effects and 
underlying mechanisms 
 
 
Aims and Objectives Study 3.1 
The overall aim of the study is to evaluate the role of comorbidities in influencing timely 
cancer diagnosis along the diagnostic pathways and their impact on emergency presentations.  
The specific objectives for Study 3.1 are to perform a critical review of the global literature 
evaluating the evidence on the effects of comorbidities, overall and by specific type, on each 
step along the cancer diagnostic pathways to elucidate likely mechanisms through which 
comorbidities can influence timely cancer diagnosis.  
 
Methods  
A critical review approach96, encompassing quantitative and qualitative research, was deemed 
particularly suitable for this study, which aimed to identify and critically evaluate relevant 
evidence and develop a comprehensive conceptual model, moving beyond existing theories. 
Differently from systematic reviews, aiming to systematically search and report evidence 
following specific guidelines (such as the PRISMA statement)97, critical reviews lack explicit and 
standard tools for evaluating the evidence96. In order to address this limitation, increasing the 
transparency of the review process and providing an explicit quality assessment of the 
evidence, in the present critical review I have included a detailed description of the methods 
used for searching and evaluating the evidence. More specifically, the review was based on a 
systematic methodology, including extensive literature searches of quantitative and qualitative 
studies, systematic data extraction and quality assessment using the Mixed Methods Appraisal 
Tool82. I included studies providing information on the effects of comorbidities on the 
following outcomes: help-seeking for possible cancer symptoms, clinicians’ decision-making on 
differential diagnosis, access to investigations, time to diagnosis, cancer stage at diagnosis and 
emergency presentations. Studies on any cancer were included in the review. Based on the 
available evidence I propose a conceptual framework illustrating how pre-existing morbidities 
can facilitate or impede the diagnostic process influencing the timeliness of cancer diagnosis. 
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Main results  
Encompassing evidence from 64 relevant publications on more than 20 different cancers, the 
review showed that comorbidities are generally associated with a higher risk of delayed help-
seeking, advanced stage and emergency presentations. However, contrasting effects emerged 
when comorbidity-specific information was available. Some comorbidities, such as 
neurological, pulmonary, cardiac and psychiatric disorders, are more strongly associated with 
delays. In contrast, hypertension and some benign gastrointestinal and musculoskeletal 
conditions are associated with earlier diagnosis. There is limited evidence on the underlying 
mechanisms and in particular on comorbidity-specific effects on clinicians’ decision-making 
and access to investigations.  
 
Conclusions 
The literature review has shown that comorbidities can facilitate or interfere with timely 
cancer diagnosis acting through different mechanisms at multiple steps of the diagnostic 
pathways. Effects vary by comorbidity type and the nature of cancer symptoms, with some 
neurological, pulmonary, cardiac, psychiatric disorders being more strongly associated with 
delays.  
 
Fulfilment of the study objectives and implications for research and practice 
The literature review has allowed to shed light on the complex role played by comorbidities in 
influencing timely cancer diagnosis along diagnostic pathways. By integrating the findings from 
qualitative and quantitative studies the review has led to an evidence-based illustration of 
various mechanisms through which comorbidities can interfere with or facilitate timely cancer 
diagnosis influencing patient's help-seeking, doctors' decision-making on diagnostic strategies 
and access to investigations. The evidence on comorbidity-specific effects reported in the 
review can inform further research and can help to develop innovative interventions aimed at 
improving cancer diagnosis for the large number of people with chronic conditions 
experiencing possible cancer symptoms. These could include tailored risk-assessment tools 
and guidelines addressing the management of specific symptom-comorbidity pairs and related 
diagnostic approaches. In order to develop improved diagnostic strategies for comorbid 
individuals who present with cancer symptom, more in-depth research is necessary based on 
large prospectively recorded population-based data, including information on specific 
comorbidities and symptomatic presentations pre-cancer diagnosis, taking socio-demographic 
factors and cancer sub-types into account. 
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Abstract 
Background 
Individuals with possible cancer symptoms often have pre-existing chronic diseases 
(comorbidities). We aimed to evaluate the evidence on the effects of comorbidities, overall 
and by specific condition, on each step along the diagnostic pathways to elucidate likely 
mechanisms through which they can influence the timeliness of cancer diagnosis. 
Methods 
We employed a systematic methodology, including extensive literature searches of 
quantitative and qualitative studies, systematic data extraction and quality assessment using 
the Mixed Methods Appraisal Tool. A narrative data synthesis complemented quantitative 
findings. Studies were included if they provided information on the effects of comorbidities on 
the following outcomes: patient help-seeking for possible cancer symptoms; clinicians’ 
decision-making regarding differential diagnosis, referrals or use of investigations; time to 
diagnosis, cancer stage and emergency presentations.  
Results 
Among 2,272 screened papers we identified 63 relevant studies (n=53 quantitative, n=9 
qualitative, n=1 mixed methods), including evidence on more than 20 different cancers, most 
frequently on colorectal (n=25), lung (n=15) and breast (n=11) cancer. A total of 34 studies 
evaluated specific comorbidities, while 29 papers only examined the overall effect of having 
one or more comorbid conditions. Comorbidities were generally associated with a higher risk 
of delayed help-seeking, advanced stage and emergency presentations, but contrasting effects 
emerged when these associations were examined for specific comorbidities. Neurological, 
pulmonary, cardiac and psychiatric disorders, were more strongly associated with delays. In 
contrast, hypertension and some benign gastrointestinal and musculoskeletal conditions were 
associated with earlier diagnosis. Evidence on the underlying mechanisms and comorbidity-
specific effects on clinicians’ decision-making and use of investigations is scant. Available data 
generally concord with the ‘alternative explanations’ hypothesis (when comorbidities and 
cancer present with overlapping symptoms) and the ‘competing demands’ hypothesis (when 
serious/complex comorbidities distract the doctor or patient from prompt cancer 
investigations; both such mechanisms are associated with prolonged intervals to diagnosis of 
cancer. Data on healthcare encounters related to monitoring of ‘risk-factor comorbidities’ (e.g. 
hypertension) show that these can offer opportunities for reporting of cancer symptoms and 
they are associated with earlier cancer diagnosis, supporting the ‘surveillance hypothesis’. 
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Further mechanisms leading to delays have emerged, included false reassurance by 
investigations performed for a chronic disease.   
Conclusions 
Different comorbidities can have multiple and sometimes contrasting effects on each step 
along diagnostic pathways and influence the timely diagnosis of cancer. Examining 
comorbidity-specific effects can inform diagnostic strategies for the large number of 
individuals with comorbidities. 
 
Key messages 
 Individuals with possible cancer symptoms often have pre-existing chronic diseases 
(comorbidities).  
 Available evidence shows that comorbidities can either facilitate or interfere with 
timely cancer diagnosis acting through different mechanisms at multiple points along 
the diagnostic pathways. 
 Effects vary by comorbidity type and the nature of cancer symptoms, with some 
neurological, pulmonary, cardiac, psychiatric disorders being more strongly associated 
with delays. 
 By evaluating morbidity-specific effects on help-seeking, clinical decision-making on 
diagnostic strategies and use of investigations, stage and emergency presentations, 
possible targeted interventions can be developed for improving cancer diagnosis. 
 
 
 
 
  
 
 
 99 
Introduction 
Individuals with possible cancer symptoms often also have a pre-existing chronic diseases. 
Chronic morbidities (hereafter called comorbidities) affect more than half of individuals over 
the age of 601, with a quarter having two or more morbidities2 3. As older age is associated with 
both a higher prevalence of chronic diseases and a higher risk of cancer, and because 
diagnostic timeliness is linked to a range of clinical, healthcare utilisation and patient-reported 
outcomes4 5, it is important to examine the role of comorbidities on cancer diagnosis. A recent 
review examined the relationships between cancer and some chronic diseases (e.g. obesity 
and diabetes), highlighting their complex effects on cancer incidence and prognosis 5. The 
available evidence indicated that obesity can increase the risk of both type 2 diabetes mellitus 
and certain cancers; some treatments for diabetes also influence the risk and prognosis of 
cancer.  
Despite an increasing recognition of the complex interplay between pre-existing chronic 
diseases and cancer, a comprehensive evaluation of their effects on the diagnostic process is 
lacking. As achieving early diagnosis of cancer is one of the principal strategies for cancer 
control4, a better understanding of how pre-existing chronic diseases influence diagnostic 
pathways for cancer is needed. It is believed that comorbidities can influence the timely 
diagnosis of cancer6 7, but the evidence on their specific effect and on the underlying 
mechanisms is scarce. Various hypotheses have been suggested (summarized in Box 1), 
including: a) an alternative explanation hypothesis, with cancer symptoms being interpreted 
by patients and/or doctors as being due to the underlying comorbidity, causing delays in the 
diagnostic process; b) a competing demand hypothesis, with comorbidities distracting the 
patient’s and/or the doctor’s attention from the cancer diagnosis; c) a surveillance effect, with 
comorbid patients having more frequent healthcare encounters, offering opportunities for 
earlier cancer diagnosis8-11; d) a pathological hypothesis, with some comorbidities or their 
treatments interacting with cancer pathogenesis and influencing cancer aggressiveness at the 
cellular or physiological level9 12.  
A few reviews have considered the overall effect of having any versus no comorbidity11 13-15, 
but they lacked an evaluation of comorbidity-specific effects on different steps along the 
diagnostic pathways. This is however essential for informing the development of targeted 
interventions aimed at improving early cancer diagnosis for the large number of individuals 
with pre-existing chronic conditions. 
In this review we aimed to evaluate the available literature on the role of comorbidities, 
overall and by specific type of comorbidity, in influencing timely cancer diagnosis along the 
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diagnostic pathways. As we specifically aimed to increase our understanding on the underlying 
mechanism through which comorbidities influence timely cancer diagnosis, we examined the 
available evidence on their effects on patients' help-seeking for cancer symptoms; clinicians’ 
decision-making regarding referrals and use of investigations; time to diagnosis; cancer stage 
and emergency presentations.  
 
Box 1: Theories on possible mechanisms through which comorbidities might influence the 
cancer diagnosis 
Alternative explanation: Cancer symptoms can be attributed by patients and/or doctors to a 
pre-existing chronic condition or its treatment, delaying the diagnostic process. This 
mechanism might be relevant when symptoms of cancer and of the chronic condition 
overlap.8-11 
Competing demands: Chronic conditions can distract the patient’s and/or the doctor’s 
attention from appraising and investigating new symptoms that might be due to cancer, 
particularly if symptoms are vague. This mechanism might be relevant in the case of chronic 
conditions that are complex to manage or that require urgent clinical attention (for example 
heart problems) or are perceived to be of particular gravity by the patient and/or healthcare 
provider.16  
Surveillance effect: Some chronic conditions are associated with frequent healthcare 
encounters for monitoring or treatment of chronic conditions. These encounters can offer 
opportunities for patients to mention possible cancer symptoms to the healthcare provider, or 
the healthcare provider might notice a new sign/symptom and this might lead to earlier cancer 
diagnosis. This mechanism might be particularly relevant in the case of ‘risk factors’ conditions, 
such as monitoring/management of hypertension or hypercholestorolaemia.17   
Pathological hypothesis: Some chronic conditions or their treatments interact with cancer 
pathogenesis, influencing cancer aggressiveness at the cellular or physiological level9 12.  
 
Methods 
Search strategy and key words 
The review included original research based on quantitative, qualitative and mixed methods, 
with no language or publication time restrictions. The inclusion of qualitative studies based on 
in-depth interviews was deemed necessary in order to acquire insights into the complex 
effects of comorbidities and better understand the underlying mechanisms linking 
comorbidities to help-seeking, diagnostic approaches, use of investigations and timely cancer 
diagnosis.  
We included studies providing information on the effects of comorbidities on the following 
process and outcome measures characterizing the diagnostic journey: a) process measures - 
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patients' help-seeking for cancer symptoms; clinicians’ decision-making regarding referrals, 
diagnostic approaches and use of investigations; time to diagnosis; b) outcome measures- 
stage at diagnosis; emergency presentations.  
The use of an iterative method, with various search term combinations and a ‘snowball’ 
approach, with one reference leading to others18, is particularly suited to identify qualitative 
papers. Identification of relevant qualitative papers is often difficult because indexing is less 
well-developed than for quantitative studies.  We relied on a combination of search strategies, 
including in-depth searches of electronic databases (PubMed, EMBASE, PsychInfo, CINAHL) 
using MeSH and free text key words, searching names of key authors and articles listed as 
'related' in PubMed, and searching the references in relevant publications. The last search date 
was April 2018. 
Because we were interested solely on the influence of morbidity on symptomatic patients, we 
excluded studies on cancer diagnosis following screening, studies on childhood cancers and 
those evaluating the effect of comorbidities on events occurring after the cancer diagnosis 
(e.g. cancer treatment, postoperative complications, mortality). We only included original 
research and excluded editorials and reviews. Studies on any cancer type were included. 
The systematic search combined the following terms: ‘comorbidit*’ or ‘co-morbid*’ or 
‘chronic’ and ’neoplasm’ or ‘cancer’ and ’emergenc*’ or ‘urgent’ or ‘stage’ or ‘help-seeking’ or 
‘delay*’ or 'time to diagnosis' or ‘diagnostic’ or ‘diagnostic interval’ or ‘patient interval’ or 
‘referrals’ or ‘investigation*’.  
For many terms used in this review there is no internationally agreed definition and sometimes 
ambiguous terminology is used in the literature. We have chosen simple definitions embracing 
the most commonly used terms (Box 2). 
Initially, one reviewer (CR) conducted the search, screened titles and abstracts and excluded 
irrelevant publications. Subsequently two reviewers (CR, AK) evaluated the full-text of relevant 
articles and extracted information following standard methods19 20. Qualitative papers were 
repeatedly read in order to identify common or contrasting themes. Using the extracted 
results we developed textual summaries and tables, which enabled us to further refine 
emerging themes. Any disagreement was resolved via a discussion. Employing an iterative 
process with discussions between reviewers a consensus was reached and we developed a 
final narrative synthesis of key themes shared across studies18 21.  
All included studies were assessed and synthesised using qualitative methods. We used quotes 
from qualitative studies to illustrate the findings and complement the quantitative 
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information. In particular, while quantitative studies can provide an indication of the frequency 
and size of the effect in the population, qualitative research has been used to gain more in-
depth information on the underlying mechanisms. Due to marked heterogeneity between 
studies in terms of exposures and outcomes no quantitative synthesis was performed. A 
systematic evaluation of the evidence was performed assigning a quality score to each 
reference according to the Mixed Methods Appraisal Tool (MMAT)22. The MMAT is a validated 
quality assessment tool to support reviews including qualitative, quantitative and mixed 
methods studies and evaluates each study based on various criteria specific for the different 
study designs. The highest possible score is 100% if all criteria are met. Two reviewers (CR and 
AK) assigned quality scores independently. The level of agreement between reviewers was 
high and minor disagreement regarding only a few sub-scores was resolved by discussion. In 
line with previous publications 23 24 we decided not to exclude studies based on the quality 
scores, but rather to take an inclusive approach aimed at identifying research that could give a 
relevant contribution. 
 
Box 2: Key Terminology  
For many terms used in this review there is no internationally agreed definition and 
inconsistent and sometimes ambiguous terminology is used in the literature. For the purpose 
of this review, we have chosen simple definitions embracing the most commonly used terms.  
Comorbidity: one or more co-existing chronic conditions affecting a patient diagnosed with 
cancer or with possible cancer symptoms or investigated for a possible cancer. In the literature 
definitions and data sources for identifying comorbidities vary widely25. Comorbidity measures 
can range from aggregated scores based on secondary care records (for example, Charlson 
comorbidity index), specific comorbidities identified through case note reviews of primary or 
secondary care records and patient reported measure of long standing conditions. 
Emergency cancer diagnosis/emergency presentation: cancer diagnosed shortly after the 
patient has had an emergency hospital admission. Definitions in the literature vary widely15, 
but our definition is in line with a frequently used standard definition based on the Routes to 
Diagnosis algorithm26. 
Diagnostic time or diagnostic interval: time from first symptomatic presentation in primary 
care to cancer diagnosis. Definition in line with the Aarhus statement27. 
Diagnostic delay: prolonged time before the cancer diagnosis, according to the definitions 
provided by the authors of each primary study included in the review. Frequently adopted 
definitions of diagnostic delay include >3 months, >6 months or median time significantly 
longer compared to a study-specific reference group. Evaluating the diagnostic interval rather 
than diagnostic delay is preferable, as the latter requires subjective adjudication/judgements 
which may have poor reproducibility28, but as this information was not always reported in 
primary studies, we considered both measures.    
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Help-seeking or patient interval: time from when a patient first notices a symptom to first 
medical visit for that symptom. This can be based on actual patient experiences or on intended 
help-seeking behaviour depending on the design of the included primary studies. Definition in 
line with the Aarhus statement27. 
Help-seeking delay or patient delay: prolonged time between first noticing a symptom and 
initial help-seeking for the symptom, according to the definitions provided by the authors of 
each primary study included in the review. Frequently adopted definitions of delay include >3 
weeks, >3 months or median time significantly longer compared to that observed for a 
reference group. Evaluating the patient interval rather than patient delay is preferable, as the 
latter requires subjective adjudication/judgements which may have poor reproducibility28, but 
as this information was not always reported in primary studies, we considered both measures. 
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Results 
We screened 2,272 papers and identified 63 relevant studies (Figure 1). As described in table 1, 
among the relevant studies, 15 provided information on the effect of comorbidities on help-
seeking, 22 on time to diagnosis or delays, 14 on referrals, diagnostic processes or 
investigations, 21 on stage at diagnosis and 17 on emergency presentations. A few publications 
examined multiple measures of interest. About half of the studies (n=34) examined the effect 
by specific comorbidity type. Most studies were based on quantitative methods, with 9 
qualitative and 1 mixed methods study. Comorbidity measures varied between studies, 
including aggregated measures or scores based on secondary care records(n=28 studies) (most 
frequently, the Charlson comorbidity index); specific comorbidities identified through case 
note reviews of primary or secondary care records (n=26); patient reported measure of long 
standing conditions (n=8); and retrospective qualitative reports by healthcare providers (n=1).  
In 28 publications comorbidities were associated with increased risk of prolonged time to help-
seeking, diagnostic delays (with definitions varying by study), advanced stage or emergency 
presentation. In 14 studies effects in opposing directions were reported with some 
comorbidities increasing and others decreasing the risk of delays. In five publications, the 
examined comorbidities consistently facilitated prompt help-seeking, diagnostic timeliness or 
reduced the risk of emergency presentation and advanced stage. Ten studies reported no 
significant effect of comorbidities on any of the examined outcomes. The most frequently 
studied cancers were CRC (n=25 studies), lung (n=15) and breast (n=11). Sample sizes in 
quantitative studies ranged between 72 and 133,540. Most studies included patients 
diagnosed with cancer, with only a few studies including individuals with possible cancer 
symptoms (n=4) or affected by a comorbidity (n=1). One study included healthcare providers. 
We hereafter examine associations between comorbidities and specific aspects of the 
diagnostic process. 
 
Effect on help-seeking for possible cancer symptoms  
Publications providing information on help-seeking for possible cancer symptoms (n=15) 
reported how comorbidities were associated with delays (n=5 studies)29-34 or showed 
contrasting effects with some comorbidities increasing prompt help-seeking and others 
delaying help-seeking (n=5 studies)35-39. In three papers40-42 comorbidities had no effect on 
help-seeking, while in one paper comorbidities were associated with prompt help-seeking43.  
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Research examining specific comorbidities (n=12 studies) has shown how the effects can vary 
by comorbidity type and symptom characteristics. For example, a quantitative study on lung 
cancer38 showed how patients with COPD took twice as long to consult with lung cancer 
symptoms (mean help-seeking interval 166 versus 81 days), while those with a history of renal 
failure or chest infections had a significantly shorter help-seeking interval than non-comorbid 
patients (mean interval 53 versus 102 and 31 versus 102 days, respectively). A survey on help-
seeking for various cancer symptoms37 showed how hypertension increased the likelihood of 
help-seeking for cough (OR=2.0; 95%CI 1.1-3.5) or abdominal bloating (OR=2.3; 95%CI 1.1-4.8). 
Urinary comorbidities increased help-seeking for abdominal bloating (OR=5.4; 95%CI 1.2-23.7) 
and rectal bleeding (OR=5.8; 95%CI 1.4-23.8). In contrast cardiac comorbidities were 
associated with a lower likelihood of help-seeking for change in bowel habits (OR=0.4; 95%CI 
0.2-1.0). These findings would seem to concord with a ‘competing demands’ mechanism, 
whereby comorbidities may lead to delays if they are perceived to be of particular gravity 
(such as heart problems) diverting attention from new symptoms, particularly if those are 
vague. On the other hand, in line with the surveillance hypothesis, some comorbidities, such as 
hypertension, can enable the reporting of cancer symptoms during healthcare encounters 
performed for the chronic problem.  
Evidence from qualitative studies supporting a likely alternative explanation 
mechanism 
While quantitative studies provided information of the size of the effect in the population, 
with some indication on possible underlying mechanisms, additional details on specific 
mechanisms were provided by qualitative research. Six such studies illustrated underlying 
mechanisms as summarized in Table 2.  
Various authors have shown how patients (and their carers) may attribute cancer symptoms to 
pre-existing diseases offering alternative explanations. This has been reported most frequently 
in the case of chronic respiratory comorbidities (COPD and asthma) delaying help-seeking for 
lung cancer symptoms, as well as in the case of gastro-intestinal comorbidities delaying help-
seeking for colorectal cancer symptoms 29 30 35 38. A lung cancer patient delaying help-seeking 
reported: "I thought it was my asthma getting worse because I was getting more breathless I 
honestly truly believed it was my asthma getting worse”. (Female, age 55-59)29. Another 
patient whose lung cancer was opportunistically detected reported: "I've always been 
breathless for 30-odd, it's 34 years since I got this heart disease, then I have COPD and 
emphysema”. (Male, 55-59 years) 29.  
 
 
 106 
Patients sometimes attributed new symptoms to comorbidity treatments. For example, a 
colorectal cancer patient reported: "I suppose really, I’d hear so much from different people, 
that you get side effects with Statins ... and it was a while after when I got these sensations 
[bowel movements] you know, that; and I thought ooh, you know, is it because I’m taking these 
Statins, the different ones…" (Female, age 73, colorectal cancer)35. 
Some comorbidities increased patients' worries about appearing hypochondriacal 30: "When I 
used to go back to them I used to think, 'Is it me?'  Because I was depressed I thought that 
maybe I am overreacting sometimes and I used to feel guilty going to them to be honest... I was 
thinking is it really pain or is it in my mind? (Colorectal cancer patient diagnosed as an 
emergency)". 
Evidence from qualitative studies supporting a likely surveillance mechanism 
Sometimes patients feel that help-seeking for vague symptoms is only appropriate if the 
consultation is needed for a co-existing morbidity44. Patients with comorbidities can acquire 
substantial experience, allowing them to identify subtle changes in their symptoms compared 
to their underlying comorbidity and non-response to comorbidity medication, which can 
trigger help-seeking: "It wasn't like my normal asthma cough, I'd use my inhaler it had no 
impact al all...still continue coughing.” (Female, age 45-49)29 
Familiarity with the healthcare provider and/or system or preferential pathways for patients 
with chronic diseases may also facilitate help-seeking for other health concerns. A patient with 
COPD reported: "Cause, I'm allowed to get an emergency appointment...at any time, you 
know, I've been told you just ring them up, you tell them what your problems is..." (Female, age 
74)39. Comorbid patients can also have previous positive healthcare experiences motivating 
them to seek help promptly when they anticipate that a prescription can alleviate symptoms: 
"I thought it might be chest infection in which case you know, antibiotics and away you go 
(Female, age 65-69, lung cancer) 29.  
In some cases, patients did not notice any symptoms and the cancer is detected incidentally 
when undergoing diagnostic investigations for a comorbidity: "...had it not been picked up on 
the scan I still wouldn't have gone to the GP." (Female, 65-69, lung cancer)29.  
Overall, the evidence suggests that comorbidities can influence help-seeking for cancer 
symptoms through multiple and sometimes competing mechanism, depending on 
comorbidity, cancer symptom characteristics and health-care system factors. Qualitative 
studies illustrate how comorbidities can interfere with symptom attribution and help-seeking, 
most frequently because they provide alternative explanations. Some limited evidence also 
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shows how comorbidities can facilitate help-seeking and reporting of cancer symptoms 
through various mechanisms.   
 
Post-presentation effects  
Comorbidities can influence the diagnostic processes taking place after patients have initially 
presented to their doctor with possible cancer symptoms. In particular, they can have an effect 
on healthcare providers’ decision-making (sometimes in combination with patient factors) 
regarding referring the patient for specialist investigations, as well as affecting access to and 
performance of diagnostic tests.  
Effects on the diagnostic process, referrals and use of investigations 
Some publications provided information on the diagnostic process and use of investigations 
(n=14). Among them, nine studies examined specific comorbidities, based on quantitative 33 42 
45, qualitative 29 35 36, mixed methods34 or significant event audits46 47. The remaining five studies 
only examined the overall effect of any comorbidity41 48-51. Evidence based on interviews with 
healthcare providers is particularly scant51 52. 
There was no significant association of having any comorbidity versus none on GP referrals to a 
specialist for gynaecological cancers41 or on gastroscopy rates among oesophago-gastric 
cancer patients50. On the other hand studies examining specific comorbidities have shown how 
congestive heart failure or coronary artery disease can lead to missed opportunities to 
promptly refer patients for endoscopic examination45, despite symptoms of colorectal cancer, 
in line with the competing demands mechanisms. Psychiatric illness was also associated with a 
significant delay before GP referral to a specialist or colonoscopy (with referral occurring after 
more than 60 days) in a study on colorectal cancer (OR=4.0 (95%CI 1.1-13.9))33. Moreover, 
patients consulting more frequently for a variety of complaints seemed to be referred less 
frequently for investigations in another study34. 
Effects on the diagnostic interval 
A number of studies provided information on effects of comorbidity on diagnostic delay or 
time between the initial visit with possible cancer symptoms and the cancer diagnosis (n=22). 
Eleven of them examined comorbidity-specific effects using either quantitative10 33 42 53 54, 
qualitative29 31 35 46 47 or mixed methods34, while the remaining studies only examined the 
overall effect of any comorbidity32 41 49 51 52 55-60.  
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Overall, having any comorbidity was strongly associated with diagnostic delays, according to 
two large quantitative studies on leukemia and myeloma58 59 and a lymphoma study49. For 
example, chronic lymphocytic leukemia patients with a comorbidity versus none had OR=2.83 
(95%CI 2.5-3.3) of diagnostic delay (defined as longer than the average time of 63 days 
between first symptomatic presentation and diagnosis)59. Diagnostic delay was also reported 
for upper aerodigestive tract cancer patients with comorbidity versus none (OR=2.84; 95%CI 
1.35-5.98)55 and for oral cancers32. In particular, among patients with laryngeal cancer55, a 
diagnostic interval of more than one year was experienced by 42% of patients with Charlson 
comorbidity score>3 versus 7% for those with comorbidity score 0-2. 
A study10 classifying comorbidities as competing demands and alternative explanations 
showed that both comorbidity types are associated with longer diagnostic intervals for 
colorectal cancer: a single competing demand delayed diagnosis by 10 days, and four or more 
comorbidities by 32 days; a single alternative explanation delayed diagnosis by 9 days. Some 
specific comorbidities were associated with longer diagnostic intervals: the longest being 26 
days for inflammatory bowel disease (1.33; 95%CI 1.18-1.51), but coronary heart disease 
(OR=1.20; 95%CI 1.09-1.31), anxiety/depression (OR=1.12; 95%CI 1.03-1.22) and diverticular 
disease OR=1.18; 95%CI 1.03-1.35) were also associated with longer diagnostic intervals. 
Comorbidity effects were stronger among individuals aged 80 or more.  
Similarly, mental health problems and gastro-intestinal comorbidities were associated with 
longer diagnostic interval in a large study on colorectal cancer42. Psychiatric illness was also 
associated with delayed diagnosis of oesophageal cancer (median time from alarm symptom 
to diagnosis 90 days in comorbid versus 35 days in non-comorbid patients, p<0.001)53.  
Evidence from qualitative studies supporting a likely alternative explanation 
mechanism 
Additional details on specific mechanisms were provided by qualitative research and 
significant event audits (Table 2). In particular, in agreement with the alternative explanation 
hypothesis, significant event audits47 and patient interviews29 highlighted how comorbidities 
sometimes lead to missed opportunities because symptoms are attributed by the doctor to a 
comorbidity or its treatments despite patients repeated symptomatic presentations. For 
example, a lung cancer patient diagnosed as an emergency reported: ‘To my GP I always said 
that I felt out of breath but he thought because I was asthmatic it had to do with the asthma’ 
(Male, lung cancer)30. Alternative explanations are sometimes reinforced between doctors and 
patients: "I was getting breathless, I was getting breathless. But as I say again I was putting it 
all down to my asthma...The doctors were saying 'take your blue inhaler, your blue thing more 
often'." (Female, age 61, lung cancer)35. Various lung cancer studies report similar findings: 
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"...when I went to see the consultant (for cardiac problems) I did mention to him purely as an 
after thought...I had a slight ache in the chest which I put down to advancing age or something 
and, you know. He said that is a classic what they call walk through angina..." 31.  
Interviews with GPs52 support these findings, with a study showing that comorbidities led to 
primary care delays for 23% of cancer patients, most frequently because of alternative 
explanations: in 90% of comorbid lung cancer patients with primary care delays symptoms 
were ascribed to a pre-existing disease; in 10% of cases delays were due to competing 
demands, as an acute disease diverted clinical attention. Review of GP free text notes34 also 
showed how comorbidities led to missed diagnostic opportunities in patients with a history of 
diverticulitis, gynaecological conditions or urinary tract infection with both GPs and specialists 
initially attributing colorectal cancer symptoms to these conditions or to comorbidity 
medications.  
Evidence from qualitative studies supporting a likely competing demand mechanism 
Doctors sometime prioritize the treatment of comorbidities or worry about a comorbid 
patient’s poor health status delaying invasive investigations. A patient with possible cancer 
symptoms reported: ’...Oh yeah, everything has been pushed into the side grass because she 
said, “Nobody will operate when you’ve got this high blood pressure, we must get it down.” So 
we are focusing on that at the moment…” (Female, 79 years)36.  
Evidence from qualitative studies indicating multiple mechanism  
Often comorbidities can act through multiple mechanisms simultaneously, with GP interviews 
showing how comorbidities can contribute to misinterpretation of blood tests or to symptoms 
being attributed to comorbidities when a chest x-ray is negative52. According to reports from 
both doctors and patients over-reassurance from investigations in conjunction with 
comorbidities, as well as reluctance to refer patients again after a negative test can lead to 
delays: "Because I had the x-ray in July Dr didn't think it (pain) would be anything but we would 
keep an eye on it...I was going to the doctors maybe once a fortnight, once a month and every 
time it was for something else..." (Female 55-59, lung cancer patient)29. A GP reported: “It’s a 
big step for us to then refer them on, and say, I know this chap’s a smoker and he’s got a 
persistent cough, his bloods are normal, his chest X-ray shows nothing. I’d be grateful if you 
could exclude a lung cancer. We don’t do many of those do we?”51.  
Sometimes the diagnostic process can be particularly complicated and referring patients for 
investigations can lead to the diagnosis of other previously undetected morbidities distracting 
healthcare providers from the underlying cancer, which is only diagnosed after multiple visits. 
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Healthcare providers, both in primary and secondary care, often have to overcome diagnostic 
challenges due to alternative explanations and competing demands when dealing with 
patients with comorbidities46.  
Evidence from qualitative studies supporting a likely surveillance mechanism 
In contrast to previously reported mechanisms leading to delays, healthcare providers 
sometimes go beyond possible alternative explanations and refer patients for 
investigations:"...I went to the doctors...and his diagnosis was haemorrhoids, but he referred 
me to [name of hospital]." (Male, age 33, colorectal cancer) 35. Visits for a comorbidity can also 
offer healthcare providers opportunities to identify cancer signs or symptoms not mentioned 
by patients. For example, according to significant event audits, a nurse noticed weight loss in a 
patient repeatedly seen for COPD and despite the patient's initial refusal, the nurse convinced 
the patient to consult the GP46.  
Overall, the limited evidence suggests that comorbidities can influence doctors’ decision-
making regarding diagnostic processes and access to diagnostic investigations, through various 
mechanisms. These include alternative explanations, competing demands and over-
reassurance following previous investigations resulting in a non-cancer diagnosis. In contrast, 
comorbidities sometimes provide opportunities for earlier diagnosis that can be seized by 
healthcare professionals.   
 
Effect on performance of investigations 
The evidence on the effects of comorbidities on performance of investigations is extremely 
scant. One study48 showed a higher risk of colorectal cancer diagnosed within 5 years from a 
negative colonoscopy among patients with comorbidities (OR=1.16; 95%CI 1.1-1.3). In most 
cases a cancer diagnosis following a previous negative colonoscopy is due to missed lesions or 
incomplete polypectomy. Comorbidities might lead to difficulties with bowel preparation 
and/or increased technical difficulties for the endoscopist, because of past abdominal or pelvic 
surgery, or reduced patient tolerance during the examination, interfering with the endoscopic 
examination and compromising early cancer diagnosis.  
 
Effect on emergency presentations 
The majority of published evidence (n=15 studies) suggests that patients affected by 
comorbidities have a higher risk of diagnosis of cancer as an emergency 47 50 61-72. For example, 
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an English study on emergency presentations for patients with any cancer reported a RR=1.34 
(95%CI 1.1-1.7) for a Charlson comorbidity score of 1 versus 071. For colorectal cancer the risk 
of emergency presentation was higher for patients with one versus no comorbidity (OR=1.5; 
95% CI = 1.4-1.6), and higher for 3+ versus no comorbidity (OR=2.0; 95% CI 1.8–2.2)61. A US 
study reported an OR=1.89 (95%CI 1.7-2.2) for one versus no comorbidity among colorectal 
cancer patients and OR=3.79 (95%CI 3.1-4.6) for lung cancer, with even higher risks with 
increasing number of comorbidities69. Only a few studies (n=6) examined the effect of specific 
comorbidities on emergency presentations30 66 73-75, but the available data shows that some 
comorbidities are associated with particularly high risks, including dementia, cardiac and 
neurological diseases66 (e.g. dementia OR=2.46; 95%CI 2.2-2.8; congestive heart failure 
OR=1.49; 95%CI 1.4-1.6). Obesity was also associated with emergency presentations in one 
study74.  
In contrast, a Swedish study reported a ‘beneficial’ effect of certain types of comorbidities, as 
it found a higher prevalence of hypertension among non-emergency colon cancer patients73. 
Regular visits for blood pressure management might have provided opportunities for earlier 
diagnosis.  
Evidence from qualitative studies supporting a likely alternative explanation 
mechanism 
More details on specific mechanisms through which comorbidities might influence the risk of 
emergency presentation were provided by a qualitative study30 and by a significant event 
audit47 (Table 2). In line with the alternative explanation hypothesis qualitative research30 has 
highlighted how patients and doctors sometimes attribute cancer symptoms to the 
comorbidity. For example, a patient diagnosed with gastro-intestinal cancer following an 
emergency presentation reported repeatedly presenting with symptoms to her GP over six 
months, with her GP telling her: ’sounds like IBS’. The patient then decided to go to an 
emergency department to exclude other causes: ’Just thought, it can’t still just be IBS and I 
should…even though I don’t really consider it an A&E problem, but I probably should go to A&E 
and have it actually properly investigated…’ (F, upper GI cancer)30.  
Significant event audits47 also highlighted how emergency presentations sometimes occurred 
as cancer symptoms were interpreted by patients and doctors as being due to a comorbidity 
which provided an alternative explanation. For example, persistent back or abdominal pain 
were interpreted by doctors as being due to a comorbidity and treated for 6 months before a 
63-year old woman was diagnosed with metastatic ovarian cancer. Similar events occurred in 
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the presence of diverticulitis in patients later diagnosed with colorectal cancer as an 
emergency.  
Some comorbidities, such as depression, can lead to emergency presentations by interfering 
with patients’ symptom attribution and help-seeking due to worries and/or possible 
alternative explanations. A patient diagnosed as an emergency reported: ‘…Because I was 
depressed I thought that maybe I am overreacting sometimes…’ (F, colorectal cancer)30. 
Overall, the limited evidence suggests that comorbidities mostly increase the risk of 
emergency presentations, with research on comorbidity-specific effects and the underlying 
mechanisms being extremely scant.  
 
Effect on cancer stage at diagnosis 
All relevant studies were quantitative ones. Some studies (n=14) have shown an association 
between comorbidities and advanced stage8 9 53 69 76-84. No significant effect was reported by 
other authors85-87, while some studies (n=9) reported a reduced risk of advanced stage8 9 69 76 80 
87 88 for comorbid patients. A total of 9 studies examined the effect of specific comorbidities on 
stage, often reporting contrasting effects by comorbidity type. One large study76 on 14,096 
patients with different cancers and examining 42 specific comorbidities found that most of 
them were associated with an increased risk of advanced stage. The risk was particularly high 
for dementia, neurological, pulmonary, cardiac and major psychiatric disorders, with Odds 
Ratios ranging between 1.27 and 6.26. These findings support the competing demand 
hypothesis, whereby comorbidities might have distracted the patient and/or doctor and 
interfered with prompt investigations of cancer symptoms. Psychiatric comorbidities were also 
associated with more advanced cancer stage in other publications9 53 (e.g. OR=1.27 for 
advanced breast cancer, p<0.019; advanced oesophageal cancer occurred in 37% versus 18% 
(p=0.009) of patients with and without psychiatric illness53. One small study found contrasting 
effects by type of psychiatric comorbidity: major depression increased the risk of advanced 
stage breast cancer, while phobia decreased the risk82.  
Yasmeen et al81 reported a significantly higher risk of advanced stage breast cancer for women 
with ‘unstable’ (life threatening or difficult to control) or ‘stable’ comorbidities compared to 
those with no comorbidity. The study found that their findings could not be explained by 
differences in mammography use, as the association was significant among older women who 
had the highest use of mammography. The authors had two possible explanations for their 
findings: a) competing demands might have led to delays or difficulties with referrals and 
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further investigations; b) disease factors, such as pathophysiological interactions between 
comorbidities, ageing and cancer progression in line with studies showing that some 
comorbidities (e.g. metabolic disorders, diabetes) can be associated with cancers of greater 
malignant potential89-91. A large study on 11,312 head and neck cancers has shown that 
patients with alcohol and tobacco-related comorbidities and repeated consultations have the 
highest risk of advanced stage, while non-comorbid patients with repeated consultations are 
at lower risk of advanced stage (e.g. 39% versus 6%; p<0.05)84. Delays are probably related to 
complex clinical situations, but the study did not provide sufficient evidence for disentangling 
the underlying mechanisms. 
Contrasting effects on stage at diagnosis of prostate and breast cancer were reported in some 
studies examining various specific comorbidities8 9 80. For example, the risk of advanced stage 
was increased by severe renal disease, substance abuse and vascular comorbidities among 
prostate cancer patients8, and by diabetes, haematological and psychiatric comorbidities 
among breast cancer patients9 (Odds Ratios ranging between 1.15 and 2.06). These effects 
might be due to competing demands mechanisms, but biological interactions between some 
comorbidities (e.g. diabetes, severe renal diseases) and cancer progression might also have 
played a role. In contrast, a surveillance effect might explain the protective effect of other 
comorbidities associated with a lower risk of advanced cancer stage, such as hypertension, 
dyslipidemia and coronary artery disease among prostate cancer patients (Odds Ratios ranging 
between 0.67 and 0.84)8 and benign breast, gastrointestinal, musculoskeletal and 
cardiovascular diseases among breast cancer patients (Odds Ratios between 0.62 and 0.87)9. 
Another large study on prostate cancer92 also found that various comorbidities had a 
protective effect on the risk  of advanced stage possibly due to a surveillance effect.  
As suggested by Siddiqui et al.79 the same comorbidity can have different effects, depending 
on its severity and possibly its management: poorly controlled diabetes was associated with 
more advanced colorectal cancer stage (OR=2.1; 95%CI 1 to 4.4; p=0.02), while this was not 
the case for well-controlled diabetes.  
Overall, the evidence suggests that comorbidities can play an important role in influencing 
cancer stage, but effects vary by comorbidity characteristics. The evidence on the underlying 
mechanisms is extremely limited, as the information is based only on quantitative studies with 
only a few evaluating in detail specific comorbidities. Widely used aggregate measures can 
lead to biased results when some comorbidities increase and others decrease the risk of 
advanced cancer.    
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Discussion 
Main findings 
Overall, the evidence indicates that comorbidities can have marked and sometimes contrasting 
effects on timely cancer diagnosis, acting through various mechanisms and affecting different 
phases of the diagnostic pathways. About half of the studies examined the overall effect of 
having any comorbidity and they frequently showed an increased risk of delayed help-seeking, 
emergency presentations and advanced cancer stage among patients with comorbidities. 
However, in studies providing comorbidity-specific information contrasting effects become 
apparent, with some comorbidities facilitating and others interfering with early diagnosis. A 
number of comorbidities are associated with a particularly high risk of delays, including 
dementia, neurological, pulmonary, cardiac and psychiatric disorders. In contrast, ‘risk factor’ 
comorbidities such as hypertension and hypercholestorlaemia and some benign 
muscoloskeletal and gastrointestinal conditions can be associated with earlier cancer 
diagnosis.  
Research on the underlying mechanisms is scant, but what there is supports the alternative 
explanations, competing demands and surveillance hypotheses. Other mechanisms have 
emerged, including false reassurance / over-reassurance (among doctors and patients) 
following diagnostic investigations performed for a comorbidity and positive expectations due 
to previous experiences with comorbidities. There is little evidence on the effects of 
comorbidities on diagnostic processes and use to investigations.  
 
Interpretation and comparison with the literature 
By integrating the findings from qualitative and quantitative studies we obtained an evidence-
based picture of the likely mechanisms through which comorbidities can interfere with or 
facilitate timely cancer diagnosis influencing patient's help-seeking, diagnostic strategies and 
use of investigations. A comprehensive illustration of these mechanisms is shown in Figure 2. 
While the possible role of comorbidities has been considered in theoretical models6 25 and 
some previous reviews13 14, they only evaluated the overall effect of any comorbidity, without 
providing a detailed analysis of the impact of specific comorbidities on different aspects of the 
diagnostic process. Some underlying mechanisms, such as the alternative explanations, 
competing demands and surveillance effects8-11 have been previously hypothesised, but this 
review has substantiated and amplified our understanding on possible mechanisms, thanks to 
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a comprehensive examination of the available evidence on each phase of the diagnostic 
journey. We have also highlighted areas where more research is warranted. In particular, 
specifically designed studies (for example vignette studies) would be needed to better 
understand the impact of comorbidities on clinicians’ decision-making regarding diagnostic 
strategies and use of investigations, as currently the limited available information is only 
indirectly provided by a few interview studies and significant event audits. 
Research has mostly focused on colorectal, lung and breast cancers, but the available data 
suggests that similar mechanisms might apply across cancer types. Some specific comorbidities 
appear to be associated with a higher risk of delays independently of cancer site. In particular, 
psychiatric illness and dementia are associated with delayed diagnosis of breast, prostate and 
gastro-intestinal cancers. Even though evidence on the underlying mechanisms is scant, 
psychiatric illnesses might interfere with timely cancer diagnosis providing alternative 
explanations, as cancer symptoms are sometimes interpreted by both patients and doctors, as 
psychogenic symptoms or related to psychiatric medications53. Communication difficulties, as 
well as anxiety and worry of appearing hypochondriacal might also play a role in delaying 
reporting of cancer symptoms in patients with mental health problems30 36. Considering that 
psychiatric illnesses affect approximately one-quarter of the general population in England93 
and other western countries53 94, appropriate interventions are needed for limiting the risk of 
diagnostic delays if these patients also develop cancer. Interventions should aim to improve 
patient’s help-seeking behaviour, as well as diagnostic strategies and access to specialists and 
diagnostic investigations. 
According to the Social Cognitive Theory95 the decision by a patient to seek help can be 
influenced by a person’s perceived ability to discuss a symptom and receive help (‘self-
efficacy’), socio-cultural and structural barriers and opportunities, as well as ‘outcome 
expectations’. In line with this theoretical framework, comorbidities can represent 
‘opportunities’ to discuss cancer symptoms44, but also barriers if the chronic disease is 
perceived as more important 11 96. Self-efficacy is affected by previous experiences (in addition 
to social models and social persuasion). Among comorbid patients previous positive or 
negative healthcare experiences for their chronic disease can affect help-seeking for cancer 
symptoms. Similar mechanisms can play a role in influencing not only patients, but also 
doctors’ clinical decision-making when evaluating the possibility of cancer in the presence of 
comorbidities. Barriers and opportunities, outcome expectations and previous experiences 
with differential diagnosis can all influence doctors’ decision-making. Guidelines, availability of 
diagnostic tests and criteria for accessing diagnostic services for patients with comorbidities 
can help to improve diagnostic strategies and timely cancer diagnosis.  
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Patients’ concerns, values and tolerance of uncertainty can also influence the diagnostic 
decision making. Despite the increasing attention to patient-centred care, this has mainly 
focused on screening and treatment decisions, while shared decision making in diagnostic 
decisions has been relatively neglected97. This might also be due to the uncertainty regarding 
benefits and harms of possible alternative diagnostic strategies. Considering that patient-
centred diagnosis can help improve diagnostic safety and quality98 99, more research is needed 
on these issues, particularly for patients with comorbidities.     
 
The impact of comorbidities on timely cancer diagnosis might also be influenced by biological 
mechanisms at tumour level affecting cancer progression. A ‘pathological hypothesis’8 is 
supported by some studies5 9 12. Comorbidities might affect the immune system, as exemplified 
by severe renal diseases being associated with a compromised immune system and metastatic 
prostate cancer8. Moreover, research on diabetes suggests direct and indirect effects of insulin 
on cancer growth in patients with diabetes and/or obesity90 91. Poorly controlled type 2 
diabetes has been shown to increase the risk of advanced colorectal cancer79, possibly due to a 
biological effects of prolonged hyperinsulinemia and poor glycaemic control. Given the 
increasing prevalence of diabetes, which affects 9% of the English adult population100 
appropriate strategies are needed for limiting its impact on advanced cancer. Examining 
biological mechanisms is however beyond the scope of this review, as the evidence mainly 
relies on laboratory rather than population studies.  
 
Possible limitations 
Definitions of comorbidities and methods of data collection vary substantially across studies, 
ranging from self-reported information to summary comorbidity measures based on electronic 
health-records, mostly referring to hospital admissions with different and often poorly defined 
time-windows pre-cancer (from 5 years to 3 months pre-cancer or only including the hospital 
admission when cancer was diagnosed). These factors might have contributed to the variability 
of findings across studies. Effects of comorbidities might also be influenced by their severity, 
but such information is rarely reported. Moreover, it is often difficult to distinguish between 
comorbidities that are truly unrelated to the cancer and situations where cancer symptoms 
were misinterpreted leading initially to a non-cancer diagnosis. The latter cases should not be 
considered as comorbidities, but such distinctions are difficult to make, as the timing of 
comorbidity and cancer symptom onset is very rarely reported. 
 
 
 117 
More than half of included studies (n=38) did not specifically aim to investigate the effects of 
comorbidities, and relevant information often emerged only after in-depth examination of full-
text publications. We cannot exclude the possibility that some studies were not identified in 
our review. Publication bias might have limited the number of studies showing no impact or a 
protective effect of comorbidities on timely cancer diagnosis. As the majority of studies 
providing information on the underlying mechanisms were retrospective and based on reports 
by cancer patients, recall bias might have influenced the findings. When patients are asked to 
recall experiences and reasons for delays after having been diagnosed with cancer, their 
answers might mask a sense of guilt if they delayed help-seeking101. More prospective studies 
are needed, as well as research including information provided by healthcare professionals.  
The effects of comorbidities might also be modified by patient’s socio-demographic 
characteristics. Some studies suggested that competing demands mechanisms might affect 
particularly older patients, but specifically designed large prospective studies are needed to 
explore this further. 
Because we were interested solely on the influence of comorbidity on symptomatic patients, 
we excluded studies on cancer diagnosis following screening, however this would merit to be 
examined in future research. 
 
Implications for research and practice 
The review can inform the development of strategies aimed at improving early cancer 
diagnosis and reduce emergency presentations, helping to develop targeted interventions for 
the large number of people with chronic conditions who experience possible cancer 
symptoms. The prevalence of comorbidity and multimorbidity has increased over the last 
decades in the general population and in cancer patients, possibly due to lifestyle factors and 
improved life expectancy3 102-105. For example, among patient with colorectal cancer, 
comorbidity prevalence went from 47% to 62% between 1995 and 2010102. This underscores 
the importance for research studies, clinical practice guidelines and healthcare providers 
dedicating increasing attention to improving diagnostic approaches and management of 
cancer in the context of comorbidity106-109.  
When patients present with multiple conditions, it is often necessary for healthcare providers 
to prioritise the optimal management of serious chronic diseases over investigating possibly 
vague symptoms. However, comorbidities often share common risk factors with cancer and 
they can influence the behaviour and aggressiveness of cancer89. For example, smoking 
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simultaneously affects the risk of COPD and lung cancer; diet and other life-style factors affect 
the risk of cardiovascular and metabolic diseases and various cancers. Moreover, as 
highlighted by this review, comorbid patients often experience increased risk of delays along 
their diagnostic journey. The presence of cancer should therefore be carefully considered in 
patients with comorbidities who are experiencing changing or new symptoms. In addition to 
allowing sufficient time during primary care encounters for a thorough and holistic evaluation 
of complex patients, tailored guidelines, appropriate diagnostic services for patients with 
multiple morbidities and greater integration between primary and secondary care are needed 
in order to facilitate earlier cancer diagnosis for this higher risk group. Increasing efforts should 
be dedicated to patients with chronic conditions raising both patient and healthcare provider 
awareness on benefits of screening and on the importance of not under-estimating possible 
cancer symptoms.  
There is limited evidence, based mainly on qualitative studies29 30 and significant event audits46 
47, on the effect of specific symptom-comorbidity pairs. For example, breathlessness in 
patients with asthma or cardiac comorbidities can be associated with delayed help-seeking if 
these patients also develop lung cancer. Similarly, abdominal pain in the presence of mental 
health problems or benign GI comorbidities (e.g. IBS) can lead to delays in the diagnosis of 
colorectal and upper GI cancers. Large studies providing information on specific comorbidity-
symptom pairs associated with increased risks of delays could help to develop appropriate 
interventions for raising cancer awareness and targeted diagnostic strategies and guidelines. In 
addition to quantitative population-based research, qualitative studies including both patients 
and healthcare providers, could allow to gain a more in-depth understanding of psychological 
factors influencing help-seeking and diagnostic decision-making that could be addressed for 
improving timely cancer diagnosis in complex clinical situations.   
Research and policy efforts should focus in particular on comorbidities with a high prevalence 
in the general population and potentially playing a relevant role in affecting timely cancer 
diagnosis. This is the case for mental health issues, affecting one in four people in western 
countries 53 93 94 and associated with an increased risk of diagnostic delays for various common 
cancers. Interventions are needed in order to facilitate timely help-seeking and reporting of 
cancer symptoms in these patients. In addition, educational interventions and appropriate 
guidance for healthcare providers and easier access to investigations and specialist advice can 
limit the risk of diagnostic delays in patients with mental health problems and presenting 
possible cancer symptoms. Similarly, given the increasing prevalence of diabetes, affecting 9% 
of the English adult population100, appropriate strategies are necessary for limiting the risk of 
advanced cancer.  
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In conclusion, the evidence indicates that comorbidities can have multiple and contrasting 
effects on timely cancer diagnosis, acting through various mechanisms and affecting various 
points along the diagnostic pathways. By evaluating comorbidity-specific effects on help-
seeking for potential cancer symptoms, diagnostic strategies and use of investigations, stage at 
diagnosis and emergency presentations, possible targeted interventions can be identified in 
order to improve cancer diagnosis for the large number of individuals with comorbidities. 
These could include innovative risk-assessment tools and guidelines for specific symptom-
comorbidity pairs and tailored diagnostic approaches encompassing primary and secondary 
care and multidisciplinary diagnostic centres. 
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Figure 1: Flow of studies for literature review on comorbidities 
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Figure 2: Mechanisms through which comorbidities can facilitate or interfere with timely cancer diagnosis  
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Table 1: Description of studies
Authors (Country)
Comorbidity-
specific
N. of participants Cancer site
Help-
seeking
Time to 
diagnosis or 
delays
Referrals/ 
diagnostic 
process
EP Stage Earlier diagnosis, help-
seeking, early stage or 
non-EP
Delayed diagnosis, help-
seeking, late stage or EP
No effect Quant Qual
Abgral l -Barbry, 
2012  (France)
V V V V (depress ion) 94 patients  
undergoing 
colonoscopy
CRC 50
Ahn, 2013 (USA) V V V 454 cancer patients Lung 50
Al l i son, 1998 
(Canada)
V V V 188 cancer patients Upper aero-
digestive tract
50
Askari , 2013 (UK) V V V 1,911 cancer 
patients
CRC 75
Beckett, 2014 (UK) V V V 133,530 cancer 
patients
Lung 75
Birt, 2014 (UK) V V V V V V V 35 patients  (17 
cancer patients)
Lung 100
Bjerager, 2006 (DK) V V V 84 cancer patients Lung 50
Black, 2015 (UK) V V V V V 27 cancer patients  
diagnosed as  EP
Various  cancers 75
Burgess , 2000 (UK) V V V V (psychiatric 
comorbidi ties )
158 cancer patients Breast 50
Brandenbarg, 2018 
(NL)
V V V V V V V 287 cancer patients CRC 75
Cheung, 2016 (UK) V V V 67,202 cancer 
patients  
CRC 75
Corner, 2006 (UK) V V V V V 22 cancer patients Lung 100
Cunningham, 2018 
(UK)
V V V V V (COPD) 40 patients  with 
COPD
Lung 75
Desai , 1999 (USA) V V (phobia) V (depress ion) V V (psychiatric 
comorbidi ties )
72 cancer patients Breast 50
El -Charnoubi , 2012 
(DK)
V V V V (psychiatric or 
sever medica l  
comorbidi ties )
157 patients  
advanced/ 
inoperable cancer
Breast 75
Fazio, 2005 
(Canada)
V V V V 768 cancer patients Colon 100
Fisher, 2004 (USA) V V V V 549 cancer patients CRC 50
Included measure Impact Study design MMAT 
score (%) 
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Authors (Country)
Comorbidity-
specific
N. of participants Cancer site
Help-
seeking
Time to 
diagnosis or 
delays
Referrals/ 
diagnostic 
process
EP Stage Earlier diagnosis, help-
seeking, early stage or 
non-EP
Delayed diagnosis, help-
seeking, late stage or EP
No effect Quant Qual
Fisher, 2010 (USA) V V V (effect on time to 
diagnos is )
V (no effect 
on s tage)
V 468 cancer patients CRC 75
Fleming, 2005 
(USA)
V V(cardiovascular, 
musculoskeleta l , GI, 
benign breast 
diseases)
V(diabetes , 
endocrine, 
psychiatric, 
haematologic 
diaseses)
V V 17,468 cancer 
patients
Breast 100
Fleming, 2006 
(USA)
V V(coronary artery 
diseases , benign 
hypertens ion, 
dys l ipidemia)
V(vascular, severe 
renal  diaseses , 
substance abuse)
V V 5,076 cancer 
patients
Prostate 100
Friese, 2009 (USA) V V V 3,831 cancer 
patients
Multiple 
myeloma
75
Friese, 2011 (USA) V V V 5,086 cancer 
patients
Leukemia 75
Gonzalez, 2001 
(USA)
V V V 32,074 cancer 
patients
CRC, breast, 
prostate 
melanoma
75
Gornick, 2004 
(USA)
V V (women with CRC; 
men with s tomach)
V (for men with 
prostate)
V 21,240 cancer 
patients
CRC, breast, 
uterine, ovarian, 
prostate, 
bladder, 
s tomach 
75
Gunnarson, 2011 
(Sweden)
V V (hypertens ion, but 
not s ign.)
V V 604 cancer patients Colon 50
Gunnarson, 2014 
(Sweden)
V V V V (diabetes , 
heart, respiratory 
problems)
1,117 cancer 
patients
Colon 75
Gurney, 2015 (NZ) V V (vi ra l  hepati ti s , 
intestina l  disease)
V (27 out of 42 
investigated 
comorbidi ties ) 
V V (42 speci fic 
comorbidi ties
14,096 cancer 
patients   
Breast, colon, 
recta l , l iver, 
s tomach, 
ovarian, uterine, 
bladder, kidney
100
Henry, 2009 (USA) V V V 27,325 cancer 
patients
CRC 75
Huo, 2015 (China) V V V 1,431 cancer 
patients
Breast 50
Markar, 2018 V V V 121,786 
oesophageal  and  
115,736 gastric 
cancer patients
Oesophago-
gastric
50
McLachlan, 2015 
(UK)
V V V V V V V 29 cancer patients Lung, CRC 100
Included measure Impact Study design MMAT 
score (%) 
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Authors (Country)
Comorbidity-
specific
N. of participants Cancer site
Help-
seeking
Time to 
diagnosis or 
delays
Referrals/ 
diagnostic 
process
EP Stage Earlier diagnosis, help-
seeking, early stage or 
non-EP
Delayed diagnosis, help-
seeking, late stage or EP
No effect Quant Qual
McPhai l , 2013 (UK) V V (CRC, lung, 
prostate)
V (breast, 
cervica l )
V 131,754 cancer 
patients
CRC, cervica l , 
breast, lung, 
prostate
75
Mitchel l , 2007 
(Canada)
V V (obes i ty) V V 455 cancer patients CRC 50
Mitchel l , 2013 (UK) V V V V V (SEA) V GP reports  on 132 
cancer patients
Lung 75
Mitchel l , 2015 (UK) V V V V V (SEA) V 222 cancer patients  
diagnoses  as  an 
emergency 
14 di fferent 
cancer types
75
Mor, 1990 V V V 625 cancer patients CRC, lung, breast 25
Mounce, 2017 (UK) V V V V 4,521 cancer 
patients
CRC 100
Nikonova, 2015 
(Canada)
V V V V 279 cancer patients Lymphoma 50
O’Rourke, 2008 
(USA)
V V V (psychiatric 
comorbidi ties )
V V (psychiatric 
comorbidi ties )
160 cancer patients Oesophageal 75
Pruitt, 2014 (USA) V V V 83,330 cancer 
patients
CRC 50
Rabeneck, 2006 
(Canada)
V V V 41,356 cancer 
patients
CRC 75
Raval , 2016 (USA) V V V V 
(cardiometabol ic
, respiratory, 
mental  
comorbidi ties )
103,820 cancer 
patients
Prostate 100
Reid, 2004 (USA) V V V V 
(a lcohol/tobacco 
related 
comorbidi ty)
11,312 cancer 
patients
Head and neck 75
Renzi , 2016 (UK) V V V (various  
comorbidi ties )
V V V 62 patients  with 
cancer symptoms
Various  75
Robinson, 2011 
(DK)
V V V V (no effect 
on patient 
and GP 
delay)
V 648 cancer patients Gynaecologica l 75
Included measure Impact Study design MMAT 
score (%) 
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Authors (Country)
Comorbidity-
specific
N. of participants Cancer site
Help-
seeking
Time to 
diagnosis or 
delays
Referrals/ 
diagnostic 
process
EP Stage Earlier diagnosis, help-
seeking, early stage or 
non-EP
Delayed diagnosis, help-
seeking, late stage or EP
No effect Quant Qual
Sal ika , 2017 (UK) V V (hypertens ion, 
hypercholesterolemi
a)
V (heart 
comorbidi ty)
V V V 936 patients  with 
cancer symptoms
Various  50
Shawidhi , 2014 
(UK)
V (gastroscopy 
rates)
V V (effect of 
comorbidi ty and 
gastroscopy rates  on 
EP)
V (no effect 
of 
comorbidi ty 
on 
gastroscopy 
rates)
V 22,488 cancer 
patients
Oesophago-
gastric
75
Siddiqui , 2008 
(USA)
V V (poorly control led 
diabetes)
V (wel l -
control led 
diabetes)
V V (diabetes) 269 cancer patients CRC 75
Sikka, 2010 (USA) V V V 20,311 cancer 
patients
CRC, lung 75
Sikka, 2012 (USA) V V V (s tage and lung 
cancer)
V (CRC and lung) V (s tage and 
CRC)
V 20,311 cancer 
patients
CRC, Lung 75
Singh, 2009 (USA) V V (congestive heart 
fa i lure, coronary 
artery disease)
V (mental  
health, 
diabetes , 
COPD)
V V 513 cancer patients CRC 100
Smith, 2009 (UK) V V (chest infection, 
renal  fa i lure)
V (COPD) V V 360 cancer patients Lung 50
Solsky, 2017 V V V 263 cancer patients Gastric 50
Teppo, 2009 
(Finland)
V V V V 221 cancer patients Larunx, tongue, 
pharynx
75
Tsang, 2013 (UK) V V V 74,763 cancer 
patients
Various  50
Van Hout, 2011 
(NL)
V V V V (psychiatric 
comorbidi ties  
associated with 
primary care delay)
V V (various  
comorbidi ties )
197 cancer patients CRC 75
Wagland, 2017 
(UK)
V V V V 16 GPs Lung 50
Included measure Impact Study design MMAT 
score (%) 
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Authors (Country)
Comorbidity-
specific
N. of participants Cancer site
Help-
seeking
Time to 
diagnosis or 
delays
Referrals/ 
diagnostic 
process
EP Stage Earlier diagnosis, help-
seeking, early stage or 
non-EP
Delayed diagnosis, help-
seeking, late stage or EP
No effect Quant Qual
Wallace, 2014 (UK) V V (dementia , 
cerebrovasc.,  l iver 
disease, heart 
fa i lure)
V (diabetes , 
AMI)
V V 82,777 cancer 
patients
CRC 100
Walter, 2016 (UK) V V V V (depress ion, 
anxiety, GI 
comorbidi ties : 
s igni ficant effect on 
health-system 
interval , but not on 
patient interval )
V V 2,677 patients  with 
cancer symptoms
CRC 75
Walter, 2015 (UK) V V (respiratory 
comorbidi ty and 
total  diagnostic 
interval )
V V 963 patients  with 
cancer symptoms
Lung 75
Xiao, 2016 (USA) V V (COPD and sol id 
tumor)
V (various  serious  
comorbidi ties )
V V 11,083 cancer 
patients
Prostate 75
Yasmeen, 2012 
(USA)
V V (s table and 
unstable 
comorbidties )
V V 3,316 cancer 
patients
Breast 75
Zafar, 2008 (USA) V V V V 682 cancer patients CRC 50
Included measure Impact Study design MMAT 
score (%) 
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Table 2: Factors influencing help-seeking and timely cancer diagnosis in relation to comorbidities 
Themes Patient's reporting of symptoms and help-seeking Doctor’s decision-making and diagnostic process 
No clear distinction between 
patients’/doctors’ role 
Factors delaying the cancer diagnosis  
Alternative explanations Symptom normalized or attributed to comorbidity or its treatment (Black, 
2015; Birt, 2014; McLachlan, 2015; Corner, 2006; Smith, 2009; Cunningham, 
under review; Mor, 1990; Mitchell, 2015; Brandenbarg, 2018) 
Symptom attributed to comorbidity or its treatment (Black, 2015; Birt, 2014; 
McLachlan, 2015; Corner, 2006; Bjerager, 2006; Mitchell, 2015; 
Brandenbarg, 2018) 
(Walter, 2016; Walter, 2015; O’Rourke, 
2008; Mounce 2017) 
Competing demands/Priorities Priority given to serious/problematic comorbidity (Salika, 2017) Priority given to serious/problematic comorbidity (Bjerager, 2006; Renzi and 
Whitaker, 2016) 
(Wallace, 2014; Gurney, 2015; Fleming, 
2005; Yasmeen, 2012; Reid, 2004; Singh, 
2009; Mounce 2017) 
Overconfidence/trust in test 
(after tests for comorbidities) 
Diagnostic tests done for comorbidity over-ruled the possibility of other 
diseases (Birt, 2014; Renzi and Whitaker, 2016; Black, 2015) 
Diagnostic tests done for comorbidity over-ruled the possibility of other 
diseases. (Birt, 2014; Wagland, 2017; Mitchell, 2013; Mitchell, 2015) 
 
Fatalism, worry, anxiety  Worry about appearing hypochondriacal due to frequent help-seeking for 
comorbidity or due to specific comorbidity (depression) (Renzi and Whitaker, 
2016; Black, 2015) 
Negative experiences with health service and poor health status due to 
comorbidity can lead to fatalism or preference for non-invasive approaches 
(Renzi and Whitaker, 2016; Cunningham, under review). 
Patient’s poor health status due to comorbidities can interfere with doctor’s 
propensity to refer for invasive investigations (Renzi and Whitaker, 2016) 
(Desai, 1999) 
Communication difficulties Difficulties communicating due to mental or physical comorbidity (dementia, 
psychiatric problems, hearing problems) 
 (O’Rourke, 2008) 
Factors facilitating timely cancer diagnosis  
Surveillance effect/ 
Opportunities 
Opportunity offered by a visit for comorbidity (less worried of being seen as 
hypochodriacal or ‘time-waster’ in case of non-specific symptom) (Whitaker, 
2015; Birt, 2014; Corner, 2006; Cunningham, under review) 
Opportunity offered by a visit for comorbidity can lead to further 
investigations of persistent symptoms (McLachlan, 2015; Mitchell, 2013) 
(Gunnarsson, 2011; Fleming, 2005; 
Smith, 2009; Raval, 2016) 
Priorities Excluding cancer or other serious disease takes priority over other 
comorbidities (Black, 2015) (Desai, 1999)  
Guidelines, availability of tests, criteria for accessing diagnostic services for 
patients with specific comorbidity (McLachlan, 2015; Cunningham, under 
review) 
 
Self-efficacy Perception of self-efficacy due to familiarity with healthcare provider/system. 
Ability to identify changes in symptoms compared to comorbidity or non-
response to comorbidity medication (Birt, 2014) 
Experience with differential diagnosis for complex patients; possibility of 
specialist advice (Mitchell, 2013; Mitchell, 2015) 
 
Positive expectations Positive outcome expectation due to previous positive experiences with 
comorbidity (Birt, 2014) 
Previous experiences with missed/near missed cancer diagnoses (Mitchell, 
2013; Mitchell, 2015) 
(Smith, 2009) 
Note: Information on mechanisms are mainly based on qualitative studies. Some quantitative studies provided information on underlying mechanisms, but it was often impossible to distinguish between the role played by 
patients and doctors. 
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Study 3.2- Contrasting effects of comorbidities on emergency colon cancer 
diagnosis: evidence from a longitudinal data-linkage study in England 
 
 
Background and link to study 2 and 3.1 
In the longitudinal data-linkage study performed for paper 2, I examined the overall effect of 
having any comorbidity on emergency presentations, showing how it increased the risk of 
emergency colon cancer diagnosis. However, as suggested by the literature review performed 
for study 3.1 specific comorbidities might have differential effects on diagnostic timeliness, 
with some comorbidities possibly acting as barriers and others as facilitators for early cancer 
diagnosis. Evidence on the effects of specific comorbidities on emergency presentations is 
lacking, while this could help improve strategies for diagnosing cancer earlier for the large 
number of individuals who have pre-existing chronic conditions. 
 
Aims and Objectives 
The specific objective of Study 3.2 is to perform a longitudinal data-linkage study to evaluate 
comorbidity-specific effects on the risk of colon cancer being diagnosed following emergency 
presentation rather than non-emergency routes, taking symptomatic consultations, socio-
demographic characteristics and cancer sub-site into account.  
 
Methods  
The longitudinal data-linkage study is based on the same cohort of 5,745 colon cancer patients 
diagnosed in England 2005-2010 described for study 2. Using primary and secondary care 
records I examined pre-diagnostic GP consultation patterns and related symptoms and specific 
comorbidities recorded during the months and years pre-cancer diagnosis, comparing patients 
diagnosed with colon cancer following emergency and non-emergency presentation. Building 
on the literature review, I examined comorbidities potentially influencing the colon cancer 
diagnosis through different mechanisms: 1) ‘serious’ or complex comorbidities 
diagnosed/treated in secondary care, which can interfere with the cancer diagnosis through 
competing demands: e.g. cardiac, chronic respiratory, neurological diseases; 2) comorbidities 
possibly providing alternative explanations for signs/symptoms of cancer: gastrointestinal 
conditions (irritable bowel syndrome, diverticular, coeliac, inflammatory bowel, other GI 
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diseases), gynaecological conditions, anxiety/depression; 3) comorbidities potentially offering 
opportunities for earlier diagnosis through regular GP visits: hypertension monitoring.  
In addition to using conventional statistical methods, I also employed potential-outcomes or 
counterfactual approaches within the causal inference framework for determining 
comorbidity-specific effects on emergency presentations. When using observational data for 
estimating average effects in the population, traditional epidemiological methods can lead to 
biased results due to non-comparability of the groups under examination. Potential-outcomes 
approaches can overcome this limitation74-76 and they can be useful to critically consider the 
complex relationships between exposures and outcomes. 
 
Main results  
The work performed for study 3.2 has led to a paper entitled “Contrasting effects of 
comorbidities on emergency colon cancer diagnosis: A longitudinal data-linkage study in 
England”, which has been submitted for a possible publication. The paper is included in this 
chapter in its submitted form (inclusive of tables, figures and references).  
The findings have also been presented at various conferences (listed on pages 10-11). 
The study has shown that among men diagnosed with colon cancer as an emergency, those 
with a 'serious' comorbidity (i.e. diabetes, cardiac, neurological, respiratory diseases) 
diagnosed/treated in secondary care) had more frequently consulted their GP for cancer alarm 
symptoms (anaemia, rectal bleeding, change in bowel habit) compared to patients without 
‘serious’ comorbidities (22% versus 10%, respectively, p<0.001). Multivariable analysis, taking 
socio-demographic factors, cancer symptoms and cancer sub-site into account, showed that 
colon cancer patients with 'serious' comorbidities had a higher risk of emergency 
presentations (Men: OR=2.40; 95%CI 2.0-2.9; Women: OR=1.98; 95%CI 1.6-2.4). Similarly, 
women aged less than 60 with a gynaecological (OR=3.41; 95%CI 1.2-9.9) or a recent onset 
benign gastro-intestinal condition (OR=2.84; 95%CI 1.1-7.7) had a higher risk of emergency 
colon cancer diagnosis. In contrast, GP visits for hypertension monitoring decreased the risk of 
emergency presentations.  
 
Conclusions 
The longitudinal data-linkage study has shown that most comorbidities increased the risk of 
emergency colon cancer diagnosis, but the effects varied by socio-demographic factors and by 
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type and timing of comorbidity onset. Comorbid patients consulted more frequently with 
cancer symptoms than non-comorbid individuals in the pre-diagnostic year. This suggests that 
comorbidities may interfere with the diagnostic process due to ‘competing demands’ or 
because they provide ‘alternative explanations’. In contrast, some comorbidities, such as 
hypertension monitoring, may offer opportunities for earlier diagnosis. Traditional 
epidemiological methods and counterfactual-based approaches yielded similar findings. 
 
Fulfilment of the study objectives and implications for research and practice 
The study has shown that the risk of emergency presentation is particularly high for some 
subgroups, including patients with ‘serious’ comorbidities diagnosed or treated in secondary 
care (diabetes, cardiac, respiratory diseases) and women aged less than 60 with a recent 
diagnosis of a benign gastrointestinal or gynaecological condition. By shedding light on 
possible mechanisms leading to emergency presentations and characterizing higher risk 
groups, the study findings can inform interventions aimed at optimizing diagnostic strategies 
and health services in order to reduce emergency cancer diagnoses. For complex patients, 
such as those with comorbidities, greater integration between primary and secondary care, 
and more extensive use of multi-disciplinary diagnostic centres can be particularly important. 
International comparisons on emergency cancer diagnoses could provide insights into the role 
played by healthcare factors in influencing diagnostic timeliness in patients with pre-existing 
chronic conditions. Patient, doctor and healthcare system factors will all need to be further 
investigated in order to better understand the underlying mechanisms and address the 
complex relationship between comorbidities and cancer diagnosis.  
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Abstract  
 
Background: One in three colon cancers are diagnosed as an emergency, which is 
associated with worse cancer outcomes. Chronic conditions (comorbidities) affect large 
proportions of adults and they might influence the risk of emergency presentations (EP).  
Methods: We aimed to evaluate the effect of specific pre-existing comorbidities on the 
risk of colon cancer being diagnosed following an EP rather than through non-
emergency routes. The cohort study included 5,745 colon cancer patients diagnosed in 
England 2005-2010, with individually-linked cancer registry, primary and secondary 
care data. In addition to multivariable analyses we also used potential-outcomes 
methods. 
Results: Colon cancer patients with comorbidities consulted their GP more frequently 
with cancer symptoms during the pre-diagnostic year, compared with non-comorbid 
cancer patients. EP occurred more frequently in patients with 'serious' or complex 
comorbidities (diabetes, cardiac and respiratory diseases) diagnosed/treated in hospital 
during the years pre-cancer diagnosis (43% EP in comorbid versus 27% in non-
comorbid individuals; multivariable analysis Odds Ratio (OR), controlling for socio-
demographic factors and symptoms: men OR=2.40; 95%CI 2.0-2.9 and women 
OR=1.98; 95%CI 1.6-2.4. Among women younger than 60, gynaecological (OR=3.41; 
95%CI 1.2-9.9) or recent onset gastro-intestinal conditions (OR=2.84; 95%CI 1.1-7.7) 
increased the risk of EP. In contrast, primary care visits for hypertension monitoring 
decreased EPs for both genders.  
Conclusions:  Patients with comorbidities have a greater risk of being diagnosed with 
cancer as an emergency, although they consult more frequently with cancer symptoms 
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during the year pre-cancer diagnosis. This suggests that comorbidities may interfere 
with diagnostic reasoning or investigations due to ‘competing demands’ or because they 
provide ‘alternative explanations’. In contrast, the management of chronic risk factors 
such as hypertension may offer opportunities for earlier diagnosis. Interventions are 
needed to support the diagnostic process in comorbid patients. Appropriate guidelines 
and diagnostic services to support the evaluation of new or changing symptoms in 
comorbid patients may be useful.  
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Background 
Internationally emergency diagnoses occur in up to 33% of colorectal cancers [1], with 
a higher risk for colon (31%) than rectal cancers (15%) [2]. Reducing emergency 
presentations is an important public health target [3], as they are associated with poor 
cancer survival, independently of stage at diagnosis [1], worse patient experience [4] 
and disruptions to hospital services [5].  One-year survival is 49% after emergency 
diagnosis of colorectal cancer compared to more than 80% for non-emergency routes 
[6]. Although some emergency diagnoses may be unavoidable, for example in rapidly 
progressing cancers with minimal or no prodromal symptoms until an acute presentation 
[1] [7], in a large proportion of cases emergency presenters have consulted their doctor 
with relevant symptoms during the months before the emergency cancer diagnosis [8-
12]. Socio-economically deprived individuals, women, the youngest and oldest age-
groups have increased risk of emergency presentations [1, 2, 8, 13], but population-
based evidence on why such inequalities occur and how to reduce them is scant. Less 
frequent help-seeking for cancer symptoms and diagnostic delays due to atypical 
presentations are possible contributing factors.   
Chronic conditions (hereafter called comorbidities) affect more than 50% of older adults 
[14-16]. Comorbidities might confer a higher risk of emergency cancer diagnosis [1], 
but current evidence is limited and mostly relates to studies evaluating the overall 
presence and number of comorbidities, without consideration of morbidity type and 
potential effect modification by presenting symptom and socio-demographic 
characteristics. Comorbidities providing ‘alternative’ explanations and those interfering 
with the cancer diagnosis through ‘competing demands’ (being unrelated to cancer but 
competing for clinical attention) can be associated with longer diagnostic intervals [17], 
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but their specific effects on emergency presentations is unknown. Some comorbidities 
requiring regular follow-up visits might offer opportunities for earlier diagnosis [18]. 
In this study, using linked cancer registry, primary and secondary care data with clinical 
information for up to 10 years pre-cancer [8], we aimed to provide population-based 
evidence on the effect of specific comorbidities on primary care consultations for 
cancer-related symptoms during the year before a colon cancer diagnosis. We also 
aimed to estimate the effect of specific comorbidities on the risk of cancer being 
diagnosed through emergency rather than non-emergency routes, accounting for socio-
demographic factors and symptoms. 
When using observational data for estimating average effects in the population, 
traditional epidemiological methods can lead to biased results due to non-comparability 
of examined groups. Potential-outcomes or counterfactual approaches can overcome 
this limitation. Similar approaches allowing to emulate randomized studies using 
observational data [19-21] are increasingly used for estimating treatment effects. They 
are also valuable for primary care and public health research [22]. When examining 
complex factors, for which many possible interventions exist, it is challenging to 
estimate causal effects [23] and in such circumstances potential-outcomes are 
particularly useful to clarify the relevance of the issue under examination [24-26] and 
critically consider the complex relationships between exposures and outcomes. 
Thus, in addition to using conventional methods, we aimed to employ potential-
outcomes approaches for determining the effects of specific comorbidities on the risk of 
cancer being diagnosed through emergency rather than non-emergency routes. 
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Methods 
Study population and data sources 
We included colon cancers (ICD-10 C18, further classified into distal C18.5-C18.7 and 
proximal C18.0-C18.4[27-29] tumours) diagnosed in England 2005-2010 recorded in 
the Cancer Registry and linked to primary care (Clinical Practice Research Datalink-
CPRD) and secondary care data (Hospital Episode Statistics-HES). CPRD provides 
prospectively collected patient-level information on diagnoses, signs/symptoms and 
tests. Study inclusion criteria were: ages 18 years or over at cancer diagnosis, no 
previous cancer, minimum one year of CPRD records pre-cancer, meeting CPRD 
quality criteria. CPRD covers 6.9% of the UK population and is representative of the 
general population[30], and as expected by the proportion of national coverage, 6.5% of 
all incident colon cancers registered in England during the study period were linked to 
active and up-to-standard CPRD records (N=6,316 out of 97,937 colon cancers 
diagnosed 2005-2010). After excluding patients with missing socio-demographic or 
route to diagnosis, N=5,745 individuals were included. Further details are reported 
elsewhere [8, 31]. 
 
Study variables 
The study outcome was emergency cancer diagnosis, defined according to the Routes to 
Diagnosis algorithm, i.e. diagnosis following presentation to Accident and Emergency, 
GP emergency referrals, or emergency pathways for in/out-patients [6, 32]. Non-
emergency diagnoses included routine GP referrals, two-week wait referral, 
inpatient/outpatient elective and screening.  
The main explanatory variables were comorbidities recorded before the diagnosis of 
cancer. Referring to the literature [17] and clinical experts we compiled a list of 
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comorbidities potentially influencing the colon cancer diagnosis through different 
mechanisms: 1) ‘serious’ or complex comorbidities diagnosed/treated in secondary care, 
which can interfere with the cancer diagnosis through competing demands: e.g. cardiac, 
chronic respiratory, neurological diseases; 2) comorbidities possibly providing 
alternative explanations for signs/symptoms of cancer: gastrointestinal (GI) conditions 
(irritable bowel syndrome (IBS), diverticular, coeliac, inflammatory bowel, other GI 
diseases), gynaecological conditions (endometriosis, dysmenorrhoea), 
anxiety/depression; 3) comorbidities potentially offering opportunities for earlier 
diagnosis through regular GP visits: hypertension monitoring. Some comorbidities 
might act through multiple mechanisms: e.g. anxiety/depression, gynaecological 
conditions or inflammatory bowel diseases might provide alternative explanations for 
cancer symptoms (abdominal pain, diarrhoea, constipation), and also interfere with the 
ability to focus on cancer symptoms through competing demands.  
'Serious' or complex comorbidities (see ‘1’ above) were defined using relevant ICD-10- 
diagnosis codes in hospital care records (Hospital Episodes Statistics-HES) [33, 34] 
relating to hospital care episodes during a two-year period before the cancer diagnosis. 
As linked HES records were available from 2003 onwards, a two-year pre-diagnostic 
window was chosen allowing the same HES observation period for all patients. We also 
created a binary variable coded as one if any HES record of ‘serious’ non-GI 
comorbidity versus none, excluding GI-conditions to focus on the competing demand 
mechanism.  
Comorbidities possibly providing alternative explanations and those offering 
opportunities for earlier diagnosis (see ‘2’ and ‘3’ above) were defined using relevant 
Medcodes/Readcodes in CPRD relating to consultations for up to 10-years before the 
diagnosis of cancer. Comorbidities possibly presenting with abdominal symptoms (GI 
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and gynaecological conditions), thus providing alternative explanations, were 
categorized as ‘new onset' (if first recorded in the pre-diagnostic year) and 'chronic/past' 
(if already recorded 2-10 years pre-cancer). We hypothesised that 'new onset' 
comorbidities might include mis-diagnoses (where cancer symptoms were mis-
interpreted as benign conditions), rather than true comorbidities (chronic conditions not 
related to cancer). Due to sparse data, IBS and diverticular disease were grouped 
together.  
Further explanatory variables were pre-diagnostic alarm symptoms/signs (rectal 
bleeding, change in bowel habit, anaemia) and other abdominal symptoms (e.g. 
abdominal pain, constipation, diarrhoea)[10, 35, 36]. As previously described[8] 
Medcodes/Readcodes for symptoms were applied to CPRD records in the 10 years pre-
diagnosis. Socio-demographic characteristics included gender, age and deprivation 
(Index of Multiple Deprivation for England). 
 
Statistical analysis 
We compared comorbidities, signs/symptoms and socio-demographic characteristics 
among emergency versus non-emergency presenters. We examined whether 
consultation rates for cancer symptoms during the pre-diagnostic year varied by specific 
comorbidities, controlling for socio-demographic factors, using Poisson regression. 
Random effects were added to account for patient-level clustering of repeat 
consultations. We evaluated the proportion of emergency presenters with alarm 
symptoms recorded in the pre-diagnostic year by comorbidity status, to evaluate if 
opportunities for earlier diagnosis vary by comorbidity type.  
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Using multivariable logistic regression we examined the risk of emergency 
presentations for different comorbidities, controlling for socio-demographic 
characteristics, cancer sub-site, GP consultations and signs/symptoms. Random effects 
accounted for possible patient clustering by practice. Men and women were examined 
separately and we assessed effect modification by age. 
Finally, we estimated the effects of comorbidities on the risk of cancer being diagnosed 
through emergency rather than non-emergency routes in the population of colon cancer 
patients. We used a potential-outcomes approach with our observational data, 
considering that covariates (socio-demographic factors and symptoms) might have 
differential effects on the exposure (comorbidity) and also affect the outcome 
(emergency presentations) (see Additional file 1 for a graphic representation and 
methodological details).  
Statistical analyses were performed using STATA14 (Stata Corp., College Station, TX, 
USA). 
 
Results 
Comorbidities recorded prior to cancer diagnosis among emergency or non-
emergency presenters 
Among the 5745 colon cancer patients, 34% of women and 30% of men were diagnosed 
as emergencies. Overall, emergency cancer diagnosis occurred in 43% of patients with 
pre-existing 'serious' non-GI comorbidity versus 27% in individuals without 
comorbidity (p<0.001). Examining specific pre-existing 'serious' comorbidities has 
shown that almost all of them were more prevalent in emergency than non-emergency 
presenters (Table 1).  
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Primary care comorbidities were similar in emergency and non-emergency presenters, 
except for a higher frequency among non-emergency presenters of haemorrhoids in 
women and hypertension monitoring in both genders (Table 1). The most frequent 
primary care comorbidities were anxiety/depression and IBS/diverticular disease. 
IBS/diverticular diseases showed a stable prevalence 2-5 years pre-cancer (women: 
1.4% to 2.3%; men: 0.5% to 1%), with a marked increase in the pre-diagnostic year 
(women: 6.2%; men: 3.5%) (data not shown).  
 
Consultations with potential cancer symptoms among comorbid and non-comorbid 
patients 
Consultation rates with potential cancer symptoms over the 5-years pre-diagnosis were 
stable up to the pre-diagnostic year, when a marked increase was observed for 
emergency and non-emergency presenters. However, among female emergency 
presenters with ‘serious’ non-GI comorbidities diagnosed/treated in secondary care, GP 
consultations with potential cancer symptoms started increasing two years pre-diagnosis 
(Figure 1). Comorbid individuals consulted more frequently with cancer symptoms 
during the pre-diagnostic year than non-comorbid individuals, controlling for socio-
demographic factors and cancer sub-site (Figure 2). Among emergency presenters, the 
proportion of patients with cancer alarm symptoms (rectal bleeding, anaemia, change in 
bowel habit) recorded in primary care in the pre-diagnostic year (i.e. indicating possible 
missed diagnostic opportunities) was 21% among men with 'serious' hospital-treated 
comorbidities versus 11% among non-comorbid men (p<0.001) (Table in Additional 
file 2). Patients with anxiety/depression also more frequently had alarm symptoms 
recorded the year before emergency cancer diagnosis compared to those never having 
had anxiety/depression (women: 36% versus 18% (p=0.002); men 22% versus 13% 
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(p=0.021). Similarly, female emergency presenters with IBS/diverticular disease had 
more frequent records of alarm symptoms in the year pre-cancer diagnosis compared to 
those never having had IBS/diverticular disease (32% versus 19%; p=0.008).  
 
Multivariable analysis examining the effect of comorbidities on emergency 
presentations  
Men and women with pre-existing ‘serious’ non-GI comorbidities diagnosed/treated in 
secondary care had a significantly higher risk of emergency presentations, controlling 
for socio-demographic factors and symptoms (Figure 3). In contrast, hypertension 
monitoring decreased the risk of emergency presentation. Among women, 
gynaecological and IBS/diverticular diseases increased the risk of emergency 
presentations. New onset alarm symptoms decreased emergency presentations for both 
genders.  
Examining the effects of comorbidities stratified by age and controlling for deprivation, 
cancer sub-site and symptoms, showed how the risk of emergency presentation was 
particularly high for women aged less than 60 with gynaecological conditions 
(OR=3.41; 95%CI 1.2-9.9) and for those with recent IBS/diverticular disease diagnoses 
(OR=2.84; 95%CI 1.2-7.7) (Table 2). The risk was also higher for women aged 70-79 
with gynaecological or ‘serious’ non-GI comorbidities, and for women aged 80 or more 
with a past history of IBS/diverticular disease or ‘serious’ non-GI comorbidities. For 
men, age-stratified results (data not shown) were similar to those for all age-groups 
combined shown in Figure 3.  
The findings obtained through standard multivariable analysis were corroborated using 
potential-outcomes methods (Table 3 and Box). At population level, the risk of 
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emergency presentation for both genders was increased by ‘serious’ non-GI 
comorbidities. Age-stratified analyses showed a particularly high average risk for some 
subgroups of colon cancer patients, such as women aged less than 60 with a recent 
IBS/diverticular disease or benign gynaecological diagnosis, and women aged 80 or 
more with a past history of IBS/diverticular disease.   
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Box - Results using the potential-outcomes approach: Estimating the average effect 
of comorbidities on emergency presentations in the population of colon cancer 
patients 
Table 3 shows the potential outcome mean (POmean, i.e. the proportion of emergency 
cancer diagnoses) we would expect among the population of colon cancer patients if 
nobody had the examined comorbidity. After estimating the potential outcome mean 
expected if everybody had that comorbidity, we calculated the difference between the 
two means (i.e. the risk difference or average treatment effect, ATE) shown in Table 3. 
The ATE corresponds to the average effect of each comorbidity on the risk of 
emergency presentations. All estimates accounted for socio-demographic 
characteristics, cancer symptoms and other comorbidities.  
As shown by the POmean in Table 3, in the absence of ‘serious’ non-GI comorbidities, 
30% of women with colon cancer and 25% of men can be expected to have an 
emergency presentation. Based on the ATE, the presence of ‘serious’ comorbidity 
would significantly increase these proportions, adding a further 12% and 15% of 
emergency presentations among women and men, respectively. Overall, this would 
result in 42% of comorbid women with colon cancer and 40% of comorbid men having 
an emergency presentation. Significant effects were also found for COPD, diabetes and 
cardiac disease. 
In contrast, hypertension monitoring during the pre-diagnostic year had an average 
protective effect, albeit small, in women and men (ATE=-9% and ATE=-4%). The other 
comorbidities recorded in primary care had no significant average effect when analysing 
all age-groups together. However, focusing on women aged less than 60 with colon 
cancer, if they never had a diagnosis of IBS/diverticular disease the average risk of 
emergency presentation can be expected to be 35%. New onset IBS significantly 
increased emergency presentations (ATE=22%), while chronic/past IBS decreased the 
risk (ATE=-29%). Thus, the overall risk of emergency presentations for women aged 
less than 60 with colon cancer and new onset IBS/diverticular disease would be 57%, 
while it would be 6% for those with a chronic/past IBS. Gynaecological conditions also 
significantly increased the risk for women aged less than 60 (ATE=26%). Examining 
women aged 80 or more with colon cancer has shown that if older women never had 
IBS/diverticular disease we could expect an average risk of emergency presentation of 
43%. If older women had a past history of IBS/diverticular disease the risk would be 
significantly higher (ATE=23%), with an overall risk of emergency presentations of 
66%. COPD and cardiac diseases also had significant effects in older women.  
Findings for men did not differ by age-group (data not shown) and thus age-stratified 
results are only reported for women in Table 3.  
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Discussion  
Summary 
Most comorbidities increased the risk of emergency colon cancer diagnosis, but the 
effects are complex and vary by socio-demographic factors and by type and timing of 
comorbidity onset. Comorbid patients consulted more frequently with cancer symptoms 
than non-comorbid individuals in the pre-diagnostic year and some comorbidities 
offered opportunities for earlier diagnosis. The risk of emergency presentations was 
particularly high for some subgroups, including patients with ‘serious’ comorbidities 
diagnosed/treated in secondary care (diabetes, cardiac, respiratory diseases) and women 
aged less than 60 with a recent diagnosis of IBS/diverticular disease or benign 
gynaecological conditions. One-fifth of emergency presenters with ‘serious’ 
comorbidities, diagnosed/treated in secondary care, presented with cancer alarm 
symptoms in primary care during the pre-diagnostic year, suggesting opportunities for 
reducing emergency presentations. One in three female emergency presenters with a 
recent diagnosis of IBS/diverticular disease consulted their GP with cancer alarm 
symptoms in the year pre-cancer diagnosis.  
Traditional epidemiological methods and counterfactual-based approaches yielded 
similar findings. 
 
Strengths and limitations 
A detailed examination of specific comorbidities prospectively recorded in primary and 
secondary care allowed us to substantially add to the literature, highlighting how 
comorbidities can influence the risk of emergency presentations, acting through 
different mechanisms, with patients' gender and age modifying their effect. It is the first 
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population-based study, using high-quality primary and secondary care data linked to 
cancer registration and routes to diagnosis data, showing contrasting effects of different 
comorbidities on emergency presentations. By identifying higher risk groups the study 
can help develop targeted strategies for reducing emergency presentations. A substantial 
proportion of emergency presenters had primary care consultations with alarm 
symptoms during the pre-diagnostic year, particularly among comorbid patients, 
suggesting that there are opportunities for earlier diagnosis. Sensitivity analyses 
changing the time-window for defining 'serious' comorbidities diagnosed/treated in 
hospital (e.g. including only comorbidities recorded more than 6 or 12 months pre-
cancer) confirmed an increased risk of emergency presentation for comorbid patients 
(data not shown).  
Relying on routinely collected data we probably underestimated the prevalence of 
symptoms and comorbidities, but this likely occurred in a non-differential way, as 
information was prospectively recorded.  
Linked data was only available for our analyses up to 2010. Emergency presentations 
for colorectal cancer have decreased in England between 2006 and 2010 (from 27% to 
24%), however no further reductions have been reported since 2010 [2] [6]. Inequalities 
in emergency presentations [2] and poorer survival for cancer patients diagnosed as an 
emergency [37] are persisting problems.  
 
Comparison with existing literature 
The relationship between comorbidities and emergency presentations is complex, with 
multiple pathways possibly leading to delays (influenced by biological, psychological 
and organizational factors affecting patients and doctors) [1, 13, 38-41]. Recent research 
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reported how ‘competing demands’ and ‘alternative explanation' comorbidities 
(including IBS/diverticular diseases) are associated with longer diagnostic intervals [17], 
but their effects on emergency presentations were unknown. ‘Serious’ comorbidities 
probably require immediate attention 'competing' with timely investigations of cancer 
symptoms [40, 42, 43], increasing the risk of emergency presentations. IBS or 
diverticular disease can lead to delays by providing alternative explanations, influencing 
patients' help-seeking and/or referrals for investigations. A Dutch study [44] reported 
how sometimes doctors attribute colorectal cancer symptoms to pre-existing conditions 
in patients with a history of diverticulitis or gynaecological conditions. Our data has 
shown that the effect can vary depending on the time between the benign diagnosis and 
the cancer diagnosis, with gender and age modifying the effect.  
A recent IBS/diverticular disease diagnosis might include cases in which cancer 
symptoms were mis-attributed to a benign condition. This is supported by our findings 
showing a marked increase in IBS/diverticular disease records shortly before the cancer 
diagnosis. The 'baseline' prevalence of IBS/diverticular disease 2-5 years pre-cancer in 
our sample was low and similar to previous primary care studies (2.5%) [45, 46]. IBS 
prevalence in the general population varies widely [46], depending on diagnostic criteria 
and data sources [47], but what is noteworthy here is the increase during the pre-
diagnostic months. Some cases might have been 'working' diagnoses possibly followed 
by investigations, nevertheless our study highlighted how a recent IBS diagnosis can 
increase emergency presentations particularly in women.  
In contrast, long-standing IBS/diverticular diseases had a protective effect in younger 
women, suggesting that in these circumstances women and/or doctors recognized that 
symptoms had changed. Familiarity with the healthcare system, more opportunities to 
discuss symptoms with the doctor and tumour biology might also have played a role, 
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with some women with long-standing symptoms possibly having slow-growing and less 
aggressive cancers. Differently from younger women, older women with a past history 
of IBS/diverticular disease had an increased risk of emergency presentations. Advanced 
age might have prevented invasive investigations due to patients' health status, their 
preferences or barriers accessing healthcare [48]. 
Patients sometimes attribute cancer symptoms to comorbidities or delay reporting them 
due to worries about wasting doctors' time [41, 49]. We could not examine cancer 
awareness or timely reporting of symptoms, however our study highlighted how 
comorbid patients consulted significantly more with cancer symptoms than non-
comorbid individuals. Thus, diagnostic delays cannot simply be explained by patients 
not seeing their doctor for cancer symptoms. 
 
Implications for research and practice 
One in three colon cancers are diagnosed as an emergency, with higher risks for 
comorbid patients especially if belonging to the youngest or oldest age-groups. 
Reducing emergency cancer diagnosis is an important public health target, given its 
negative consequences in terms of survival, independently of stage [1] [3]. Appropriate 
interventions are necessary for the large number of individuals with comorbidities who 
experience potential cancer symptoms. Innovative diagnostic strategies need to be 
developed targeting higher risk groups and taking into account the specific mechanisms 
through which comorbidities might affect diagnostic timeliness. In particular, greater 
integration between primary and secondary care, as well as more extensive use of multi-
disciplinary diagnostic centres, which are currently being evaluated in different 
countries [50-52], can play an important role for complex patients, such as those with 
comorbidities. Sufficient consultation time is important especially for patients with 
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multi-morbidities and vague symptoms in order to adopt a holistic approach and reduce 
delays [53]. Optimization of healthcare services [54-56] and support from nurses could 
help to free up consultation time. In addition to system-wide approaches, targeted 
interventions are needed. For example, colon cancer diagnosis in women can be 
particularly complex because of gynaecological conditions and the higher prevalence of 
IBS [47, 57], highlighting the importance of innovative technologies and safety-netting 
strategies tailored for higher risk groups.  
International evidence on emergency cancer diagnosis is scant, but what there is 
suggests that the problem is not limited to the UK [1], particularly for cancers initially 
presenting with non-specific symptoms. More international data could provide insights 
into the role played by healthcare factors in influencing diagnostic timeliness. A 
detailed analysis of type and timing of comorbidities and specific pathways is necessary 
to better understand the mechanisms leading to delays and identify appropriate 
interventions. The effects of comorbidities are complex and patient, doctors and 
healthcare system factors all need to be considered in order to reduce their impact on 
emergency presentations and improve cancer outcomes.  
 
Conclusions 
The study highlighted how most comorbidities increased the risk of emergency colon 
cancer diagnosis, but the effects are complex and vary by socio-demographic factors 
and by type of comorbidity. The risk of emergency presentation was particularly high 
for some subgroups, including patients with ‘serious’ comorbidities diagnosed/treated in 
hospital during the years pre-cancer diagnosis (diabetes, cardiac, respiratory 
diseases) and women aged less than 60 with a recent diagnosis of IBS/diverticular 
disease or benign gynaecological conditions.  By identifying higher risk groups the 
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study can help develop targeted strategies for reducing emergency presentations. A 
substantial proportion of emergency presenters had primary care consultations with 
alarm symptoms during the pre-diagnostic year, particularly among comorbid patients. 
This suggests that comorbidities may interfere with diagnostic reasoning or 
investigations due to ‘competing demands’ or because they provide ‘alternative 
explanations’. In contrast, the management of chronic risk factors such as hypertension 
may offer opportunities for earlier diagnosis. Interventions are needed to support the 
diagnostic process in comorbid patients. Appropriate guidelines and diagnostic services 
to support the evaluation of new or changing symptoms in comorbid patients may be 
useful. 
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comorbid and non-comorbid patients diagnosed with colon cancer following 
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Table 1: Socio-demographic characteristics, comorbidities and cancer alarm symptoms among individuals diagnosed 
with colon cancer following emergency (EP) and Non-emergency presentation (non-EP)  
 
   WOMEN       MEN     
  Non-EP  EP Total p-value  Non-EP  EP Total p-value 
  N=1859 N=940 N=2799   N=2072 N=874 N=2946  
    % %  %      % %  %    
Age (years)           
18-59  14.5 15.4 14.8 <0.001  14.1 15.8 14.6 <0.001 
60-69  24.1 15.6 21.3   29.4 19.5 26.5  
70-79  33.9 25.2 31.0   34.8 33.1 34.3  
80+  27.5 43.7 32.9   21.6 31.7 24.6  
SES (deprivation quintile)            
1 (least deprived)  23.1 19.2 21.8 0.005  24.4 23.0 24.0 0.064 
2  21.5 21.7 21.6   22.0 22.7 22.2  
3  21.5 21.5 21.5   20.6 17.4 19.7  
4  18.3 18.5 18.4   17.5 19.2 18.0  
5 (most deprived)  10.9 15.5 12.5   11.1 14.1 12.0  
Comorbidities recorded in secondary care 0-24 months pre-diagnosis       
Myocardial infarction  1.5 2 1.7 0.317  2.4 4.8 3.1 0.001 
Congestive heart failure  2.2 5.4 3.3 <0.001  2.3 6.5 3.6 <0.001 
Peripheral vascular disease 0.5 3.2 1.4 <0.001  2.4 4.9 3.2 <0.001 
Cerebrovascular disease  1.7 3.4 2.3 0.003  1.2 3.2 1.8 <0.001 
Dementia  0.8 3.9 1.8 <0.001  1.0 2.8 1.5 <0.001 
COPD  8.1 13.1 9.8 <0.001  7.5 13.0 9.1 <0.001 
Rheumatic disease  2.3 1.9 2.1 0.552  0.7 1.5 0.9 0.035 
Peptic ulcer disease  1.4 2.5 1.8 0.046  2.1 2.2 2.1 0.865 
Mild liver disease  0.6 1.9 1.0 0.001  0.7 2.1 1.1 0.002 
Diabetes without complications 5 7.3 5.8 0.010  7.6 10.4 8.5 0.013 
Diabetes with complications 0.2 0.6 0.3 0.035  0.3 0.8 0.5 0.095 
Hemiplegia or paraplegia  0.1 0.6 0.3 0.013  0.4 1.0 0.6 0.035 
Renal disease  1 3.7 1.9 <0.001  2.0 5.2 2.9 <0.001 
Moderate or severe liver disease 0.3 0.3 0.3 0.814  0.2 0.1 0.2 0.636 
'Serious' non-GI comorbidities recorded in secondary care 0-24 months pre-diagnosis°     
0  79.4 65.7 74.8 <0.001  76.3 60.6 71.7 <0.001 
1-2  19.8 31.1 23.6   22.2 34.6 25.8  
3+  0.8 3.2 1.6   1.5 4.8 2.5  
Gynaecological conditions recorded in primary care        
New onset pre-diagnostic year 0.3 0.3 0.3 0.217      
Chronic/past  1.3 2.2 1.6       
IBS or Diverticular disease recorded in primary care^       
New onset pre-diagnostic year 5.1 6.0 5.4 0.468  3.4 2.3 3.1 0.256 
Chronic/past  5.4 6.1 5.6   2.7 2.5 2.6  
Haemorrhoids recorded in primary care         
New onset pre-diagnostic year 2.0 0.7 1.6 0.005  2.0 1.1 1.8 0.251 
Chronic/past  3.7 2.2 3.2   3.3 3.3 3.3  
Inflammatory bowel disease or ulcerative colitis recorded in primary care^      
New onset pre-diagnostic year 0.1 0.0 0.0 0.717  0.1 0.1 0.1 0.808 
Chronic/past  0.5 0.4 0.5   0.6 0.6 0.6  
Other benign GI conditions recorded in primary care^       
New onset pre-diagnostic year 0.8 0.4 0.7 0.404  0.6 0.5 0.5 0.198 
Chronic/past  2.4 2.0 2.3   1.3 0.6 1.1  
Anxiety/depression recorded in primary care       
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New onset pre-diagnostic year 4.4 5.6 4.8 0.189  7.1 7.8 7.3 0.655 
Chronic/past  22.5 20.5 21.9   17.7 18.7 18.0  
Hypertension monitoring in primary care        
30 days to 12 months pre-
diagnosis 62.18 45.74 56.66 <0.001  55.84 39.7 51.05 <0.001 
13-24 months   23.02 24.68 23.58 0.329  15.88 15.68 15.82 0.890 
25-36 months   18.18 17.02 17.79 0.448  13.18 13.27 13.20 0.944 
37-48 months   14.52 15.74 14.93 0.392  11.1 11.21 11.13 0.929 
49-60 months   14.04 14.36 14.15 0.817  9.85 8.92 9.57 0.438 
Cancer alarm symptoms recorded in primary care        
Change in bowel habit            
New onset pre-diagnostic year 6.7 2.0 5.1 <0.001  7.0 2.4 5.6 <0.001 
Chronic/past  1.7 1.6 1.7   1.3 1.0 1.2  
Rectal bleeding           
New onset pre-diagnostic year 10.1 3.3 7.8 <0.001  10.3 2.9 8.1 <0.001 
Chronic/past  4.4 3.9 4.3   4.6 2.6 4.0  
Anaemia            
New onset pre-diagnostic year 17.5 11.7 15.6 <0.001  15.8 7.7 13.4 <0.001 
Chronic/past   8.7 11.2 9.5     5.9 7.3 6.3   
°Serious non-gastrointestinal (non-GI) comorbidities include all the HES comorbidities, excluding peptic ulcer, liver disease, 
inflammatory bowel disease and ulcerative colitis 
^Due to sparse data some comorbidities have been grouped together. Other benign GI conditions include coeliac disease, 
gallbladder diseases and others.   
IBS: irritable bowel syndrome  
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Figure Legends 
Figure 1: Consultation rates in primary care for cancer symptoms pre-diagnosis for 
emergency (EP) and non-emergency presenters (non-EP) with and without hospital-
treated comorbidities  
Legend figure 1: Observed data points and fitted local polynomial regression lines  
 
Figure 2: Incidence Rate Ratios (IRR) for primary care consultations with relevant 
symptoms during the pre-diagnostic year  
Legend figure 2: Poisson multivariable regression including in the model all the variables 
shown in the figure, as well as cancer sub-site. SES=Socio-economic status; New onset 
comorbidity=comorbidity first recorded during the year pre-cancer diagnosis; 
Chronic/past=already recorded >12 months pre-cancer diagnosis; Hypertension 
monitoring between 30 days and 12 months pre-cancer diagnosis. 
 
Figure 3: Likelihood of emergency colon cancer diagnosis:  Mixed effects 
multivariable logistic regression Odds Ratios  
Legend figure 3: Adjusted ORs from multivariable regression analysis including in the 
model all the variables shown in the figure, as well as socio-demographic characteristics 
and number of consultations in the pre-diagnostic year. New onset 
comorbidity=comorbidity first recorded during the year pre-cancer diagnosis; 
Chronic/past=comorbidity already recorded >12 months pre-cancer diagnosis; 
Hypertension monitoring between 30 days  
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Figure 1: Consultation rates in primary care for cancer symptoms pre-diagnosis for 
emergency (EP) and non-emergency presenters (non-EP) with and without hospital-
treated comorbidities 
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Figure 2: Incidence Rate Ratios (IRR) for primary care consultations with relevant 
symptoms during the pre-diagnostic year  
 
Legend: Poisson multivariable regression including in the model all the variables shown in the figure, as well as cancer sub-site. 
SES=Socio-economic status; New onset comorbidity=comorbidity first recorded during the year pre-cancer diagnosis; 
Chronic/past=already recorded >12 months pre-cancer diagnosis; Hypertension monitoring between 30 days and 12 months pre-cancer 
diagnosis. 
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Figure 3: Likelihood of emergency colon cancer diagnosis:  Mixed effects multivariable 
logistic regression Odds Ratios 
 
Legend: Adjusted ORs from multivariable regression analysis including in the model all the variables shown in the 
figure, as well as socio-demographic characteristics and number of consultations in the pre-diagnostic year. New 
onset comorbidity=comorbidity first recorded during the year pre-cancer diagnosis; Chronic/past=comorbidity 
already recorded >12 months pre-cancer diagnosis; Hypertension monitoring between 30 days 
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Chapter 5 - The complex landscape of emergency cancer 
diagnoses: what have we learned and how can we move forward 
 
Introduction 
According to recent data, emergency diagnoses still occur in 23% of colorectal cancers in 
England6, with much higher figures for colon than rectal cancer (31% and 15%, respectively)30. 
After an initial decrease between 2006 and 2010 (from 27% to 23%)6 34 no further reductions 
have been reported since 20106 (Appendix Figure and Table). Cancer patients diagnosed as an 
emergency have significantly poorer survival compared to patients diagnosed through non-
emergency routes3 4, even accounting for stage at diagnosis5. This highlights the importance of 
reducing emergency presentations, as also underscored by the Independent Cancer 
Taskforce10 and Public Health England Cancer Board Plan for 2017-202183. The geographic 
variability of emergency presentations both nationally98 and internationally (ranging between 
14% and 33%)31, as well as the decreasing trend over the last decade in England, suggest that 
modifiable patient and/or healthcare system factors are contributing to the problem and that 
further reductions might be achievable. However, population-based evidence on the clinical 
events preceding emergency presentations and on the specific role played by patient, tumour 
and healthcare factors11 is scant. Such information is crucial to develop effective strategies for 
earlier diagnosis.  
In this thesis I used an epidemiological population-based approach examining person-level 
data in order to profile variations in risk and identify groups at higher risk of emergency 
presentations, offering insights on potential opportunities for earlier diagnosis.  By analysing in 
detail the type and timing of symptoms, comorbidities and benign diagnoses prospectively 
recorded during the months and years before the diagnosis of colon and rectal cancers I aimed 
to increase the present state of scientific understanding on the interplay between 
demographic, clinical and tumour factors in influencing emergency presentations. This could 
inform the targeting of further early diagnosis research and the development of interventions 
and strategies aimed at reducing emergency presentations particularly among higher risk 
groups or high-risk clinical scenarios.  
In this final chapter I discuss how the work I have conducted can contribute to the knowledge 
base on emergency colorectal cancer diagnosis, taking the available literature on the topic into 
account. Strengths and limitations of the research presented in this thesis are considered. 
Finally, the implications for further research, policy and practice are discussed.  
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Discussion  
 
Main contribution of the thesis  
Pre-diagnostic consultations and related symptoms among emergency and non-emergency 
presenters 
The first research question addressed in this thesis (Study 1)1 aimed to increase our 
understanding on whether colorectal cancer patients diagnosed as an emergency differ from 
non-emergency presenters in their primary care consultation patterns and symptoms. It also 
aimed to evaluate possible opportunities for reducing emergency presentations. The study 
allowed to acquire novel insights into the pre-diagnostic period. It showed that emergency 
presenters have similar ‘background’ consultation history as non-emergency presenters during 
the 2-5 years pre-cancer. During the year before the cancer diagnosis more than 95% of 
emergency and non-emergency presenters consulted their doctor. These findings seem to 
refute the hypothesis that emergency presenters may represent a patient group with reduced 
access to primary care, or a propensity to use primary care less often than non-emergency 
presenters.  
However, fewer than half of emergency presenters had records of relevant cancer symptoms, 
a proportion that was significantly lower than for non-emergency presenters. This finding 
seems to strongly indicate that disease/tumour factors (such as the symptom signature) are 
important in contributing to the risk of emergency diagnosis of colon and rectal cancers, with 
emergency presenters having less typical symptoms.  
Nonetheless, even though emergency presenters seem to have tumours associated with less 
typical symptoms, one out of five emergency presenters had typical 'alarm' symptoms (rectal 
bleeding, change in bowel habit, anaemia) recorded in primary care during the 2-12 months 
pre-cancer diagnosis and 16% had 3 or more consultations with relevant symptoms. This 
suggests that there are opportunities for reducing emergency colorectal cancer diagnosis in a 
subgroup of patients.  
While other studies have also shown that most emergency presenters do have primary care 
consultations before their cancer diagnosis,36 44 99, most previous research did not consider 
whether consultations occurred for relevant symptoms. A strength of my study has been to 
provide detailed information on the type and timing of symptoms recorded in primary care, 
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and to compare emergency and non-emergency presenters for their symptomatic 
presentations, while accounting for socio-demographic characteristics.  
The study also identified socio-demographic subgroups at higher risk of emergency diagnosis, 
including women, older and more deprived people. While the overall socio-demographic 
variation in emergency presentations is in line with other studies84 11 33 53, a novel contribution 
is that the higher risk among these subgroups cannot simply be explained by less frequent 
symptomatic presentations, as the variation in risk persists even after accounting for 
symptoms recorded in primary care. Thus, further in-depth research as well as more clinical 
and public health efforts focusing on higher risk groups are warranted in order to improve 
early cancer diagnosis and reduce emergency presentations. 
 
Possible inequalities in emergency cancer diagnosis  
The second research question of this thesis (Study 2) was to increase our understanding on 
why certain subgroups of the population have a higher risk of emergency cancer diagnosis, 
shedding light on possible inequalities. As nearly one in three colon cancers are diagnosed 
following an emergency presentation, which is double the risk compared to rectal cancers, I 
focused in particular on colon cancer patients. Moreover, since approximately half of colon 
cancers occur in women, who have both a higher risk of emergency presentations1 84 and also 
lower 12-month survival than men6, I specifically focused on increasing our understanding on 
reasons for emergency cancer diagnoses among women.  
In addition to examining symptomatic presentations, this work also included an analysis of the 
likely role of benign diagnoses, such as IBS and diverticular disease, recorded during the 
months or years pre-cancer. Moreover, cancer sub-sites have been taken into account, as 
proximal colon cancers occur more frequently in women than men, which might partially 
explain variations in symptoms and diagnostic difficulties85.  
By examining women and men separately, taking also age, social deprivation and an overall 
comorbidity measure into account, the study provided new insights into the diagnostic 
complexities contributing to emergency presentations and highlighted subgroups at 
particularly high risk. In particular, study 2 has shown that women diagnosed as an emergency 
presented with alarm symptoms more frequently than men during the 2-12 months pre-
cancer, with one in five women having alarm symptoms and multiple relevant consultations, 
compared with 14% for men. This suggest that there might be more frequently missed 
opportunities for earlier diagnosis in women than in men. Moreover, the increase in 
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consultations with relevant symptoms occurred earlier in women with proximal colon cancer, 
who were also at increased risk of emergency diagnosis. The higher risk of emergency colon 
cancer among women persisted even after accounting for cancer sub-sites and symptoms, 
indicating that other factors might also play a role. Women were twice as likely to receive a 
benign diagnosis (IBS or diverticular disease) recorded in the year before their emergency 
presentation compared to men presenting with similar symptoms. A particularly high risk of 
emergency colon cancer diagnosis was observed among women aged 40-59 years with 
symptoms consistent with a recent onset IBS or diverticular disease. This highlights that 
differential diagnosis can be particularly difficult in women. Even though I was not able to 
ascertain whether benign diagnoses represented mis-diagnoses or ‘working diagnoses’ 
awaiting diagnostic confirmation, the study findings indicate that receiving a benign diagnosis 
can contribute to the increased risk of emergency presentations in women. Furthermore, past 
records of anaemia 2-5 years pre-cancer were associated with emergency presentations in 
women but not in men, highlighting the need for prompt investigations of this early sign, 
especially in women. Recent primary care research supports the use of innovative diagnostic 
approaches, such as quantitative faecal haemoglobin testing (FIT), to aid the diagnostic process 
of colorectal cancer and other serious bowel diseases in individuals with non-specific 
symptoms and anaemia91. 
A parallel can be drawn between my findings regarding variation by sex in the risk of 
emergency presentation with colon cancer (and the role of new onset benign diagnosis, such 
as IBS and diverticular disease in women) and sex differences in the diagnostic process 
previously reported for urological cancers. Specifically, studies on urinary tract (bladder and 
renal) cancer100 101 have shown that women on average have longer diagnostic intervals42, a 
higher risk of multiple consultations before specialist referrals40, and a higher risk of 
emergency presentations84.  Positive predictive values of various possible cancer symptoms 
are generally lower in women compared to men64 102 (for example, urinary tract infections are 
genuinely more common in women than men due to anatomical reasons) and this might 
influence doctors’ interpretation of symptoms as being due to a benign disease.  
The study findings highlight the diagnostic complexities that doctors face, particularly in the 
case of some patient subgroups, such as younger women who often present with non-specific 
symptoms making differential diagnosis between cancer and benign conditions exceptionally 
challenging. This suggests the need for innovations in technologies and diagnostic strategies.  
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The role of comorbidities in influencing timely cancer diagnosis and emergency 
presentations 
The third research question addressed in this thesis focused on examining the possible role 
played by comorbidities in influencing timely cancer diagnosis and their impact on emergency 
presentations.  
The risk of cancer increases substantially after the age of 60, and more than half of the 
population in this age group will have one or more pre-existing chronic diseases 
(comorbidities) 92 93 103. A recent review examined the relationships between cancer and some 
chronic diseases (obesity and diabetes), highlighting their complex effects on cancer incidence 
and prognosis 104. However, despite the increasing recognition of the relevance of chronic 
diseases in cancer patients, a comprehensive evaluation of their effects on the diagnostic 
process is lacking.  It is generally believed that chronic diseases can delay the diagnosis of 
cancer, but the evidence is mixed and little is known on the underlying mechanisms 31 57 60 105-
107. Improving early cancer diagnosis is one of the principal strategies for cancer control108 and 
we need to better understand how pre-existing chronic diseases influence diagnostic pathways 
for cancer.  
 
A critical review of the literature on the role of comorbidities on timely cancer diagnosis 
The literature review I completed for Study 3.1 added to the available evidence and allowed to 
increase our understanding on how comorbidities, overall and by specific morbidity type, can 
affect different steps along the diagnostic pathway in patients with cancer. In particular, the 
review covered the global literature and identified more than 60 primary studies on chronic 
morbidities and cancer diagnosis from various countries, such as the USA, UK, Canada, 
Netherlands and Denmark, covering more than 20 different cancers, with larger studies 
including more than 133,000 cancer patients. The only prior review specifically focusing on the 
topic was limited to colorectal cancers and examined a single early diagnosis metric (cancer 
stage) including only 9 relevant primary studies95.  
A strength of my critical review has been to provide a comprehensive analysis of comorbidity-
specific effects on patients’ help-seeking for possible cancer symptoms, clinician's decision-
making regarding investigations, time to cancer diagnosis, cancer stage and emergency cancer 
diagnosis. This allowed me to describe the complex mechanisms through which chronic 
morbidities can influence the cancer diagnosis, taking into account prior theories including the 
‘competing demands’, ‘alternative explanation’ and ‘surveillance’ hypotheses95 105 109 110. The 
review showed that comorbidities are generally associated with a higher risk of delayed help-
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seeking, advanced stage and emergency presentations. However, contrasting effects emerged 
when comorbidity-specific information was available. Some comorbidities, such as 
neurological, pulmonary, cardiac and psychiatric disorders, were more strongly associated with 
delays. In line with the 'competing demands' hypothesis serious or complex comorbidities 
might distract doctors and patients from the cancer diagnosis, particularly in case of cancers 
presenting with vague symptoms, leading to delays. The review also supported the 'alternative 
explanation' hypothesis, showing how delays can occur when comorbidities and cancer 
present with overlapping symptoms. In contrast, hypertension and some benign 
gastrointestinal and musculoskeletal conditions were associated with earlier cancer diagnosis. 
These conditions might be associated with more frequent healthcare encounters offering 
opportunities for discussing possible cancer symptoms, in agreement with the 'surveillance' 
hypothesis. The review highlighted additional mechanisms, including false reassurance by 
investigations performed for a chronic disease which can lead to delays. 
By integrating the available evidence from quantitative and qualitative studies and 
encompassing disease, patient, healthcare provider and system factors, the critical review has 
allowed me to propose a comprehensive conceptual framework illustrating how pre-existing 
chronic diseases can act through different and sometimes contrasting mechanisms and 
influence the diagnostic process at multiple stages of the diagnostic pathway. The findings can 
guide further research and inform the development of interventions aimed at improving 
cancer diagnosis for the large number of people with chronic conditions who experience 
possible cancer symptoms. 
 
A data-linkage study on comorbidity-specific effects on emergency colon cancer diagnosis 
Building on the literature review and on my previous work for studies 1 and 2, I performed 
further in-depth analyses on the role of specific comorbidities on the risk of emergency colon 
cancer diagnosis using individually-linked cancer registration, primary and secondary care data 
providing prospectively recorded clinical information for up to 10 years pre-cancer. This study 
(Study 3.2) has extended the available evidence, as most of previous population-based 
research on emergency presentations only evaluated the overall impact of having any 
comorbidity, without examining specific comorbidities and potential effect modification by 
type and timing of presenting symptoms and demographic characteristics31.   
The work I have performed for Study 3.2 has shown that overall emergency presentations 
occurred in 43% of comorbid versus 27% of non-comorbid individuals. However, the impact of 
comorbidities varied depending on the type of comorbidity, with patients' age and gender 
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modifying the effect. A specific contribution of the study has been the identification of patient 
subgroups at particularly high risk of being diagnosed with colon cancer as an emergency 
rather than through non-emergency routes. Higher risk groups included individuals with pre-
existing ‘serious’ or complex comorbidities (diabetes, cardiac, respiratory diseases) diagnosed 
or treated in hospital during the years pre-cancer diagnosis. Moreover, women aged less than 
60 with a recent diagnosis of a benign gastrointestinal or gynaecological condition were at 
significantly higher risk. Patients with comorbidities had a greater risk of emergency 
presentation although they consulted more frequently with cancer symptoms during the year 
pre-cancer diagnosis. This suggests that comorbidities may interfere with diagnostic reasoning 
or investigations due to ‘competing demands’ or because they provide ‘alternative 
explanations’. A recent study also reported how ‘competing demands’ and ‘alternative 
explanation' comorbidities (including IBS/diverticular diseases) can be associated with longer 
diagnostic intervals 105, but their effects on emergency presentations were previously 
unknown.  
The in-depth analysis for study 3.2 has shown that the relationship between comorbidities and 
emergency presentations is complex, with different mechanisms possibly coming into play, 
which is in line with the available literature 11 31 54 55 57 111 112. By shedding light on comorbidity-
specific effects on emergency presentations and characterizing higher risk groups, the study 
findings can inform interventions aimed at optimizing diagnostic strategies and health services 
in order to reduce emergency cancer diagnoses. For complex patients, such as those with 
comorbidities, greater integration between primary and secondary care and more extensive 
use of multi-disciplinary diagnostic centres can be particularly important.  
 
Strengths and Limitations 
The strengths of the research presented in this thesis include the use of population-based data 
providing detailed information on symptoms, comorbidities and benign diagnoses recorded 
prospectively pre-cancer diagnosis and the comparison between emergency and non-
emergency presentations defined according to validated methodologies4. Missing information 
on routes to diagnosis and socio-demographic characteristics were negligible thanks to the 
high quality of the data sources. Moreover, the study cohort was comparable to colorectal 
cancer patients in the Cancer Registry not linked to CPRD in terms of demographic 
characteristics. The work conducted for this thesis has demonstrated the usefulness of linked 
cancer registration and primary care data (such as CPRD) for early diagnosis research.  
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A further strength of the project is the use of potential-outcome or counterfactual approaches 
in addition to standard epidemiological methods. Standard methods included Poisson 
regression to examine variations in consultation rates for relevant symptoms over the 5 years 
pre-cancer diagnosis, and mixed effects multivariable logistic regression for examining the risk 
of emergency presentations by patient and tumour characteristics and clinical history, with 
random effects to account for clustering of patients by GP practice.  
As traditional epidemiological methods can lead to biased results when using observational 
data for estimating average effects in the population, due to non-comparability of examined 
groups, the concept of potential outcomes was applied to overcome this possible limitation74-
76. Potential-outcome approaches are particularly valuable for primary care and public health 
research77 to clarify the relevance of the issue under examination79-81 and to critically consider 
the complex relationships between exposures and outcomes. Overall, potential-outcome 
methods corroborated the results obtained through standard multivariable analyses, further 
strengthening the research findings.  
The critical review of the literature on the role of comorbidities allowed me to propose a 
comprehensive conceptual framework illustrating how pre-existing chronic diseases can act 
through different and sometimes contrasting mechanisms and influence the diagnostic process 
at multiple stages of the diagnostic pathway. Specific strengths include the integration of the 
available evidence from quantitative and qualitative studies, and the consideration of disease, 
patient, healthcare provider and system factors.  
The critical review approach also has limitations. In particular, differently from systematic 
reviews, it lacks explicit and standard tools for guiding the review process and evaluating the 
evidence96. While I have attempted to address this limitation by following a systematic 
methodology and assessing the quality of the evidence using the Mixed Methods Appraisal 
Tool82, future studies would benefit from tools and guidance specifically developed for critical 
reviews. This would ensure consistent quality when performing and reporting this type of 
reviews. 
The longitudinal data-linkage studies included in this thesis also have some limitations. Clinical 
records on symptomatic presentations do not fully reflect all symptoms experienced by 
patients. However, this can be assumed to apply equally to emergency and non-emergency 
presenters. CPRD are electronic versions of case notes and thus only include information 
reported by patients (either spontaneously, or elicited by the doctors as part of history taking 
during the consultation) and considered relevant by doctors. While routine data sources may 
contain inaccuracies, the validity of diagnostic coding and consultation rates in CPRD has been 
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extensively confirmed63 66. Sometimes doctors record information only in free-text format 
rather than READ codes113, but I did not have access to free-text information and this might 
have led to an underestimation of symptoms. Interviews with patients/doctors could be used 
to verify the validity and improve accuracy, but this was beyond the purpose of the present 
work. Similarly, I lacked data on patient experience which could provide important insights. 
The possibility of linking CPRD records to patient experience data could be considered in future 
studies to overcome this limitation. 
Similarly, the examined comorbidities reflect those recorded by the doctor in primary or 
secondary care. There is likely under-recording particularly of less serious comorbidities. 
Severity of comorbidities, social complexities, as well as psychological and behavioural factors 
might also play a role in influencing emergency cancer diagnoses, but the data-sets used for 
this thesis did not provide such information.  
In this thesis I used an epidemiological population-based approach to profile variations in risk 
and identify groups at increased risk of emergency presentations, offering insights on potential 
opportunities for earlier diagnosis. It has not been possible to evaluate the specific 
contributions of various patient factors (for example, missing follow-up visits or refusing 
invasive investigations) and healthcare factors (delays in diagnostic work-up, waiting time to 
access specialist investigations, previous tests with normal/borderline results). Further 
quantitative and qualitative studies are needed to gain additional insights into the doctor-
patient interactions preceding the emergency cancer diagnoses and the clinical management 
of symptomatic patients. These could include an analysis of prescriptions, referrals and type 
and timing of investigations performed before an emergency cancer diagnosis. 
The study should be extended to more recent cancer cohorts and to other cancer sites with a 
relatively high proportion of emergency diagnoses (e.g. lung cancer) in order to provide further 
up-to-date evidence on opportunities for reducing emergency presentations in patients 
affected by different cancers. 
 
 
Moving forward taking the research findings and previous evidence into account 
Implications for policy and practice 
Overall, the research I have conducted for this thesis has revealed that the vast majority of 
individuals diagnosed with colorectal cancer as an emergency have had primary care 
consultations during the year before the cancer diagnosis, refuting the hypothesis that 
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emergency presenters are a patient group with reduced access to primary care. This is also in 
line with other studies36 44 99. However, less than half of emergency presenters had records of 
relevant symptoms and one in five had typical alarm symptoms 2-12 months pre-cancer 
diagnosis1. This indicates that opportunities for earlier diagnosis were present in a subgroup of 
patients. Typical alarm symptoms were associated with a lower risk of emergency cancer 
diagnosis, while this was not the case for less specific symptoms. Proximal cancers, 
comorbidities, the oldest and youngest age groups and female gender were associated with 
higher primary care consultation rates with relevant symptoms and also with an increased risk 
of emergency cancer diagnosis. The findings suggest that diagnostic complexities, due to 
tumour factors (cancer sub-site and symptoms) and patient factors (comorbidity, age, sex) play 
an important role in contributing to emergency presentations. 
The central role of diagnostic complexities in influencing emergency presentations, rather than 
patients’ inadequate use of primary care services or poor performance of some GPs, is also 
supported by other studies. Research on emergency presentations for a variety of conditions 
(from injuries to chronic diseases)114 has shown that people with higher emergency attendance 
had higher primary care consultation rates, contradicting a common believe that people use 
emergency services instead of primary care. Moreover, multimorbidity explained much of the 
association between social deprivation and emergency attendance; patient experience with 
primary care was not associated with emergency attendance, once multimorbidity was taken 
into account. According to a recent survey by the King’s Fund115, an increasing number of 
patients with complex conditions access emergency services and the authors suggest that 
emergency presentations in general are mostly explained by patient complexity and longevity 
rather than by poor primary care performance114. Likewise, some studies evaluating variations 
of emergency presentations for lung and colorectal cancer by GP practices found no evidence 
of an association with practice characteristics116 117. This highlights how rather than being a 
problem affecting specific practices, emergency presentations need to be viewed as a system-
wide issue, where patient and tumour related complexities interact with healthcare system 
factors in primary and secondary care. As shown by the work I have conducted for the present 
project and by other recent publications31 99 118 emergency presenters are not a homogeneous 
category and multifaceted coordinated efforts are needed addressing different population 
sub-groups and the clinical and organizational factors contributing to their increased risk.  
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Approaches for addressing the diagnostic complexities associated with emergency 
presentations 
Notable efforts and resources have been invested over the last decade in the UK and 
internationally to improve early cancer diagnosis for symptomatic patients108 119 acting at 
multiple levels. These include extensive population awareness campaigns to improve prompt 
help-seeking for possible cancer symptoms; initiatives in the primary care setting to facilitate 
differential diagnosis and access to diagnostic investigations, with the development and 
dissemination of clinical decision support tools120 121 , new NICE guidelines and the promotion 
of more rapid cancer referral pathways122. These efforts have been useful in shortening the 
diagnostic intervals for patients with typical ‘alarm’ symptoms123. Less has been done to 
address the challenge of diagnosing cancer earlier in approximately half of the individuals with 
cancer initially presenting with non-specific symptoms124. Recent efforts have however been 
dedicated to bridging this gap125, for example through multidisciplinary diagnostic centres125-
128. 
While emergency presentations are decreasing, 23% of colorectal cancers (and one in three 
colon cancers) are still diagnosed through this route6 34, with a proportion of cases occurring in 
patients who have seen their GP with alarm symptoms. In my Study 11, one in five emergency 
presenters had GP records of alarm symptoms; moreover, my studies 2 and 3 have shown that 
proximal cancers, female gender and comorbidities despite being associated with more 
frequent consultations with relevant symptoms increased the risk of emergency presentations, 
suggesting that opportunities for earlier diagnosis are more likely to be missed in such 
subgroups.  
A recent in depth case-note review study118 reported that among emergency presenters who 
had previously seen their GP with relevant symptoms, 30% had an emergency diagnosis while 
awaiting a secondary care appointment; 19% experienced a genuine missed opportunity for 
earlier investigation (which occurred more frequently in women than men); and only a small 
minority of patients had refused or did not attend follow-up appointments or investigations.  
Conceptual models and frameworks on diagnostic safety31 60 129 130 can be helpful for 
considering potential areas of improvement. They highlight how system and cognitive factors 
can contribute to diagnostic delays, with missed opportunities potentially occurring during the 
different phases of the diagnostic process (initial assessment; diagnostic test performance and 
interpretation; follow-up and coordination)60. 
In the following section I will discuss possible areas of improvement, taking previous evidence 
into account.   
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Timely referrals and prompt access to diagnostic services  
The available evidence highlights the need of more timely specialist referrals and prompt 
access to diagnostic investigations, as well as systematic use of safety-netting, dedicating 
particular attention to higher risk groups. The dual role of the GP as a patient advocate and as 
a gatekeeper can create tension131  and can influence timely cancer diagnosis, as suggested by 
ecologic studies showing that healthcare systems with a strong GP gatekeeper role have 
poorer cancer survival compared to other systems132. Approaches need to be developed that 
can mitigate the negative effects and at the same time sustain the advantages of such systems.  
 
Diagnostic capacity, advances in technologies and tailored diagnostic strategies 
Advances in diagnostic technologies, organizational factors and diagnostic capacity in primary 
and secondary care are key elements that need to be considered for improving early cancer 
diagnosis and reducing emergency presentations. A study on upper gastrointestinal endoscopy 
use has shown that patients from primary care practices in England with the highest 
endoscopy rates had fewer emergency admissions, compared to practices with the lowest 
endoscopy rates133. Recent innovations in diagnostic technologies can be especially important 
and their prompt implementation in clinical practice should be facilitated in parallel with a 
continuous evaluation of their population-level impact. For example, according to recent 
research91 134 135 and NICE guidelines21, quantitative FIT can be useful for patients presenting in 
primary care with abdominal symptoms in order to identify those who might benefit from 
further investigations. While FIT is not currently recommended at national level for patients 
with cancer alarm symptoms, who should be investigated following the urgent referral 
pathways, ongoing studies are investigating its potential benefits also for higher risk groups136.     
Efforts should especially focus on subgroups of the population at increased risk of delayed 
cancer diagnosis, due to non-specific symptoms and/or patient characteristics (age, sex, 
comorbidities), by developing targeted diagnostic strategies and guidelines. For example, 
guidelines consider the need of specific testing strategies in middle-aged women with a recent 
diagnosis of IBS, in order to reduce the risk of delayed ovarian cancer diagnosis. In fact, new 
onset IBS in middle-aged women is an indication for CA125 testing according to NICE 
guidelines21; yet new onset IBS is not currently considered a clear indication for quantitative 
faecal haemoglobin testing (FIT) for supporting early colorectal cancer diagnosis in middle-
aged individuals.  
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Similarly, a recent study137 has shown major differences between men and women in 
sensitivity and diagnostic performance of flexible sigmoidoscopy and various colonoscopy 
referral strategies, suggesting that specific approached for men and women might be 
indicated.  
 
 
Multidisciplinary diagnostic centres 
Multi-disciplinary diagnostic centres for accelerating the diagnostic process for patients with 
low risk and non-specific symptoms have recently been developed in England and Denmark125-
128. The benefits (and potential harms in terms of over-diagnosis/overtreatment) for specific 
patient groups accessing these centres will have to be evaluated, as well as the population-
level impact in terms of diagnostic timeliness and possible effects on inequalities. Initial 
reports from Denmark show promising results127 128, however access to these centres might 
vary by patients’ clinical and socio-demographic characteristics and GP referral procedures and 
criteria; there might also be system-wide effects with potential shifting of resources from 
other diagnostic pathways. Notwithstanding the need to prospectively evaluate the benefits 
and possible unintended consequences, multi-disciplinary centres could be particularly useful 
in the case of complex clinical presentations due to coexisting chronic diseases. 
 
Decision support tools  
Even though the majority of individuals who develop cancer are affected by pre-existing long 
term conditions, limited attention has been dedicated to improving diagnostic approaches 
specifically for these complex patients92 93 103. The available decision-support tools are based on 
simple algorithms108, while more sophisticated systems that take advantage of artificial 
intelligence might be necessary to provide more effective support in the case of complex 
patients.  
 
Interplay between system factors and cognitive factors  
The interplay between system factors and cognitive and psychological factors in influencing 
doctors’ decision-making regarding referrals and investigations also need to be considered in 
order to reduce possible missed opportunities and improve diagnostic timeliness. Doctors have 
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to balance the risk of missing or delaying a cancer diagnosis with using often scares and costly 
diagnostic resources wisely119 138. In some circumstances this might lead to diagnostic delays 
and diagnostic errors. Individual tolerance for clinical uncertainty, access to services and 
cognitive bias can all play a role139. There is only limited evidence on the impact of system-
related interventions to reduce diagnostic errors138. However, some interventions addressing 
the working environment associated with errors (including time pressure and fatigue) and 
interventions centred on improved information technology140 and greater patient involvement 
have shown promising results138 141.   
 
Patient involvement and safety-netting 
More active and systematic involvement of patients in the diagnostic process should be 
encouraged as it can be a low-cost intervention with possible benefits across diagnostic 
pathways. Patients can play a central role in contributing to safety-netting142 and preventing 
diagnostic delays. By sharing the diagnostic plan with patients and clearly communicating 
when there is uncertainty and that multiple visits or investigations might be needed to reach a 
diagnosis, patients might feel more empowered to raise diagnostic concerns and prompt the 
healthcare provider to think comprehensively about differential diagnoses. Moreover, giving 
patients easy and timely access to their medical records and inviting them to take a more pro-
active role in tracking and following-up their test results might contribute to safety-netting and 
preventing delays in cancer diagnosis107 142. 
Increasing attention has been dedicated to patient-centred care, but this has mainly focused 
on screening and treatment decisions, while shared decision-making during the diagnostic 
process has been relatively neglected143. In the context of diagnostic decision-making there is 
often considerable uncertainty on benefits and harms (in terms of possible complications, 
overdiagnosis and anxiety associated with different testing strategies), particularly for complex 
patients. Moreover, clinicians have to find a balance between the desire to reassure patients 
who are at low risk of having a malignant disease and the need not to miss a timely cancer 
diagnosis119. Sharing diagnostic decisions with patients is often difficult and there is little 
specific advice on how to achieve this. While some general recommendations have been 
published107 142 as part of safety-netting approaches, more specific advice and support is 
needed. Considering the limited time available during a typical GP visit, greater support from 
specifically trained nurses, involving them in the coordination and provision of diagnostic and 
safety-netting activities, could help reduce some of the GP workload. 
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Organizational innovations and integration of services 
There is no evidence of an impact of national cancer strategies on reducing socio-economic 
inequalities in cancer survival in England144, which calls for the development of more effective 
interventions specifically aimed at higher risk groups. In addition to encouraging prompt help-
seeking in case of possible cancer symptoms through cancer awareness campaigns, there is a 
need to improve the ability of health services to deal with patients with complex socio-
demographic and clinical characteristics. GPs have recently highlighted how the current 8-10 
minute appointment is insufficient for managing complex cases and have advocated 
organizational innovations in response to the increasing pressure in primary care145-147. These 
include closer integration between primary, secondary and social services. Greater support 
from non-medical staff, including specialized nurses and administrative personnel, is also 
needed to allow the doctor to dedicate more time to clinical decision-making and 
communication with patients.   
It is worth noting that, in addition to interventions for improving early diagnosis in 
symptomatic patients, optimizing screening for colorectal cancer and reducing inequalities in 
screening uptake will also be important, as detecting more asymptomatic cancers might 
reduce the incidence of emergency presentations31. 
 
A 'systems thinking' approach to address the complexities of emergency presentation 
Besides specific interventions, in order to address complex health problems such as diagnosing 
cancer earlier and reducing emergency presentations there is the need to adopt a 'systems 
thinking' approach148, which acknowledges that 'every intervention, from the simplest to the 
most complex, has an effect on the overall system, and the overall system has an effect on 
every intervention'. System thinking has recently been adopted to tackle complex problems 
such as obesity and tobacco control148. It allows to first analyse the system building blocks 
(including various stakeholders, technologies and medicines, service delivery, financing, 
information, governance and human resources) and their mutual influences and 
interconnectedness; it then uses this information to design and evaluate interventions that 
take into account the system level effects. Anticipating positive, negative and non-linear 
effects, as well as synergies and possible unintended consequences of interventions on various 
components of the system is paramount to optimizing the delivery and quality of healthcare. 
For example, a recent Australian trial of a complex intervention to reduce time to cancer 
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diagnosis failed to show an impact149, not only because of the limited follow-up, but possibly 
also because it focused on patient awareness campaigns and GP education on risk assessment 
and referral pathways, without addressing other crucial system factors including timely access 
to specialist and diagnostic services. 
 
Implications for research 
In this thesis I used an epidemiological population-based approach to profile variations in risk 
and identify groups at increased risk of emergency presentations, offering insights on potential 
opportunities for earlier diagnosis.  Further research is needed to examine the specific 
contribution of patient factors (for example, missing follow-up visits or refusing invasive 
investigations) and healthcare factors (including delays in diagnostic work-up, waiting time to 
access specialist investigations, previous tests with normal/borderline results). Studies based 
on detailed reviews of individual cases50 118 and qualitative interview studies39 can be useful to 
disentangle the specific contributions of different patient and healthcare factors and increase 
our understanding of the underlying mechanisms. Despite being very onerous and therefore 
typically limited to relatively small sample sizes, they can complement findings from 
population-based epidemiological studies, like those included in this thesis, in order to provide 
a more comprehensive picture and inform the development of strategies for reducing 
emergency presentation at population level. 
Further population-based research using routinely collected primary and secondary care data 
would be necessary focusing on the type and timing of diagnostic investigations performed 
during the months pre-cancer diagnosis, taking socio-demographic factors, symptoms and 
comorbidities into account.  
Research efforts should also be dedicated to the development of risk-assessment tools for 
supporting diagnostic decision-making in primary care in the case of patients with specific pre-
existing chronic morbidities who also present with possible cancer symptoms. The available 
decision-support tools are based on simple algorithms108, while more sophisticated systems 
that take advantage of artificial intelligence might be necessary in the case of complex 
patients. 
Evidence is also needed on the cost/benefits and long-term effects on healthcare utilization of 
interventions aimed at reducing emergency cancer diagnoses. A recent study has suggested 
that redirecting diagnoses from emergency presentation to non-emergency routes can 
produce large benefits for patients, against modest additional costs to the National Health 
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System150. Studies should also consider the effectiveness and cost/benefits of different 
diagnostic strategies and models of organization of health services for improving the timeliness 
of cancer diagnosis for the large number of individuals with chronic diseases. Such evidence 
would also be important to inform the development of appropriate guidelines that account for 
patient complexities due to comorbidities, age and gender. Current guidelines typically pay 
little attention to the presence of co-existing conditions151.  
There is also little evidence on how to take patient priorities and values into account in 
situations of diagnostic uncertainty in order to provide patient-centred care, especially in the 
case of patients with complex healthcare needs151.  
International comparisons using individual-level data on diagnostic pathways, taking tumour, 
patient and healthcare factors into account, would also be important to shed light on the role 
of healthcare system factors in influencing emergency presentations.  
 
Conclusions 
In conclusion, by adopting a population-based approach using linked electronic health records 
covering the months and years pre-cancer diagnosis, the project has allowed to profile 
variations in risk and identify groups at increased risk of emergency presentations, offering 
insights on potential opportunities for earlier diagnosis.   
The work included in this thesis has provided novel insights on the distinct influence of host 
factors (age, sex, comorbidities) and tumour/disease factors (presenting symptoms and 
tumour sub-sites) on the risk of emergency diagnosis of colorectal cancer, suggesting potential 
responsible mechanisms that can be targeted by future interventions. The findings indicated 
that complex clinical presentations, due to non-specific symptoms, comorbidities, benign 
diagnoses and demographic factors can play an important role in influencing emergency 
cancer diagnoses.  
While emergency presentations present a complex multi-factorial problem with an important 
contribution from tumour factors, optimising the contribution of patient and healthcare 
system factors is possible and can be a promising approach that can further minimise the 
percentage of patients diagnosed as emergencies. System-wide approaches, including greater 
integration between primary and secondary care, multidisciplinary diagnostic centres, the use 
of novel diagnostic technologies and organizational innovations might help to seize the 
opportunities for earlier diagnosis where those are present, and reduce emergency 
presentations.  
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Appendix 
 
Additional figure referring to Chapter 1- Backgrounds, aims and methods 
overview 
 
Flow diagram of Routes to diagnosis algorithm. Source: NCIN Technical Supplement, available 
at http://www.ncin.org.uk/publications/data_briefings/routes_to_diagnosis 
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Additional findings referring to Chapter 3 - Inequalities in emergency 
cancer diagnosis: a longitudinal data-linkage study 
 
I have initially analysed variations in consultation patterns and emergency presentations by 
socio-demographic characteristics on the total sample of 5745 colon and 3234 rectal cancer 
patients diagnosed in England between2005-2010 with linked CPRD data. I have presented the 
findings as an oral presentation at the 10th Annual Meeting of the Cancer and Primary Care 
Research International (Ca-PRI) Network, Edinburgh, 18th–20th April 2017: “Variations of 
primary care consultations and symptoms by socio-demographic patient characteristics and 
impact on emergency colorectal cancer diagnosis: A longitudinal data-linkage study in 
England”, by Renzi C, Lyratzopoulos G, Rachet B. 
Table 1 shows the characteristics of the colon and rectal cancer patients. 
 
Table 1: Diagnosis of cancer after Emergency Presentation (EP)  by socio-demographic 
characteristics and cancer sub-site (N=8,979) 
  Colon Cancer     Rectal Cancer   
  Non-EP  EP Total p-value  Non-EP  EP Total p-value 
  N=3931 N= 1814 N=5745   N=2729 N= 505 N=3234  
    % %  N     %  % N   
Gender           
Men  70.3 29.7 2946 0.001  85.9 14.2 1943 0.005 
Women  66.4 33.6 2799   82.2 17.8 1291  
Age (years)          
18-59  66.5 33.5 845 <0.001  89.5 10.5 589 <0.001 
60-69  77.0 23.1 1375   88.7 11.3 856  
70-79  72.0 28.0 1878   84.8 15.2 1019  
80+  58.2 41.8 1647   75.2 24.8 770 
SES (deprivation quintile)      
   
 
1 (least deprived#) 71.1 28.9 1317 <0.001 88.2 11.8 705 <0.001 
2  68.0 32.0 1255  
 
86.7 13.3 716  
3  70.0 30.0 1179  
 
86.7 13.4 674  
4  67.2 32.8 1044  
 
79.1 20.9 604  
5 (most deprived) 61.7 38.3 702  
 
77.3 22.7 396  
Cancer sub-site     
 
    
colon proximal 67.9 32.1 2801 <0.001 
 
    
colon distal 71.2 28.8 2339  
 
    
colon unspecified 60.0 40.0 605  
 
    
rectum             84.4 15.6 3234   
Distal colon: splenic flexure, descending and sigmoid colon. Proximal colon: transverse and 
ascending colon.   
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Emergency presentations occurred in 31.6% of colon cancers and 15.6% of rectal cancer patients 
(Figure 1), with significantly higher risks for women, the youngest and oldest age groups and the 
most deprived categories (Figure 2). 
 
Figure 1: Routes to diagnosis 
 
 
 
Figure 2: Emergency cancer diagnosis by socio-demographic characteristics 
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Examining GP consultation rates during the year pre-cancer diagnosis has shown that women 
and older individuals had significantly higher consultation rates for colorectal symptoms in the 
pre-diagnostic year (Table 2).  
Table 2: Incidence rate ratios (IRR) for GP consultations with relevant symptoms during the 
year before CRC diagnosis (excluding 30 days before CRC) (N=8,979) 
  Colon Cancer Rectal Cancer 
  IRR 95% CI p-value IRR 95% CI p-value 
During the pre-diagnostic year (excluding 30 days pre-diagnosis)    
Gender         
Men 1       1    
Women 1.45 1.28 1.64 0.000 1.75 1.48 2.08 0.000 
Age (years)        
18-59 1.10 0.89 1.35 0.378 1.18 0.91 1.53 0.201 
60-69 1    1    
70-79 1.11 0.94 1.32 0.223 1.40 1.11 1.75 0.004 
80+ 1.82 1.53 2.17 0.000 1.72 1.34 2.20 0.000 
SES (deprivation quintile)        
1 (least deprived#) 1       1    
2 1.11 0.92 1.33 0.275 0.86 0.67 1.11 0.251 
3 1.06 0.88 1.27 0.547 1.18 0.92 1.52 0.202 
4 1.29 1.07 1.57 0.008 1.15 0.89 1.48 0.296 
5 (most deprived) 1.19 0.95 1.48 0.123 1.34 1.00 1.80 0.054 
Year of diagnosis        
2005-2006 1    1    
2007-2008 0.92 0.79 1.07 0.274 1.06 0.86 1.31 0.574 
2009-2010 0.90 0.77 1.05 0.182 0.84 0.69 1.03 0.094 
During the 6 months pre-diagnosis       
Gender         
Men 1       1    
Women 1.28 1.12 1.46 0.000 1.80 1.50 2.15 0.000 
Age (years)        
18-59 1.13 0.91 1.40 0.265 1.42 1.08 1.85 0.011 
60-69 1    1    
70-79 1.17 0.98 1.40 0.085 1.72 1.36 2.18 0.000 
80+ 1.56 1.30 1.89 0.000 1.81 1.40 2.34 0.000 
SES (deprivation quintile)        
1 (least deprived#) 1    1    
2 0.97 0.80 1.18 0.758 0.98 0.75 1.27 0.862 
3 1.15 0.94 1.39 0.177 1.20 0.92 1.56 0.179 
4 1.15 0.93 1.41 0.196 1.26 0.95 1.66 0.104 
5 (most deprived) 1.05 0.84 1.32 0.665 1.01 0.74 1.38 0.938 
Year of diagnosis        
2005-2006 1    1    
2007-2008 0.95 0.81 1.12 0.560 0.75 0.60 0.93 0.008 
2009-2010 0.90 0.76 1.06 0.194 0.68 0.54 0.84 0.000 
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At multivariable analysis emergency diagnosis was more likely in women than men in the case 
of colon cancer, independently of consultations and symptom history, while gender was not 
significantly associated with emergency presentations for rectal cancers. Patients aged 80 or 
more compared to 60-69 years and the most deprived group also had an increased risk of 
emergency presentation among both colon and rectal cancer patients. 
 
Table 3: Multivariable logistic regression Odds Ratios (OR) for colon and rectal cancers 
diagnosed after Emergency Presentation (EP) compared to non-EP (N=8,979)  
  Colon Cancer Rectal Cancer 
  OR 95% CI p-value OR 95% CI p-value 
Gender         
Men 1    1    
Women 1.15 1.02 1.29 0.021 1.18 0.96 1.44 0.107 
Age (years)         
18-59 1.75 1.42 2.15 0.000 0.98 0.69 1.39 0.918 
60-69 1    1    
70-79 1.39 1.19 1.63 0.000 1.31 0.98 1.75 0.069 
80+ 2.54 2.14 3.02 0.000 2.23 1.69 2.96 0.000 
SES (deprivation quintile)         
1 (least deprived#) 1    1    
2 1.17 0.99 1.39 0.062 1.08 0.80 1.47 0.616 
3 1.05 0.88 1.27 0.569 1.12 0.81 1.54 0.488 
4 1.18 0.98 1.42 0.076 1.92 1.44 2.57 0.000 
5 (most deprived) 1.50 1.22 1.83 0.000 2.09 1.50 2.90 0.000 
N. visits during the year before CRC (excluding month before CRC)    
 1.00 0.99 1.00 0.275 1.01 1.00 1.02 0.017 
Symptoms recorded during the year before CRC (excluding month before CRC)   
Anaemia  0.47 0.39 0.55 0.00 0.76 0.45 1.27 0.289 
Change bowel habits 0.30 0.21 0.42 0.00 0.32 0.20 0.51 0.00 
Rectal bleeding  0.27 0.21 0.35 0.00 0.25 0.17 0.36 0.00 
Symptoms recorded 25-60 months before CRC diagnosis     
Anaemia  1.52 1.14 2.04 0.00 2.14 1.29 3.53 0.00 
Change bowel habits 0.93 0.49 1.77 0.826 1.08 0.43 2.72 0.862 
Rectal bleeding  0.76 0.50 1.16 0.203 1.00 0.61 1.64 0.997 
Year of diagnosis         
2005-2006 1        
2007-2008 0.81 0.70 0.94 0.006 0.79 0.62 1.02 0.068 
2009-2010 0.80 0.69 0.92 0.003 0.80 0.64 1.01 0.066 
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Additional figure and table referring to Chapter 5- The complex 
landscape of emergency cancer diagnoses: what have we learned and 
how can we move forward 
 
 
Proportion of colorectal cancers by diagnostic route between 2006 and 2015 in England. 
Source: https://data.healthdatainsight.org.uk/apps/routes_to_diagnosis/route_breakdown 
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Proportion of colorectal cancers diagnosed as an emergency between 2006 and 2015 in 
England. Source: https://www.cancerdata.nhs.uk/routestodiagnosis 
 
 
